Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",A1BG,Alpha-1B-glycoprotein,13612,142,2.25 [0.90-5.68],0.0845000590089126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AAMDC,Mth938 domain-containing protein,13218,134,0.98 [0.72-1.33],0.887236625519726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AARSD1,Alanyl-tRNA editing protein Aarsd1,15572,159,0.99 [0.78-1.27],0.9563314639435664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABCA2,ATP-binding cassette sub-family A member 2,13163,138,0.94 [0.60-1.48],0.7836965546712074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABHD14B,Protein ABHD14B,15471,156,0.96 [0.75-1.22],0.7344253340997032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABL1,Tyrosine-protein kinase ABL1,15572,159,0.98 [0.80-1.21],0.8642601009054455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABO,Histo-blood group ABO system transferase,13597,143,1.03 [0.92-1.15],0.6513780980843062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ABRAXAS2,BRISC complex subunit Abraxas 2,13163,138,1.06 [0.83-1.35],0.6224843181775607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",15268,155,1.15 [0.98-1.35],0.0956676348575211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",13310,143,1.07 [0.87-1.31],0.5179921330950483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",13588,144,1.06 [0.88-1.26],0.5478754706759831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACAN,Aggrecan core protein,15501,155,1.28 [0.78-2.11],0.3311268291898644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACE,Angiotensin-converting enzyme,13597,143,0.74 [0.40-1.37],0.3373318697511041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACE2,Angiotensin-converting enzyme 2,15372,156,1.05 [0.79-1.40],0.7445917776063606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACHE,Acetylcholinesterase,13289,138,0.91 [0.54-1.51],0.7100159914280284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACOT13,Acyl-coenzyme A thioesterase 13,13524,142,1.04 [0.90-1.19],0.6117793916916197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,15635,156,0.92 [0.69-1.23],0.575869190995264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP1,Low molecular weight phosphotyrosine protein phosphatase,13206,139,0.99 [0.69-1.41],0.9560973677654442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP5,Tartrate-resistant acid phosphatase type 5,15699,160,1.20 [0.78-1.84],0.4014404478063682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACP6,Lysophosphatidic acid phosphatase type 6,15757,157,0.99 [0.80-1.23],0.950068220735312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACRBP,Acrosin-binding protein,13509,145,1.25 [0.85-1.83],0.2510438775931098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACRV1,Acrosomal protein SP-10,13206,139,1.01 [0.64-1.59],0.9759414961112616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACSL1,Long-chain-fatty-acid--CoA ligase 1,13163,138,0.81 [0.49-1.32],0.3896091565241493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTA2,"Actin, aortic smooth muscle",15372,156,1.23 [0.93-1.63],0.1382387111406653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTN2,Alpha-actinin-2,13163,138,0.99 [0.73-1.34],0.949023250288504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACTN4,Alpha-actinin-4,15330,154,1.12 [0.73-1.70],0.6103942987229345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACVRL1,Serine/threonine-protein kinase receptor R3,15502,157,1.67 [0.95-2.96],0.0769392253365764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACY1,Aminoacylase-1,15635,156,1.10 [0.88-1.38],0.4176897748398225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,13163,138,1.06 [0.80-1.42],0.6787168793018097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ACYP1,Acylphosphatase-1,13235,137,1.02 [0.80-1.31],0.84725715267355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADA,Adenosine deaminase,15813,160,1.21 [0.83-1.77],0.3243825576611459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADA2,Adenosine deaminase 2,15523,154,1.02 [0.72-1.44],0.9011876482058844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,13206,139,1.03 [0.67-1.58],0.8895047896446521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,15372,156,0.94 [0.59-1.50],0.7945935648135447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,15529,157,1.19 [0.79-1.79],0.4137187624109734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,15813,160,1.03 [0.69-1.54],0.8926898187266625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,15759,160,1.32 [0.80-2.20],0.2764748095523893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,13524,142,0.98 [0.57-1.68],0.941904980628703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,13206,139,1.36 [0.90-2.06],0.1421913180852995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,15834,160,1.33 [0.72-2.46],0.3626131741485345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,15572,159,1.30 [0.94-1.80],0.1136591720585823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,15372,156,1.44 [1.04-1.99],0.0279938338968326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,13206,139,0.95 [0.60-1.49],0.8161866151103524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,15681,158,1.14 [0.84-1.56],0.3915883099223912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL2,ADAMTS-like protein 2,13569,142,0.94 [0.56-1.59],0.8295894478028589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL4,ADAMTS-like protein 4,13218,134,0.65 [0.32-1.32],0.2377716581706896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADAMTSL5,ADAMTS-like protein 5,13588,144,0.99 [0.66-1.49],0.9712984408368316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,15268,155,1.37 [1.07-1.75],0.01331245010942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADD1,Alpha-adducin,13289,138,1.08 [0.86-1.37],0.5057887709110723
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRB3,Adhesion G protein-coupled receptor B3,15502,157,0.85 [0.56-1.31],0.465770505606753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRD1,Adhesion G-protein coupled receptor D1,13289,138,1.57 [1.03-2.39],0.0374957123555071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE1,Adhesion G protein-coupled receptor E1,13524,142,1.27 [0.96-1.69],0.0924280228074456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE2,Adhesion G protein-coupled receptor E2,15718,156,0.88 [0.54-1.45],0.6219221915963036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRE5,Adhesion G protein-coupled receptor E5,15745,160,0.94 [0.58-1.50],0.7863816451546912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRF5,Adhesion G protein-coupled receptor F5,13588,144,1.03 [0.60-1.74],0.9264003766797086
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRG1,Adhesion G-protein coupled receptor G1,15572,159,0.75 [0.53-1.06],0.1083333593542108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRG2,Adhesion G-protein coupled receptor G2,15635,156,1.40 [0.83-2.37],0.2086903440441315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADGRV1,Adhesion G-protein coupled receptor V1,13169,137,1.02 [0.81-1.28],0.8643192238282705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADH1B,All-trans-retinol dehydrogenase,13289,138,1.01 [0.81-1.25],0.9292390896567206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,15372,156,1.08 [0.92-1.27],0.3355238457948917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADIPOQ,Adiponectin,13612,142,1.00 [0.78-1.27],0.9695422325237546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADM,Pro-adrenomedullin,15780,157,1.37 [0.81-2.32],0.237352394443135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ADRA2A,Alpha-2A adrenergic receptor,13163,138,0.79 [0.61-1.04],0.0937957145920099
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFAP1,Actin filament-associated protein 1,13289,138,1.00 [0.83-1.21],0.9875568809972144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFM,Afamin,13612,142,1.75 [0.74-4.16],0.2057621117281546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AFP,Alpha-fetoprotein,15484,157,1.03 [0.84-1.27],0.7508147498627702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGBL2,Cytosolic carboxypeptidase 2,13169,137,1.18 [0.99-1.41],0.0674051917092451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGER,Advanced glycosylation end product-specific receptor,15610,155,1.31 [0.92-1.87],0.1315757530696513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGR2,Anterior gradient protein 2 homolog,15119,154,1.07 [0.93-1.24],0.3128082165572456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGR3,Anterior gradient protein 3,15244,155,1.22 [0.97-1.54],0.0893626785058396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGRN,Agrin,15718,156,1.41 [0.93-2.12],0.1016496703944936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGRP,Agouti-related protein,15813,160,1.13 [0.87-1.46],0.3593420262838959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGT,Angiotensinogen,13597,143,0.60 [0.27-1.30],0.1952319881177427
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AGXT,Serine--pyruvate aminotransferase,15635,156,1.06 [0.89-1.27],0.4993198170270815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHCY,Adenosylhomocysteinase,15635,156,0.99 [0.81-1.22],0.9293783956993052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHNAK,Neuroblast differentiation-associated protein AHNAK,13218,134,1.74 [1.10-2.74],0.0178289819528281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHNAK2,Protein AHNAK2,13218,134,1.25 [0.71-2.19],0.4446002828586936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,13509,145,1.05 [0.84-1.31],0.6576000470242197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSG,Alpha-2-HS-glycoprotein,13597,143,1.50 [0.83-2.72],0.1817618098521861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AHSP,Alpha-hemoglobin-stabilizing protein,15611,159,0.96 [0.82-1.12],0.5862593887558314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIDA,"Axin interactor, dorsalization-associated protein",13194,139,1.14 [0.97-1.35],0.1032171388334834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIF1,Allograft inflammatory factor 1,15268,155,1.25 [0.95-1.63],0.1091313797128699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIF1L,Allograft inflammatory factor 1-like,13218,134,0.90 [0.66-1.22],0.4838232545133972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",15540,157,1.07 [0.94-1.22],0.310919410217206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AK1,Adenylate kinase isoenzyme 1,15635,156,0.96 [0.77-1.19],0.7122014353807036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AK2,"Adenylate kinase 2, mitochondrial",13545,141,1.06 [0.91-1.23],0.4507632954093443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKAP12,A-kinase anchor protein 12,13289,138,0.72 [0.32-1.60],0.4167413809381127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1B1,Aldo-keto reductase family 1 member B1,15268,155,1.08 [0.90-1.30],0.3945833373668349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1B10,Aldo-keto reductase family 1 member B10,13194,139,1.07 [0.82-1.40],0.5945809569896741
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR1C4,Aldo-keto reductase family 1 member C4,15372,156,1.02 [0.79-1.31],0.9038701055276934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKR7L,Aflatoxin B1 aldehyde reductase member 4,13206,139,1.03 [0.83-1.28],0.7937980081515315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT1S1,Proline-rich AKT1 substrate 1,15248,155,1.17 [0.95-1.45],0.1400450941633198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT2,RAC-beta serine/threonine-protein kinase,13571,143,1.05 [0.92-1.19],0.4915184824495231
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AKT3,RAC-gamma serine/threonine-protein kinase,15193,154,1.03 [0.80-1.32],0.8162452645988474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALCAM,CD166 antigen,15834,160,2.02 [1.02-4.01],0.0443198359231451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH1A1,Retinal dehydrogenase 1,15634,160,1.05 [0.82-1.35],0.7095523430369428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH2,"Aldehyde dehydrogenase, mitochondrial",13509,145,0.85 [0.60-1.21],0.3647742787321771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",15603,159,1.17 [0.96-1.43],0.1090295008639833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",13571,143,0.94 [0.67-1.33],0.7269842344653759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALMS1,Alstrom syndrome protein 1,13310,143,1.01 [0.72-1.42],0.9482994240915982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALPI,Intestinal-type alkaline phosphatase,13206,139,1.01 [0.88-1.15],0.9385696369555648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ALPP,"Alkaline phosphatase, placental type",15572,159,1.00 [0.89-1.14],0.9393025558811832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMBN,Ameloblastin,15330,154,0.53 [0.28-0.97],0.0400578595620623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMBP,Protein AMBP,15763,157,1.85 [0.90-3.78],0.0937970980807237
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,13569,142,0.79 [0.42-1.47],0.4534066665585986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMFR,E3 ubiquitin-protein ligase AMFR,15248,155,1.09 [0.89-1.34],0.3997472743965262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMIGO1,Amphoterin-induced protein 1,13194,139,1.06 [0.78-1.42],0.7165691106721499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMIGO2,Amphoterin-induced protein 2,15572,159,0.97 [0.52-1.81],0.9255333731684898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMN,Protein amnionless,15330,154,0.97 [0.72-1.30],0.8233815346769124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMOT,Angiomotin,13289,138,0.95 [0.65-1.39],0.7816655142969773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMOTL2,Angiomotin-like protein 2,13471,144,1.15 [0.85-1.55],0.3779723686748922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMPD3,AMP deaminase 3,13545,141,1.00 [0.81-1.25],0.971380349898926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,12749,138,0.90 [0.63-1.28],0.555736762766818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY2A,Pancreatic alpha-amylase,15040,156,0.86 [0.63-1.17],0.3363904977852189
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMY2B,Alpha-amylase 2B,14567,150,0.81 [0.59-1.10],0.1791431707019998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANG,Angiogenin,15569,155,1.10 [0.74-1.64],0.6442258923616953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPT1,Angiopoietin-1,15593,153,1.10 [0.93-1.30],0.2748076794302764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPT2,Angiopoietin-2,15780,157,1.18 [0.83-1.67],0.3579306483733295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL1,Angiopoietin-related protein 1,15420,153,0.80 [0.50-1.30],0.3781157199253837
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL2,Angiopoietin-related protein 2,15670,156,0.74 [0.52-1.06],0.0991923150335424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL3,Angiopoietin-related protein 3,15626,155,0.97 [0.66-1.43],0.8690035737593952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL4,Angiopoietin-related protein 4,15693,156,0.98 [0.72-1.33],0.8831447729559921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANGPTL7,Angiopoietin-related protein 7,15780,157,0.81 [0.56-1.18],0.2760262922210278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANK2,Ankyrin-2,13163,138,0.93 [0.73-1.18],0.549397811973984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,13206,139,0.97 [0.79-1.20],0.7964127511821507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKRA2,Ankyrin repeat family A protein 2,13103,139,0.91 [0.67-1.23],0.5527485749794943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANKRD54,Ankyrin repeat domain-containing protein 54,15268,155,1.01 [0.79-1.29],0.926970816403072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,13218,134,0.87 [0.56-1.33],0.5133923868624782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANPEP,Aminopeptidase N,15638,154,1.47 [0.92-2.35],0.1064585829678576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA1,Annexin A1,13207,137,0.89 [0.61-1.30],0.5489269478752354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA10,Annexin A10,15248,155,1.05 [0.88-1.25],0.5993473417575301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA11,Annexin A11,15598,160,0.99 [0.80-1.22],0.9268609092118292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA2,Annexin A2,13017,132,1.20 [0.97-1.49],0.0948702525413657
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA3,Annexin A3,15759,160,1.01 [0.83-1.22],0.9594202389147428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA4,Annexin A4,15549,155,1.01 [0.83-1.23],0.8998136578369931
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ANXA5,Annexin A5,15197,154,1.14 [0.72-1.79],0.5801558192863607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AOC1,Amiloride-sensitive amine oxidase [copper-containing],15330,154,1.16 [0.93-1.45],0.1754971531791564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AOC3,Membrane primary amine oxidase,15672,155,1.28 [0.81-2.04],0.2937130755926496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP1G2,AP-1 complex subunit gamma-like 2,13509,145,0.98 [0.81-1.20],0.8696895031960418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP2B1,AP-2 complex subunit beta,13194,139,1.12 [0.82-1.54],0.4724563974695567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP3B1,AP-3 complex subunit beta-1,13524,142,1.14 [0.93-1.40],0.2051781844778845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AP3S2,AP-3 complex subunit sigma-2,13545,141,0.98 [0.70-1.39],0.928535992114088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,15572,159,1.03 [0.76-1.39],0.8545427549618482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APCS,Serum amyloid P-component,13496,141,1.62 [1.03-2.54],0.0366282045767217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,15732,156,0.97 [0.76-1.23],0.7971082980088693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APLP1,Amyloid-like protein 1,15635,156,0.97 [0.74-1.27],0.8155868342137469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA1,Apolipoprotein A-I,13612,142,0.69 [0.37-1.30],0.2523771636254821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA2,Apolipoprotein A-II,13597,143,0.71 [0.51-0.99],0.0455950090436618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOA4,Apolipoprotein A-IV,13612,142,1.12 [0.74-1.70],0.6014557556147533
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOB,Apolipoprotein B-100,13597,143,0.57 [0.29-1.12],0.1026899336318433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOBR,Apolipoprotein B receptor,13218,134,0.91 [0.62-1.33],0.616703756893815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOC1,Apolipoprotein C-I,13581,142,1.07 [0.70-1.65],0.7499862959717785
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOD,Apolipoprotein D,12970,137,0.81 [0.52-1.26],0.3600045910545633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOE,Apolipoprotein E,13612,142,1.05 [0.86-1.27],0.6580696948316138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOF,Apolipoprotein F,13597,143,0.95 [0.50-1.81],0.8714193423742567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOH,Beta-2-glycoprotein 1,15634,160,1.04 [0.70-1.54],0.8532625318603511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOL1,Apolipoprotein L1,13597,143,1.04 [0.82-1.31],0.750084437323808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APOM,Apolipoprotein M,15650,155,1.06 [0.62-1.82],0.821158602503827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APP,Amyloid-beta precursor protein,15605,160,1.22 [0.99-1.49],0.0584021660785274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APPL2,DCC-interacting protein 13-beta,13289,138,0.98 [0.85-1.13],0.7637497014828748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APRT,Adenine phosphoribosyltransferase,15508,157,0.91 [0.68-1.21],0.4995191507016023
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARAF,Serine/threonine-protein kinase A-Raf,13310,143,1.00 [0.79-1.26],0.9795073123086104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AREG,Amphiregulin,15572,159,0.80 [0.59-1.07],0.1272504308388836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARF6,ADP-ribosylation factor 6,13524,142,1.06 [0.91-1.24],0.4432527418067428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARFIP1,Arfaptin-1,13571,143,0.96 [0.76-1.21],0.7324833363436952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARG1,Arginase-1,15565,156,0.89 [0.69-1.16],0.3994150750032218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARG2,"Arginase-2, mitochondrial",13509,145,1.10 [0.79-1.52],0.5781200299193536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP1,Rho GTPase-activating protein 1,15268,155,1.10 [0.81-1.49],0.55786933165204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP25,Rho GTPase-activating protein 25,15268,155,0.99 [0.78-1.26],0.9311119538158033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP30,Rho GTPase-activating protein 30,13310,143,1.09 [0.74-1.60],0.6545160926917739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP45,Rho GTPase-activating protein 45,13289,138,0.98 [0.80-1.19],0.8143851573923988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGAP5,Rho GTPase-activating protein 5,13103,139,1.17 [0.97-1.42],0.1062724583610588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF1,Rho guanine nucleotide exchange factor 1,13545,141,1.03 [0.86-1.23],0.7412483699219281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF10,Rho guanine nucleotide exchange factor 10,13571,143,0.98 [0.82-1.16],0.7893908706850211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF12,Rho guanine nucleotide exchange factor 12,15623,160,1.01 [0.89-1.16],0.8348229610169126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARHGEF5,Rho guanine nucleotide exchange factor 5,13169,137,0.83 [0.66-1.06],0.1396922583288543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARID3A,AT-rich interactive domain-containing protein 3A,13169,137,0.94 [0.62-1.42],0.7624072578226645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARID4B,AT-rich interactive domain-containing protein 4B,15248,155,1.04 [0.75-1.44],0.8244937267345935
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARL13B,ADP-ribosylation factor-like protein 13B,13163,138,1.04 [0.83-1.30],0.7467791663115847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,13163,138,1.14 [0.77-1.70],0.517727947917068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARMCX2,Armadillo repeat-containing X-linked protein 2,13169,137,1.14 [0.92-1.41],0.2243236503118165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARNT,Aryl hydrocarbon receptor nuclear translocator,15330,154,1.36 [1.00-1.87],0.0524226510997652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,13163,138,1.06 [0.80-1.40],0.7011561301887206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARSA,Arylsulfatase A,15634,160,1.05 [0.77-1.43],0.7710563820538091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARSB,Arylsulfatase B,15572,159,1.24 [0.97-1.59],0.0830307565226679
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ART3,Ecto-ADP-ribosyltransferase 3,15672,155,1.07 [0.69-1.65],0.7764776138110167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ART5,Ecto-ADP-ribosyltransferase 5,13169,137,1.01 [0.78-1.30],0.9660558660593804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ARTN,Artemin,15330,154,0.97 [0.71-1.34],0.8712300748100467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASAH1,Acid ceramidase,13458,141,1.18 [0.86-1.63],0.2992773124687264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASAH2,Neutral ceramidase,15529,157,0.97 [0.74-1.26],0.7961161321657819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASGR1,Asialoglycoprotein receptor 1,15529,157,0.92 [0.57-1.50],0.7403042957283171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASGR2,Asialoglycoprotein receptor 2,13597,143,1.34 [0.72-2.49],0.3532634640938531
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASPN,Asporin,13588,144,1.07 [0.60-1.90],0.823166464544824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASPSCR1,Tether containing UBX domain for GLUT4,13571,143,1.10 [0.87-1.38],0.4352184570932018
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASRGL1,Isoaspartyl peptidase/L-asparaginase,13218,134,1.01 [0.85-1.18],0.9380652948697956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ASS1,Argininosuccinate synthase,13163,138,1.06 [0.86-1.29],0.596308612108522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATF2,Cyclic AMP-dependent transcription factor ATF-2,15248,155,1.10 [0.93-1.31],0.2691840165717321
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATF4,Cyclic AMP-dependent transcription factor ATF-4,13103,139,1.47 [0.99-2.18],0.0569834832438299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATG16L1,Autophagy-related protein 16-1,13524,142,0.99 [0.82-1.20],0.9416482248671804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATG4A,Cysteine protease ATG4A,15268,155,1.00 [0.79-1.27],0.9925619099055056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATOX1,Copper transport protein ATOX1,15681,158,1.06 [0.87-1.28],0.571609211913603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,13163,138,0.86 [0.59-1.25],0.417440609252692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,13163,138,1.02 [0.61-1.69],0.9481634988034
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,13163,138,1.13 [0.78-1.62],0.5148415922687559
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP1B4,Protein ATP1B4,13103,139,0.87 [0.58-1.30],0.4928344275925636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP2B4,Plasma membrane calcium-transporting ATPase 4,13163,138,0.95 [0.73-1.24],0.7241234050491009
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5F1D,"ATP synthase subunit delta, mitochondrial",13163,138,0.88 [0.62-1.24],0.4529870544104041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5IF1,"ATPase inhibitor, mitochondrial",15718,156,0.98 [0.87-1.11],0.7695362159802681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5PO,"ATP synthase subunit O, mitochondrial",15248,155,1.14 [0.85-1.51],0.3818111422825344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6AP2,Renin receptor,15268,155,1.62 [1.31-2.00],7.174107044725061e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1D,V-type proton ATPase subunit D,15572,159,0.70 [0.39-1.23],0.2138464776998768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1F,V-type proton ATPase subunit F,15218,155,1.01 [0.82-1.25],0.9169745896546356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1G1,V-type proton ATPase subunit G 1,13218,134,0.96 [0.77-1.21],0.7441682870067582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP6V1G2,V-type proton ATPase subunit G 2,13163,138,0.96 [0.81-1.14],0.6357625226915993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATRAID,All-trans retinoic acid-induced differentiation factor,13524,142,1.14 [0.71-1.81],0.5871851814053642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATRN,"Attractin, Isoform 2",13612,142,2.80 [1.05-7.42],0.0388574640160118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN10,Ataxin-10,15248,155,1.01 [0.83-1.23],0.9226765725997932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN2,Ataxin-2,13169,137,1.15 [1.02-1.29],0.024924374042675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN2L,Ataxin-2-like protein,13571,143,1.10 [0.81-1.50],0.5413499047073025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATXN3,Ataxin-3,13545,141,1.01 [0.78-1.30],0.9596964894991457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AXIN1,Axin-1,15623,160,1.01 [0.87-1.17],0.9001883789311019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AXL,Tyrosine-protein kinase receptor UFO,15672,155,1.39 [0.84-2.31],0.2024450127215631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZI2,5-azacytidine-induced protein 2,13571,143,1.05 [0.79-1.40],0.7246363143498393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZU1,Azurocidin,15136,158,0.97 [0.81-1.16],0.7149468533063928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B2M,Beta-2-microglobulin,13612,142,1.26 [0.88-1.81],0.2128984663027453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,13163,138,1.04 [0.47-2.29],0.917433906002959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",13218,134,1.57 [1.00-2.47],0.0495415742724574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B4GALT1,"Beta-1,4-galactosyltransferase 1",15718,156,1.06 [0.63-1.78],0.8171573504534874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",B4GAT1,"Beta-1,4-glucuronyltransferase 1",15634,160,0.99 [0.55-1.77],0.9701418564667968
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BABAM1,BRISC and BRCA1-A complex member 1,13206,139,1.09 [0.64-1.86],0.7500228039844862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BACH1,Transcription regulator protein BACH1,15623,160,0.95 [0.78-1.15],0.5777517781173733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG3,BAG family molecular chaperone regulator 3,15502,157,1.00 [0.71-1.43],0.9807463807413568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG4,BAG family molecular chaperone regulator 4,13206,139,1.00 [0.73-1.39],0.9828236989848352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAG6,Large proline-rich protein BAG6,15372,156,1.05 [0.72-1.56],0.7885721289176348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,15268,155,1.01 [0.81-1.27],0.910617011027446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAMBI,BMP and activin membrane-bound inhibitor homolog,15268,155,1.47 [0.95-2.26],0.0846109471371531
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BANK1,B-cell scaffold protein with ankyrin repeats,15623,160,1.01 [0.88-1.15],0.9100781081401476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAP18,Chromatin complexes subunit BAP18,13545,141,0.92 [0.72-1.18],0.4940306857167835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BATF,Basic leucine zipper transcriptional factor ATF-like,13194,139,0.94 [0.77-1.15],0.5361368459167242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAX,Apoptosis regulator BAX,15222,154,1.06 [0.91-1.24],0.458380480187149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAM,Basal cell adhesion molecule,15634,160,1.05 [0.58-1.88],0.8827218875407585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAN,Brevican core protein,15529,157,0.93 [0.61-1.42],0.7387124963374464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",13588,144,0.97 [0.57-1.65],0.9197803163075408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",13169,137,0.57 [0.38-0.85],0.0062816505214418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCHE,Cholinesterase,13334,140,1.85 [1.03-3.33],0.0395285888230092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2,Apoptosis regulator Bcl-2,13524,142,0.93 [0.67-1.28],0.6507270666090333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L1,Bcl-2-like protein 1,13545,141,1.03 [0.88-1.21],0.6909446978322518
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",15623,160,1.16 [0.85-1.58],0.3575056100684709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL2L15,Bcl-2-like protein 15,13206,139,1.04 [0.80-1.36],0.772130028684598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL7A,B-cell CLL/lymphoma 7 protein family member A,13103,139,1.01 [0.78-1.30],0.941708493616536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCL7B,B-cell CLL/lymphoma 7 protein family member B,13509,145,1.25 [0.94-1.67],0.1283689528606191
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCR,Breakpoint cluster region protein,15623,160,1.05 [0.90-1.22],0.5547667321604279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BDNF,Brain-derived neurotrophic factor,13569,142,1.17 [0.96-1.42],0.1272206891001198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BECN1,Beclin-1,13218,134,1.01 [0.77-1.33],0.9239552253253556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BEX3,Protein BEX3,13103,139,0.99 [0.70-1.39],0.932995293642232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGLAP,Osteocalcin,13569,142,0.97 [0.81-1.16],0.7585083439171438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGN,Biglycan,15249,155,0.95 [0.84-1.07],0.3979126831025031
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BHLHE40,Class E basic helix-loop-helix protein 40,13169,137,0.74 [0.57-0.97],0.0305546009189204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,13163,138,0.98 [0.52-1.83],0.9513183967118544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BID,BH3-interacting domain death agonist,15623,160,0.94 [0.76-1.16],0.569131067247543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BIN2,Bridging integrator 2,15634,160,0.96 [0.83-1.12],0.6377889549040772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BIRC2,Baculoviral IAP repeat-containing protein 2,15268,155,1.19 [0.96-1.48],0.1193177393413606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLMH,Bleomycin hydrolase,15834,160,0.99 [0.65-1.51],0.9565002414876452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLNK,B-cell linker protein,13206,139,0.99 [0.64-1.54],0.970097240696758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,13169,137,1.09 [0.89-1.33],0.4266107711153651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,13545,141,1.03 [0.70-1.53],0.8734182458357342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLVRB,Flavin reductase,15634,160,1.02 [0.83-1.25],0.8593689804377429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP10,Bone morphogenetic protein 10,13289,138,0.75 [0.42-1.31],0.3103817864900259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP4,Bone morphogenetic protein 4,15502,157,0.86 [0.62-1.19],0.3552778044138877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMP6,Bone morphogenetic protein 6,15344,156,1.02 [0.73-1.42],0.9203533037440642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BMPER,BMP-binding endothelial regulator protein,13289,138,1.62 [0.85-3.08],0.1415085888656423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,13588,144,1.04 [0.65-1.64],0.8824503812459554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,13206,139,1.04 [0.73-1.49],0.8218771944416117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOC,Brother of CDO,15372,156,1.87 [1.04-3.36],0.0372375517884775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOLA1,BolA-like protein 1,13169,137,0.97 [0.72-1.30],0.8189699934822507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BOLA2_BOLA2B,BolA-like protein 2,13218,134,1.02 [0.76-1.36],0.9156089569544276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFA2,BPI fold-containing family A member 2,12732,133,0.83 [0.71-0.98],0.0250465305532041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFB1,BPI fold-containing family B member 1,15618,159,1.02 [0.82-1.27],0.8600495869530408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BPIFB2,BPI fold-containing family B member 2,13563,143,1.01 [0.80-1.29],0.9259982129505396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRAP,BRCA1-associated protein,13412,142,1.06 [0.91-1.23],0.4333290415555511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD1,Bromodomain-containing protein 1,13310,143,0.82 [0.48-1.42],0.4884419743805629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD2,Bromodomain-containing protein 2,13169,137,1.12 [0.70-1.78],0.6464560879255905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD3,Bromodomain-containing protein 3,13163,138,0.89 [0.62-1.28],0.5356883572976454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRDT,Bromodomain testis-specific protein,13163,138,1.09 [0.70-1.68],0.7086381798551842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRK1,Protein BRICK1,15248,155,1.34 [0.98-1.84],0.0640993809157369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRME1,Break repair meiotic recombinase recruitment factor 1,13169,137,1.01 [0.69-1.47],0.966576634242708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRSK2,Serine/threonine-protein kinase BRSK2,13571,143,1.08 [0.73-1.60],0.6932611176916379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BSG,Basigin,15783,159,1.56 [0.75-3.26],0.2327751200976051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BSND,Barttin,13103,139,1.08 [0.69-1.68],0.7484805454768084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,15780,160,0.88 [0.67-1.15],0.3340721291915681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BST2,Bone marrow stromal antigen 2,15780,160,1.04 [0.81-1.34],0.7376246346015616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTC,Probetacellulin,15268,155,0.96 [0.79-1.17],0.6752590742201019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTD,Biotinidase,13612,142,2.09 [0.95-4.59],0.0670455633392588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTLA,B- and T-lymphocyte attenuator,13103,139,1.10 [0.95-1.28],0.206054895275896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN1A1,Butyrophilin subfamily 1 member A1,13485,145,0.92 [0.62-1.37],0.6943396463484457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN2A1,Butyrophilin subfamily 2 member A1,15718,156,1.64 [0.95-2.82],0.0778077509111371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN3A2,Butyrophilin subfamily 3 member A2,15623,160,1.07 [0.74-1.56],0.7130673921479255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTNL10,Butyrophilin-like protein 10,13103,139,1.08 [0.73-1.58],0.7010682653475844
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C19orf12,Protein C19orf12,15248,155,0.90 [0.70-1.15],0.3865434337498478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1GALT1C1,C1GALT1-specific chaperone 1,13163,138,0.97 [0.59-1.61],0.9179929914501764
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QA,Complement C1q subcomponent subunit A,15728,159,0.78 [0.43-1.42],0.419571112673862
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",13571,143,1.17 [0.97-1.41],0.0914669818259949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QL2,Complement C1q-like protein 2,13206,139,0.78 [0.52-1.15],0.2104379133265974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,15672,155,0.96 [0.68-1.34],0.8016815466653485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,13289,138,1.07 [0.69-1.64],0.7680906939911871
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,13571,143,0.87 [0.52-1.44],0.5861830619873638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,13262,137,0.78 [0.57-1.08],0.1301060851483827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1R,Complement C1r subcomponent,13612,142,1.35 [0.67-2.74],0.4042073955335206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1RL,Complement C1r subcomponent-like protein,13590,141,2.24 [0.96-5.23],0.0626536572950299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1S,Complement C1s subcomponent,13612,142,1.36 [0.63-2.94],0.4291229581811738
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2,Complement C2,15650,155,1.11 [0.60-2.08],0.7329062532486694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2CD2L,Phospholipid transfer protein C2CD2L,15218,155,1.22 [0.92-1.63],0.1641338268129529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C2orf69,UPF0565 protein C2orf69,13194,139,1.17 [0.93-1.48],0.1855073820833053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C3,Complement C3,12914,137,0.89 [0.61-1.30],0.5443598474666168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C4BPB,C4b-binding protein beta chain,15681,158,1.07 [0.76-1.51],0.6830122280156272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C5,Complement C5,13612,142,1.21 [0.43-3.35],0.718147897169515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7,Complement component C7,13296,138,0.70 [0.42-1.16],0.1703088809144006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7orf50,Uncharacterized protein C7orf50,13545,141,0.94 [0.48-1.86],0.8627268993777388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C8B,Complement component C8 beta chain,13612,142,1.86 [1.10-3.16],0.0207706726282226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C9,Complement component C9,13597,143,0.96 [0.69-1.33],0.8082070761478084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C9orf40,Uncharacterized protein C9orf40,13524,142,0.99 [0.82-1.19],0.8935538548585058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA1,Carbonic anhydrase 1,15259,155,1.07 [0.86-1.34],0.5482690735996829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA11,Carbonic anhydrase-related protein 11,15268,155,0.99 [0.64-1.55],0.9736640817959186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA12,Carbonic anhydrase 12,15572,159,1.21 [0.80-1.82],0.3694564173927355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA13,Carbonic anhydrase 13,15447,154,1.04 [0.91-1.19],0.5826886283943875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA14,Carbonic anhydrase 14,15780,157,1.25 [0.83-1.88],0.2945350278694951
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA2,Carbonic anhydrase 2,15588,158,0.97 [0.80-1.18],0.793122473838826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA3,Carbonic anhydrase 3,15807,160,1.09 [0.88-1.36],0.4104018196417609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA4,Carbonic anhydrase 4,15834,160,1.07 [0.59-1.92],0.8338910930721201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA5A,"Carbonic anhydrase 5A, mitochondrial",15372,156,1.00 [0.85-1.16],0.9640555266747024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA6,Carbonic anhydrase 6,15587,160,0.93 [0.74-1.15],0.4879737531222096
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA7,Carbonic anhydrase 7,13310,143,0.92 [0.58-1.49],0.7472012671214232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA8,Carbonic anhydrase-related protein,13206,139,1.13 [0.64-2.00],0.6816129636552274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CA9,Carbonic anhydrase 9,15780,157,0.90 [0.65-1.26],0.5431420776074957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CABP2,Calcium-binding protein 2,13194,139,1.17 [0.93-1.45],0.1752231703379415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,13169,137,0.60 [0.33-1.07],0.0824231533935921
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,13163,138,0.93 [0.69-1.25],0.618570251144561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,13169,137,0.96 [0.72-1.26],0.7537266196931671
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,13571,143,1.05 [0.87-1.26],0.6384551433160133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CACYBP,Calcyclin-binding protein,13257,138,0.97 [0.83-1.14],0.7196674217173815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CADPS,Calcium-dependent secretion activator 1,13194,139,1.05 [0.74-1.47],0.796636037895786
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALB1,Calbindin,15572,159,0.88 [0.63-1.22],0.4389292593601644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALB2,Calretinin,15248,155,1.13 [0.71-1.81],0.6044723106016627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCA,Calcitonin,15499,157,0.96 [0.75-1.25],0.7745541193023253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCB,Calcitonin gene-related peptide 2,13545,141,1.21 [0.84-1.73],0.3004129210223774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,15734,157,0.97 [0.84-1.11],0.6384523196827403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,13218,134,0.96 [0.78-1.20],0.7422743464564087
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CALY,Neuron-specific vesicular protein calcyon,13163,138,0.58 [0.34-0.99],0.0477148903870901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,15268,155,0.97 [0.71-1.34],0.866970759789654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,13194,139,1.15 [0.88-1.52],0.3082883220115366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,13571,143,0.98 [0.85-1.14],0.8230932198408631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CANT1,Soluble calcium-activated nucleotidase 1,15600,156,1.88 [0.94-3.77],0.0746768276884378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPG,Macrophage-capping protein,15539,154,0.98 [0.77-1.25],0.8766173292641365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPN3,Calpain-3,13509,145,0.69 [0.42-1.15],0.1565089905755295
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPS,Calcyphosin,13545,141,1.00 [0.83-1.19],0.9698119212255558
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CARHSP1,Calcium-regulated heat-stable protein 1,15248,155,1.03 [0.79-1.35],0.8067444470557845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASC3,Protein CASC3,13194,139,1.17 [0.80-1.70],0.4174164229432201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP1,Caspase-1,15248,155,0.98 [0.79-1.21],0.8250278874656567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP10,Caspase-10,15248,155,0.91 [0.75-1.11],0.3431510930322615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP2,Caspase-2,15623,160,1.01 [0.82-1.24],0.922239419159252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP3,Caspase-3,15834,160,1.01 [0.86-1.18],0.9044945194244194
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP4,Caspase-4,13310,143,0.96 [0.87-1.06],0.4677274516596182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP7,Caspase-7,13545,141,1.09 [0.90-1.32],0.3785024169992866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP8,Caspase-8,15740,157,0.92 [0.74-1.16],0.4876569659902988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASP9,Caspase-9,13206,139,1.06 [0.82-1.35],0.6680723735419444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CASQ2,Calsequestrin-2,13163,138,0.88 [0.61-1.27],0.4948392026085429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAT,Catalase,13383,141,1.00 [0.75-1.34],0.99430793686609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLIF,Cobalamin binding intrinsic factor,15613,156,0.82 [0.67-0.99],0.0388220591649726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLN1,Cerebellin-1,13169,137,1.00 [0.84-1.18],0.953470488444472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBLN4,Cerebellin-4,15780,157,1.15 [0.74-1.78],0.5252856021002166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBS,Cystathionine beta-synthase,13218,134,0.89 [0.63-1.25],0.5080319351060203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CBX2,Chromobox protein homolog 2,13163,138,1.12 [0.78-1.61],0.5368066374614111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,15529,157,1.00 [0.83-1.21],0.9788250311117056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCAR2,Cell cycle and apoptosis regulator protein 2,13545,141,1.08 [0.84-1.40],0.5577184090114107
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC134,Coiled-coil domain-containing protein 134,13509,145,1.15 [0.85-1.57],0.3685934514966413
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC28A,Coiled-coil domain-containing protein 28A,13194,139,0.65 [0.37-1.13],0.1282575510421254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC50,Coiled-coil domain-containing protein 50,13571,143,0.91 [0.73-1.13],0.401112941382006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCDC80,Coiled-coil domain-containing protein 80,15635,156,1.32 [0.89-1.98],0.1715181537109585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,13218,134,1.10 [0.84-1.44],0.474327938865976
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL11,Eotaxin,15813,160,1.67 [1.17-2.37],0.0044392286044176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL13,C-C motif chemokine 13,15785,160,1.25 [1.03-1.52],0.0238123364897705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL14,C-C motif chemokine 14,15569,155,1.11 [0.78-1.58],0.5589958419001251
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL15,C-C motif chemokine 15,15834,160,1.19 [0.88-1.62],0.2541964394501445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL16,C-C motif chemokine 16,15834,160,1.13 [0.86-1.48],0.386603924053414
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL17,C-C motif chemokine 17,15612,156,1.14 [0.98-1.33],0.0979220226181199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL18,C-C motif chemokine 18,15401,155,1.04 [0.86-1.26],0.6586071813181966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL19,C-C motif chemokine 19,15780,160,1.06 [0.95-1.17],0.2955892184817249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL2,C-C motif chemokine 2,15502,157,1.20 [0.93-1.56],0.157110635844378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL20,C-C motif chemokine 20,15813,160,1.07 [0.92-1.25],0.3686693208170062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL21,C-C motif chemokine 21,15718,156,1.16 [0.85-1.59],0.3456372418971998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL22,C-C motif chemokine 22,15475,155,1.11 [0.85-1.46],0.4532767980527113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL23,C-C motif chemokine 23,15718,156,1.05 [0.75-1.48],0.7750489451610783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL24,C-C motif chemokine 24,15693,156,1.11 [0.94-1.31],0.2041164360609935
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL25,C-C motif chemokine 25,15813,160,1.24 [0.94-1.63],0.1249507640135653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL26,C-C motif chemokine 26,15623,160,1.08 [0.94-1.25],0.2701930038531631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL27,C-C motif chemokine 27,15635,156,1.27 [1.00-1.60],0.0498529686355048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL28,C-C motif chemokine 28,15579,159,1.02 [0.80-1.29],0.899635908332104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL3,C-C motif chemokine 3,15623,160,1.19 [1.00-1.42],0.0458593835951696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL4,C-C motif chemokine 4,15661,156,1.25 [1.06-1.48],0.0096501833879257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL5,C-C motif chemokine 5,15672,155,1.05 [0.92-1.21],0.4469031867906611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL7,C-C motif chemokine 7,15623,160,1.21 [1.00-1.48],0.0559931004882202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCL8,C-C motif chemokine 8,15763,157,1.11 [0.88-1.40],0.3760645484310039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN1,CCN family member 1,15552,159,1.18 [0.99-1.41],0.0720470107973894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN2,CCN family member 2,15653,155,1.19 [0.93-1.50],0.1608857544234874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN3,CCN family member 3,15814,160,1.36 [0.92-2.01],0.121308485477203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN4,CCN family member 4,15780,157,1.11 [0.79-1.55],0.5593381326974546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCN5,CCN family member 5,15634,160,0.85 [0.60-1.22],0.3830072110565001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCND2,G1/S-specific cyclin-D2,13310,143,1.16 [0.75-1.79],0.5063627164642858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCNE1,G1/S-specific cyclin-E1,13206,139,1.11 [0.97-1.27],0.1218173726827348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCS,Copper chaperone for superoxide dismutase,15529,157,0.94 [0.70-1.26],0.6746052957503408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCT5,T-complex protein 1 subunit epsilon,15268,155,1.06 [0.78-1.43],0.7103918275297446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD101,Immunoglobulin superfamily member 2,13524,142,1.44 [0.99-2.11],0.0568035070975605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD109,CD109 antigen,15634,160,0.99 [0.65-1.50],0.9623315300532338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD14,Monocyte differentiation antigen CD14,15266,155,1.26 [0.90-1.76],0.1846634852756633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD160,CD160 antigen,15813,160,1.10 [0.80-1.49],0.564701009823016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD163,Scavenger receptor cysteine-rich type 1 protein M130,15672,155,1.12 [0.81-1.55],0.5055336114860038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD164,Sialomucin core protein 24,15634,160,1.28 [0.86-1.91],0.2192572143377978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD164L2,CD164 sialomucin-like 2 protein,13194,139,0.92 [0.59-1.43],0.7147729871449362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD177,CD177 antigen,15607,160,1.01 [0.90-1.12],0.9277797091072566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD1C,T-cell surface glycoprotein CD1c,15681,158,1.16 [0.64-2.13],0.6240133186339596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD2,T-cell surface antigen CD2,13163,138,0.71 [0.43-1.18],0.1829298197166509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD200,OX-2 membrane glycoprotein,15623,160,0.98 [0.57-1.69],0.9328555132029386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD200R1,Cell surface glycoprotein CD200 receptor 1,15571,160,0.90 [0.60-1.37],0.6306669244116054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD207,C-type lectin domain family 4 member K,15332,156,1.16 [0.80-1.69],0.4270907884440653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD209,CD209 antigen,15674,159,1.12 [0.78-1.61],0.5455688344159615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD22,B-cell receptor CD22,15813,160,1.21 [0.86-1.71],0.2727376749261899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD226,CD226 antigen,13206,139,1.28 [0.86-1.88],0.2208999087769839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD244,Natural killer cell receptor 2B4,15813,160,1.21 [0.72-2.02],0.4768907781257969
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD248,Endosialin,13569,142,0.83 [0.55-1.24],0.3620020858109529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD27,CD27 antigen,15681,158,1.05 [0.73-1.51],0.7791860992932961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD274,Programmed cell death 1 ligand 1,15529,157,1.17 [0.79-1.73],0.4417646759424046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD276,CD276 antigen,15640,155,1.03 [0.70-1.53],0.8750184117557221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD28,T-cell-specific surface glycoprotein CD28,15268,155,1.10 [0.74-1.63],0.6457668252372906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD2AP,CD2-associated protein,15635,156,1.03 [0.83-1.29],0.7683543236351482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300A,CMRF35-like molecule 8,13289,138,1.46 [0.84-2.56],0.1826578971708415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300C,CMRF35-like molecule 6,15780,160,1.44 [0.96-2.16],0.0789758977540243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300E,CMRF35-like molecule 2,15728,157,1.26 [0.88-1.80],0.2001056932028276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300LF,CMRF35-like molecule 1,15780,157,1.07 [0.84-1.36],0.5715482084789275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD300LG,CMRF35-like molecule 9,15634,160,0.94 [0.65-1.37],0.7440760301585732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD302,CD302 antigen,15572,159,1.23 [0.77-1.97],0.3848135296301423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD33,Myeloid cell surface antigen CD33,15681,158,1.16 [0.97-1.40],0.1048654144983589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD34,Hematopoietic progenitor cell antigen CD34,15720,160,1.12 [0.63-1.98],0.7045060026908352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD36,Platelet glycoprotein 4,13206,139,1.35 [0.95-1.92],0.0963076507566824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,15572,159,1.32 [0.83-2.09],0.2423032608761528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3D,T-cell surface glycoprotein CD3 delta chain,13169,137,0.85 [0.51-1.41],0.5357275555887969
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3E,T-cell surface glycoprotein CD3 epsilon chain,13310,143,0.96 [0.60-1.53],0.8580737330753262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD3G,T-cell surface glycoprotein CD3 gamma chain,13206,139,0.88 [0.71-1.09],0.2340826406753869
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD4,T-cell surface glycoprotein CD4,15599,160,1.25 [0.82-1.90],0.2924997800063224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD40,Tumor necrosis factor receptor superfamily member 5,15636,156,0.99 [0.75-1.32],0.9636093996905084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD40LG,CD40 ligand,15813,160,1.07 [0.89-1.28],0.4585932126838877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD46,Membrane cofactor protein,15511,154,1.33 [0.83-2.13],0.2392471393538487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD48,CD48 antigen,15693,156,0.84 [0.52-1.38],0.4964704848624186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD5,T-cell surface glycoprotein CD5,15763,157,1.05 [0.68-1.62],0.8154160333541904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD55,Complement decay-accelerating factor,15061,145,1.36 [0.81-2.28],0.2458082427031818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD58,Lymphocyte function-associated antigen 3,15611,155,1.13 [0.50-2.51],0.7724567231691137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD59,CD59 glycoprotein,15038,156,1.47 [0.78-2.75],0.2323871531427874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD5L,CD5 antigen-like,13534,141,1.00 [0.70-1.41],0.979514836584708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD6,T-cell differentiation antigen CD6,15783,159,1.21 [0.93-1.57],0.1485322357107097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD63,CD63 antigen,15502,157,1.14 [0.87-1.49],0.3360838645944221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD69,Early activation antigen CD69,15551,156,1.03 [0.88-1.21],0.733068426262808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD7,T-cell antigen CD7,13184,137,1.15 [0.79-1.67],0.4731628036822782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD70,CD70 antigen,15623,160,0.99 [0.71-1.39],0.9544651061053272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD72,B-cell differentiation antigen CD72,13289,138,1.28 [0.87-1.88],0.2187158879507386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD74,HLA class II histocompatibility antigen gamma chain,15780,160,0.90 [0.60-1.36],0.6273734931202584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD79B,B-cell antigen receptor complex-associated protein beta chain,15813,160,0.95 [0.68-1.32],0.7484562986757417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD80,T-lymphocyte activation antigen CD80,13588,144,1.27 [0.81-2.00],0.3048401447356913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD82,CD82 antigen,13310,143,0.85 [0.56-1.30],0.4632159702760563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD83,CD83 antigen,15623,160,1.30 [0.86-1.97],0.2112845156127074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD84,SLAM family member 5,15623,160,1.14 [0.73-1.79],0.5618678950642058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD86,T-lymphocyte activation antigen CD86,13524,142,1.12 [0.65-1.93],0.6920079376562658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD8A,T-cell surface glycoprotein CD8 alpha chain,15780,160,1.18 [0.88-1.58],0.2586863217693418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD93,Complement component C1q receptor,15024,152,1.34 [0.85-2.10],0.2060810212718499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD99,CD99 antigen,15634,160,1.56 [0.76-3.20],0.2240728075231135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD99L2,CD99 antigen-like protein 2,15634,160,1.60 [0.90-2.84],0.1093491536761502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDA,Cytidine deaminase,13565,143,0.93 [0.66-1.31],0.6870652294589561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDAN1,Codanin-1,13545,141,1.17 [0.61-2.22],0.6408752681177907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC123,Cell division cycle protein 123 homolog,13103,139,1.09 [0.87-1.38],0.4446852886249023
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC25A,M-phase inducer phosphatase 1,13103,139,1.30 [0.95-1.77],0.0990026484139249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC26,Anaphase-promoting complex subunit CDC26,13506,142,1.04 [0.83-1.30],0.7467750111122542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC27,Cell division cycle protein 27 homolog,15268,155,0.97 [0.76-1.23],0.7983217492554474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC37,Hsp90 co-chaperone Cdc37,15681,158,0.99 [0.83-1.17],0.87505593083729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDC42BPB,Serine/threonine-protein kinase MRCK beta,13524,142,1.01 [0.86-1.18],0.8904980958778975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDCP1,CUB domain-containing protein 1,15529,157,1.00 [0.74-1.34],0.9890945197407248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH1,Cadherin-1,15072,144,1.10 [0.78-1.56],0.5796845533431136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH15,Cadherin-15,15750,160,0.94 [0.67-1.32],0.7275129436680423
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH17,Cadherin-17,15635,156,1.04 [0.84-1.28],0.7440028755405215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH2,Cadherin-2,15635,156,1.13 [0.75-1.68],0.5625673842691847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH22,Cadherin-22,13310,143,1.08 [0.63-1.84],0.7879017161830434
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH23,Cadherin-23,13545,141,0.67 [0.35-1.26],0.2100154220858292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH3,Cadherin-3,15780,160,0.99 [0.67-1.47],0.9578714047807428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH4,Cadherin-4,13169,137,1.06 [0.76-1.47],0.7336244542340966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH5,Cadherin-5,15834,160,1.18 [0.75-1.84],0.4790324916988935
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDH6,Cadherin-6,15635,156,1.01 [0.70-1.46],0.9570172030107156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR1,Cadherin-related family member 1,15248,155,0.88 [0.62-1.25],0.4737100251259689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR2,Cadherin-related family member 2,15572,159,0.93 [0.78-1.12],0.4537279858663927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDHR5,Cadherin-related family member 5,15635,156,1.35 [0.92-1.97],0.1262849769282186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDK1,Cyclin-dependent kinase 1,13103,139,0.91 [0.59-1.42],0.6864063722306277
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,13571,143,1.16 [0.91-1.49],0.2294778503184967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKL5,Cyclin-dependent kinase-like 5,13169,137,1.14 [0.86-1.50],0.3688505257290936
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKN1A,Cyclin-dependent kinase inhibitor 1,15572,159,1.02 [0.89-1.17],0.7543912180594616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,15572,159,0.98 [0.84-1.13],0.7569212521712001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDNF,Cerebral dopamine neurotrophic factor,15572,159,1.16 [0.75-1.80],0.5064872173265241
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,15669,156,1.84 [1.09-3.10],0.0223191279499659
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CDSN,Corneodesmosin,15764,159,1.37 [0.99-1.89],0.0576786799670143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,15657,157,1.01 [0.56-1.83],0.9742281478921002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,13524,142,1.24 [1.02-1.51],0.0332296197699282
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,13310,143,0.89 [0.69-1.16],0.393216560098638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,13524,142,1.22 [0.81-1.82],0.3440410085533169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,13310,143,1.34 [1.00-1.81],0.0498916762841307
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,15623,160,0.96 [0.82-1.14],0.6494526338518687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,15268,155,0.86 [0.63-1.18],0.3482391818149757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,15054,154,1.09 [0.87-1.36],0.4516386953580142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,13569,142,1.28 [0.88-1.86],0.2024944480284645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,15372,156,1.08 [0.82-1.43],0.5853378882564595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPA,CCAAT/enhancer-binding protein alpha,13206,139,1.20 [0.87-1.67],0.2652888885564988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPB,CCAAT/enhancer-binding protein beta,15372,156,1.10 [0.77-1.57],0.6084334912514331
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELA2A,Chymotrypsin-like elastase family member 2A,13569,142,0.88 [0.67-1.15],0.3477639206650846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELA3A,Chymotrypsin-like elastase family member 3A,15808,160,0.80 [0.62-1.04],0.0925337346942403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,13289,138,0.84 [0.47-1.50],0.555852228482768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEMIP2,Cell surface hyaluronidase,13206,139,1.02 [0.63-1.63],0.9442614694604554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEND1,Cell cycle exit and neuronal differentiation protein 1,13169,137,0.94 [0.70-1.26],0.6812524205973025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CENPF,Centromere protein F,13310,143,0.93 [0.69-1.25],0.6259956078598445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CENPJ,Centromere protein J,13310,143,1.12 [0.92-1.36],0.2702245335709925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP112,Centrosomal protein of 112 kDa,13163,138,1.02 [0.72-1.43],0.9282166571511328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP152,Centrosomal protein of 152 kDa,13103,139,0.85 [0.57-1.28],0.4405398072380593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP164,Centrosomal protein of 164 kDa,15330,154,1.08 [0.88-1.33],0.4385508289750103
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP170,Centrosomal protein of 170 kDa,13218,134,0.92 [0.74-1.15],0.4785483339795056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP20,Centrosomal protein 20,15268,155,1.03 [0.85-1.24],0.8005961088071288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP290,Centrosomal protein of 290 kDa,13310,143,1.08 [0.82-1.44],0.5776058983239829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP350,Centrosome-associated protein 350,13103,139,0.82 [0.52-1.29],0.3838972221998563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP43,Centrosomal protein 43,15249,155,1.07 [0.87-1.31],0.5276300361311135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP85,Centrosomal protein of 85 kDa,15268,155,0.92 [0.73-1.16],0.4815395482297669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CERT,Ceramide transfer protein,15248,155,0.99 [0.79-1.25],0.9446426816681132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES1,Liver carboxylesterase 1,15663,157,1.02 [0.85-1.22],0.8433229780898492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES2,Cocaine esterase,15572,159,0.88 [0.67-1.15],0.3567997236695091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CES3,Carboxylesterase 3,15572,159,0.96 [0.78-1.19],0.7234255897775652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CETN2,Centrin-2,15248,155,1.08 [0.88-1.33],0.4670008948516747
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CETN3,Centrin-3,13524,142,1.10 [0.90-1.34],0.3724037862888198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFB,Complement factor B,13351,139,1.90 [1.16-3.11],0.0105827061880365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFC1,Cryptic protein,15268,155,1.14 [0.87-1.51],0.3419039359662352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFD,Complement factor D,13612,142,1.07 [0.45-2.55],0.8716616412616189
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFH,Complement factor H,12823,138,2.49 [1.24-5.01],0.0101977569095119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR2,Complement factor H-related protein 2,13514,140,1.05 [0.79-1.41],0.7246344054047036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR4,Complement factor H-related protein 4,13588,142,1.12 [0.89-1.41],0.3241074727302979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR5,Complement factor H-related protein 5,13425,142,1.36 [0.91-2.03],0.1366550607618272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFI,Complement factor I,13612,142,2.81 [1.27-6.20],0.0107835729831342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFP,Properdin,13612,142,1.50 [0.95-2.36],0.0819378211300622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGA,Glycoprotein hormones alpha chain,15634,160,1.27 [1.11-1.46],0.0005924346849675
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,13597,143,1.10 [0.84-1.43],0.4972793209351456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGN,Cingulin,13194,139,0.84 [0.54-1.31],0.4346569382752455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGREF1,Cell growth regulator with EF hand domain protein 1,15635,156,1.15 [0.82-1.62],0.4056438117439027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,15268,155,0.96 [0.76-1.21],0.7341985951685079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHAD,Chondroadherin,13289,138,0.97 [0.71-1.32],0.8398526918301582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",13545,141,1.37 [0.93-2.02],0.1107099196057793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHCHD6,MICOS complex subunit MIC25,13509,145,1.18 [0.72-1.94],0.5067674691464898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHEK2,Serine/threonine-protein kinase Chk2,15372,156,0.93 [0.61-1.41],0.7394928886001737
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHGA,Chromogranin-A,13569,142,1.27 [1.08-1.49],0.0041673190908405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHGB,Secretogranin-1,15717,160,1.16 [0.81-1.66],0.407024335474464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHI3L1,Chitinase-3-like protein 1,15246,153,1.09 [0.90-1.32],0.3992906854884396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHIT1,Chitotriosidase-1,15696,160,1.03 [0.93-1.14],0.5815705263214448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHL1,Neural cell adhesion molecule L1-like protein,15646,155,1.13 [0.74-1.74],0.5720507473234293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHM,Rab proteins geranylgeranyltransferase component A 1,13194,139,1.15 [0.88-1.49],0.3053269209965966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHMP1A,Charged multivesicular body protein 1a,15529,157,0.98 [0.82-1.18],0.854806420260165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHMP6,Charged multivesicular body protein 6,13588,144,1.12 [0.85-1.49],0.418357110511101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHP1,Calcineurin B homologous protein 1,13169,137,1.03 [0.83-1.27],0.798584784510473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRDL1,Chordin-like protein 1,15693,156,1.00 [0.63-1.60],0.9838070276053827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRDL2,Chordin-like protein 2,15635,156,0.79 [0.62-1.00],0.0520395960061094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CHRM1,Muscarinic acetylcholine receptor M1,13194,139,0.80 [0.50-1.30],0.3705190206559264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIAPIN1,Anamorsin,15681,158,1.05 [0.85-1.31],0.6550759388890682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CILP,Cartilage intermediate layer protein 1,13569,142,0.95 [0.70-1.28],0.7164025559182237
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CINP,Cyclin-dependent kinase 2-interacting protein,13310,143,0.96 [0.67-1.37],0.8086414890127063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIRBP,Cold-inducible RNA-binding protein,13524,142,1.08 [0.91-1.28],0.3690790494446367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CIT,Citron Rho-interacting kinase,13194,139,0.90 [0.63-1.30],0.5841469491424967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKAP4,Cytoskeleton-associated protein 4,15726,159,1.17 [0.68-2.01],0.5722422442943588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKB,Creatine kinase B-type,13569,142,0.97 [0.75-1.26],0.8154816678993507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",15578,155,0.98 [0.80-1.19],0.8273553787772149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLASP1,CLIP-associating protein 1,13103,139,1.09 [0.88-1.34],0.4333528766069823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLC,Galectin-10,15615,156,0.99 [0.80-1.22],0.9036727830653232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC10A,C-type lectin domain family 10 member A,15529,157,1.11 [0.75-1.65],0.6063265926007037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC11A,C-type lectin domain family 11 member A,15604,160,0.88 [0.66-1.18],0.394407570953715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC12A,C-type lectin domain family 12 member A,13206,139,1.32 [0.63-2.79],0.4629883425391171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC14A,C-type lectin domain family 14 member A,15634,160,1.26 [0.80-1.96],0.3185595109128283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC1A,C-type lectin domain family 1 member A,15372,156,1.37 [0.88-2.12],0.1578705875430825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC1B,C-type lectin domain family 1 member B,15780,160,1.04 [0.90-1.20],0.6225740567021957
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC2L,C-type lectin domain family 2 member L,13194,139,1.10 [0.83-1.47],0.501348326446553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC3B,Tetranectin,13292,138,2.31 [1.18-4.51],0.014397302002584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4A,C-type lectin domain family 4 member A,15623,160,1.18 [0.78-1.77],0.4400295987662078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4C,C-type lectin domain family 4 member C,15623,160,1.16 [0.86-1.58],0.333281807443323
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4D,C-type lectin domain family 4 member D,15623,160,1.05 [0.84-1.32],0.6637108785040182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4G,C-type lectin domain family 4 member G,15623,160,1.59 [1.05-2.41],0.0269477241006058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC4M,C-type lectin domain family 4 member M,13540,141,0.96 [0.68-1.34],0.797098244904128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC5A,C-type lectin domain family 5 member A,15578,156,1.60 [0.98-2.62],0.0620052285430405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC6A,C-type lectin domain family 6 member A,15268,155,1.14 [0.84-1.55],0.3877513846592305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLEC7A,C-type lectin domain family 7 member A,15813,160,1.17 [0.89-1.54],0.2633906482308545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLGN,Calmegin,13194,139,1.14 [0.80-1.63],0.48135749949278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLIC5,Chloride intracellular channel protein 5,13194,139,0.76 [0.44-1.33],0.3402527431188816
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLINT1,Clathrin interactor 1,13103,139,0.83 [0.56-1.23],0.3527730428136861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLIP2,CAP-Gly domain-containing linker protein 2,15623,160,0.98 [0.87-1.11],0.7856639844284555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLMP,CXADR-like membrane protein,15780,157,1.93 [0.98-3.80],0.0587568430987473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLNS1A,Methylosome subunit pICln,13194,139,0.88 [0.54-1.44],0.6244707028919846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",15499,157,1.02 [0.88-1.18],0.7649868718984715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLPS,Colipase,15611,159,1.09 [0.89-1.34],0.4043252967520959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSPN,Claspin,15218,155,0.88 [0.56-1.37],0.5570522758040726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN1,Calsyntenin-1,15248,155,1.00 [0.76-1.32],0.9792623443951102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN2,Calsyntenin-2,15813,160,1.02 [0.72-1.45],0.9195364528424724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLSTN3,Calsyntenin-3,13545,141,1.22 [0.75-1.99],0.4271005008526762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLTA,Clathrin light chain A,15372,156,1.10 [0.82-1.47],0.5222005598850092
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLU,Clusterin,13612,142,1.03 [0.65-1.64],0.8960221326231552
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLUL1,Clusterin-like protein 1,15613,156,0.89 [0.65-1.21],0.4561352304408476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CMC1,COX assembly mitochondrial protein homolog,13588,144,1.09 [0.91-1.29],0.3598418118585982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CMIP,C-Maf-inducing protein,13509,145,1.03 [0.85-1.25],0.7720430940745052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNDP1,Beta-Ala-His dipeptidase,15672,155,1.05 [0.77-1.44],0.7542098822035939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNGB3,Cyclic nucleotide-gated cation channel beta-3,13169,137,1.01 [0.76-1.35],0.9304528303756432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",13191,134,1.09 [0.89-1.34],0.4135179004682644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNPY2,Protein canopy homolog 2,15372,156,1.15 [0.94-1.40],0.1845186454344268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNPY4,Protein canopy homolog 4,15572,159,1.02 [0.85-1.23],0.7985259743293913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNST,Consortin,15635,156,0.97 [0.85-1.11],0.6826255058683782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTF,Ciliary neurotrophic factor,13169,137,0.87 [0.54-1.41],0.5781856575966369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN1,Contactin-1,15834,160,1.05 [0.63-1.75],0.8483743759206535
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN2,Contactin-2,15780,157,1.03 [0.75-1.41],0.8577858816618481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN3,Contactin-3,15634,160,1.88 [1.25-2.82],0.0025048813576733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN4,Contactin-4,15634,160,2.05 [1.15-3.66],0.0148143408151625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTN5,Contactin-5,15672,159,1.09 [0.74-1.59],0.6595839461256678
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTNAP2,Contactin-associated protein-like 2,15623,160,1.29 [0.92-1.80],0.1457248308036593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CNTNAP4,Contactin-associated protein-like 4,13194,139,1.04 [0.90-1.21],0.5843347165802131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COCH,Cochlin,13588,144,1.22 [0.88-1.69],0.2412508141298858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL15A1,Collagen alpha-1(XV) chain,13569,142,1.18 [0.63-2.22],0.6076393046050079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL18A1,Collagen alpha-1(XVIII) chain,15698,160,1.34 [0.73-2.46],0.3385014567337743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL1A1,Collagen alpha-1(I) chain,15834,160,1.21 [0.70-2.07],0.4925779708803561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL24A1,Collagen alpha-1(XXIV) chain,13524,142,1.17 [0.87-1.58],0.2944752715327459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL28A1,Collagen alpha-1(XXVIII) chain,13194,139,1.02 [0.82-1.28],0.8518618643383947
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL2A1,Collagen alpha-1(II) chain,13218,134,1.09 [0.89-1.33],0.4215081134299514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL3A1,Collagen alpha-1(III) chain,13569,142,0.77 [0.39-1.54],0.4596978326903164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL4A1,Collagen alpha-1(IV) chain,15635,156,1.13 [0.80-1.60],0.4946977552441073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL4A4,Collagen alpha-4(IV) chain,13288,143,1.11 [0.81-1.52],0.5068648525811543
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL5A1,Collagen alpha-1(V) chain,13289,138,0.73 [0.47-1.13],0.1545857748577813
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL6A3,Collagen alpha-3(VI) chain,15834,160,1.43 [0.96-2.15],0.0818211511741856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL9A1,Collagen alpha-1(IX) chain,15623,160,0.95 [0.69-1.30],0.7457546065369401
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COL9A2,Collagen alpha-2(IX) chain,13310,143,1.16 [0.86-1.57],0.3379826389005407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COLEC12,Collectin-12,15640,155,1.82 [1.05-3.18],0.0340484556573222
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMMD1,COMM domain-containing protein 1,13218,134,1.09 [0.83-1.41],0.5410801560556964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMMD9,COMM domain-containing protein 9,13509,145,0.87 [0.57-1.32],0.5130343655458802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMP,Cartilage oligomeric matrix protein,15451,152,1.38 [0.91-2.10],0.1314367065403603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COMT,Catechol O-methyltransferase,15203,155,1.01 [0.86-1.19],0.9015104665954354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COPB2,Coatomer subunit beta',13163,138,0.99 [0.67-1.46],0.9565811792944672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COPE,Coatomer subunit epsilon,15248,155,1.12 [0.86-1.46],0.4087586117696854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",13218,134,1.11 [0.79-1.56],0.5519145084519882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CORO1A,Coronin-1A,15314,158,0.96 [0.82-1.12],0.6054847282919695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CORO6,Coronin-6,13169,137,0.72 [0.44-1.18],0.1892457812436352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",15572,159,1.12 [0.93-1.36],0.2400864468610463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",COX6B1,Cytochrome c oxidase subunit 6B1,13588,144,0.94 [0.57-1.55],0.8169503329969326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA1,Carboxypeptidase A1,15834,160,1.03 [0.80-1.31],0.8281985810061923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA2,Carboxypeptidase A2,15719,160,0.92 [0.74-1.14],0.443005933302566
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPA4,Carboxypeptidase A4,13013,136,1.12 [0.76-1.65],0.5622288902031837
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPB1,Carboxypeptidase B,15834,160,0.88 [0.69-1.14],0.349490608808497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPB2,Carboxypeptidase B2,13581,142,2.58 [1.35-4.94],0.0042918057038691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPE,Carboxypeptidase E,15678,157,0.83 [0.59-1.17],0.2993665156264016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPLX2,Complexin-2,13103,139,1.56 [1.07-2.28],0.0209788067341732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPM,Carboxypeptidase M,15709,160,1.58 [1.08-2.33],0.0194107286245514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",13206,139,1.39 [0.82-2.36],0.2173414309312471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPPED1,Serine/threonine-protein phosphatase CPPED1,15780,160,1.09 [0.89-1.35],0.3921293188724887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPQ,Carboxypeptidase Q,13548,142,0.88 [0.58-1.35],0.5642815651209856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPTP,Ceramide-1-phosphate transfer protein,13163,138,0.90 [0.60-1.36],0.6258466345315339
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPVL,Probable serine carboxypeptidase CPVL,15757,157,1.09 [0.77-1.55],0.6331929355831589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPXM1,Probable carboxypeptidase X1,15681,158,1.21 [0.99-1.48],0.0660057772630209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CPXM2,Inactive carboxypeptidase-like protein X2,13588,144,1.71 [0.92-3.15],0.0877144440355038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CR1,Complement receptor type 1,13543,142,1.36 [0.91-2.02],0.1311741333742283
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CR2,Complement receptor type 2,15672,155,1.08 [0.80-1.47],0.6139637180405724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,15268,155,0.90 [0.76-1.07],0.2427025584999236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRADD,Death domain-containing protein CRADD,15499,157,1.05 [0.87-1.26],0.6082734994296225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREB3,Cyclic AMP-responsive element-binding protein 3,13103,139,1.13 [0.88-1.46],0.3424154067980399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREBZF,CREB/ATF bZIP transcription factor,13103,139,1.20 [0.67-2.13],0.5377520577574257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CREG1,Protein CREG1,15426,157,0.94 [0.64-1.39],0.7559469561835197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRELD1,Protein disulfide isomerase CRELD1,13289,138,1.08 [0.70-1.66],0.7269252288498653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRELD2,Protein disulfide isomerase CRELD2,15693,156,1.07 [0.82-1.40],0.6125161985973336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRH,Corticoliberin,15242,155,0.81 [0.68-0.96],0.0129122707114313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRHBP,Corticotropin-releasing factor-binding protein,15640,155,1.31 [0.80-2.16],0.2807834917415568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRHR1,Corticotropin-releasing factor receptor 1,15372,156,1.05 [0.85-1.30],0.6255995158302048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRIM1,Cysteine-rich motor neuron 1 protein,15718,156,0.83 [0.41-1.68],0.6043353158316236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRIP2,Cysteine-rich protein 2,15529,157,1.34 [0.94-1.91],0.1083710753369276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRISP2,Cysteine-rich secretory protein 2,15780,157,0.96 [0.76-1.21],0.7253988171843904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRISP3,Cysteine-rich secretory protein 3,13461,142,1.07 [0.59-1.94],0.8322756232361073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRKL,Crk-like protein,15664,156,1.00 [0.88-1.14],0.9850707194310164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRLF1,Cytokine receptor-like factor 1,15718,156,1.02 [0.60-1.73],0.9341602137676565
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRNN,Cornulin,15172,151,1.13 [0.90-1.41],0.2828639348086731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAC1,Cartilage acidic protein 1,15834,160,0.76 [0.48-1.20],0.2382849664601641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAM,Cytotoxic and regulatory T-cell molecule,15529,157,0.82 [0.61-1.10],0.1845110014234922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRTAP,Cartilage-associated protein,13194,139,1.02 [0.74-1.41],0.8918683374570644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRX,Cone-rod homeobox protein,15372,156,1.15 [1.04-1.28],0.0084462483272864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYBB1,Beta-crystallin B1,13588,144,1.06 [0.84-1.35],0.6149551833635966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYBB2,Beta-crystallin B2,13545,141,0.97 [0.71-1.32],0.8388748347260306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYGD,Gamma-crystallin D,13545,141,0.95 [0.80-1.12],0.5128818548493417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYM,Ketimine reductase mu-crystallin,13169,137,0.96 [0.77-1.19],0.6987065148135609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CRYZL1,Quinone oxidoreductase-like protein 1,13218,134,1.01 [0.84-1.20],0.9544101588547708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSDE1,Cold shock domain-containing protein E1,13163,138,1.06 [0.93-1.20],0.3762003418851435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF1,Macrophage colony-stimulating factor 1,15718,156,1.53 [0.93-2.54],0.0956569134892866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF1R,Macrophage colony-stimulating factor 1 receptor,13597,143,1.48 [1.01-2.16],0.0428125669575238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2,Granulocyte-macrophage colony-stimulating factor,13163,138,0.93 [0.58-1.47],0.7526970093289729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,15529,157,1.29 [1.05-1.58],0.0164745917960885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF2RB,Cytokine receptor common subunit beta,13206,139,1.14 [0.79-1.65],0.4711834741845432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF3,Granulocyte colony-stimulating factor,15330,154,1.34 [1.02-1.78],0.0385776665482791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSF3R,Granulocyte colony-stimulating factor receptor,13206,139,1.38 [0.88-2.15],0.1577948499418022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSH1,Chorionic somatomammotropin hormone 1,13597,143,0.90 [0.54-1.50],0.6828809544286445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSNK1D,Casein kinase I isoform delta,13206,139,1.09 [0.85-1.38],0.5020005978212225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSNK2A1,Casein kinase II subunit alpha,13571,143,1.08 [0.76-1.52],0.6758040578648337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSPG4,Chondroitin sulfate proteoglycan 4,13569,142,0.78 [0.48-1.27],0.3162888154496495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSPG5,Chondroitin sulfate proteoglycan 5,13169,137,0.88 [0.62-1.25],0.4859372973923305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSRP3,Cysteine and glycine-rich protein 3,13163,138,0.98 [0.82-1.17],0.810107350011757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST1,Cystatin-SN,11756,130,1.07 [0.90-1.28],0.4250610890544958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST3,Cystatin-C,15648,152,1.56 [0.94-2.57],0.0836771396510151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST5,Cystatin-D,15368,153,1.04 [0.80-1.35],0.7629219026190375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST6,Cystatin-M,15232,156,1.10 [0.81-1.50],0.5278772760058014
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CST7,Cystatin-F,15661,156,1.05 [0.90-1.21],0.5541157179392064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CSTB,Cystatin-B,15415,158,1.28 [0.93-1.76],0.1351314561147743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTAG1A_CTAG1B,Cancer/testis antigen 1,13283,143,0.99 [0.72-1.36],0.9393740194653384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTBS,Di-N-acetylchitobiase,13402,142,1.44 [0.78-2.64],0.2459571173872168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTF1,Cardiotrophin-1,15372,156,1.07 [0.91-1.26],0.4021305776352485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTHRC1,Collagen triple helix repeat-containing protein 1,13569,142,1.67 [0.95-2.94],0.0738269851842013
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTLA4,Cytotoxic T-lymphocyte protein 4,13569,142,0.73 [0.42-1.27],0.2650625088557603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTNNA1,Catenin alpha-1,13169,137,1.04 [0.67-1.61],0.8536211388936119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRB1,Chymotrypsinogen B,15634,160,1.08 [0.83-1.41],0.5734215646347478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRC,Chymotrypsin-C,15639,156,0.81 [0.65-1.02],0.0737277444733966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRL,Chymotrypsin-like protease CTRL-1,13545,141,0.77 [0.61-0.99],0.037414807696108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSB,Cathepsin B,15642,159,0.99 [0.76-1.29],0.947561075667669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSC,Dipeptidyl peptidase 1,15622,155,0.95 [0.68-1.32],0.7478802678125305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSD,Cathepsin D,14548,142,0.77 [0.51-1.18],0.227188753411727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSE,Cathepsin E,13289,138,0.75 [0.55-1.02],0.0706561156840233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSF,Cathepsin F,15681,158,0.90 [0.64-1.27],0.5380783200061805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSH,Pro-cathepsin H,15325,156,1.14 [0.94-1.39],0.1932521473206053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSL,Cathepsin L1,15635,156,1.59 [0.90-2.84],0.1132693578626184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSO,Cathepsin O,15813,160,0.91 [0.57-1.44],0.6816651471512819
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSS,Cathepsin S,12337,125,1.39 [0.68-2.82],0.3628634715175028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSV,Cathepsin L2,15737,157,0.82 [0.59-1.13],0.2264198518908955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTSZ,Cathepsin Z,15607,154,1.15 [0.73-1.81],0.557015449283351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CUZD1,CUB and zona pellucida-like domain-containing protein 1,13194,139,1.08 [0.70-1.66],0.7232988637049591
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CWC15,Spliceosome-associated protein CWC15 homolog,13452,142,1.06 [0.84-1.35],0.6188774531155588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CX3CL1,Fractalkine,15529,157,0.87 [0.57-1.33],0.517771701414143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXADR,Coxsackievirus and adenovirus receptor,15623,160,0.99 [0.76-1.30],0.9555278145251432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL1,Growth-regulated alpha protein,15608,155,1.03 [0.89-1.19],0.6616453408778462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL10,C-X-C motif chemokine 10,15718,156,1.02 [0.83-1.26],0.8277091817558718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL11,C-X-C motif chemokine 11,15780,160,1.01 [0.85-1.20],0.9078058809583848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL12,Stromal cell-derived factor 1,15330,154,0.93 [0.65-1.32],0.6711317400898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL13,C-X-C motif chemokine 13,15780,160,0.97 [0.77-1.22],0.8008039280171139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL14,C-X-C motif chemokine 14,15330,154,0.89 [0.69-1.14],0.348316924764291
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL16,C-X-C motif chemokine 16,15803,160,1.99 [1.12-3.51],0.0183045743943461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL17,C-X-C motif chemokine 17,15813,160,1.19 [0.89-1.59],0.2474310519547011
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL3,C-X-C motif chemokine 3,15636,156,1.04 [0.89-1.20],0.6474505076589718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL5,C-X-C motif chemokine 5,15580,154,1.10 [0.98-1.25],0.1129403428575984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL6,C-X-C motif chemokine 6,15813,160,1.11 [0.93-1.32],0.2371607577671027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL8,Interleukin-8,15507,155,1.14 [0.94-1.38],0.1895067762464523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL9,C-X-C motif chemokine 9,15718,156,1.15 [0.95-1.40],0.1457838486679121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYB5A,Cytochrome b5,13103,139,0.94 [0.75-1.18],0.595781273159876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYB5R2,NADH-cytochrome b5 reductase 2,13358,141,1.12 [0.85-1.49],0.414661263334769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",13163,138,1.07 [0.90-1.27],0.4554431784536349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYTH3,Cytohesin-3,13103,139,1.12 [0.92-1.37],0.2466620500640792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYTL1,Cytokine-like protein 1,13569,142,0.98 [0.48-1.99],0.9510947857050024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAAM1,Disheveled-associated activator of morphogenesis 1,13289,138,0.99 [0.81-1.21],0.9134929622618896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAB2,Disabled homolog 2,15780,157,1.01 [0.89-1.14],0.9181681289381024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAG1,Dystroglycan,15718,156,1.06 [0.79-1.41],0.7102035204451431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAND5,DAN domain family member 5,13206,139,1.07 [0.80-1.42],0.646199583083262
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAPK2,Death-associated protein kinase 2,13206,139,1.00 [0.75-1.33],0.9914897847619542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,15623,160,1.01 [0.90-1.14],0.8610617486819392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DARS1,"Aspartate--tRNA ligase, cytoplasmic",15499,157,0.94 [0.78-1.14],0.5165138213767994
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBH,Dopamine beta-hydroxylase,13574,142,0.89 [0.78-1.01],0.0798418103976097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBI,Acyl-CoA-binding protein,15556,159,1.11 [0.94-1.32],0.2215659770257293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBN1,Drebrin,13206,139,1.09 [0.81-1.47],0.5698085832474188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBNL,Drebrin-like protein,15718,156,0.97 [0.84-1.13],0.7376632356694941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",15681,158,1.17 [0.78-1.74],0.4549008708834751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCC,Netrin receptor DCC,13194,139,0.52 [0.22-1.22],0.1316740992691656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCDC2C,Doublecortin domain-containing protein 2C,13103,139,1.24 [1.01-1.52],0.0412454089330152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCLRE1C,Protein artemis,13103,139,1.49 [1.00-2.23],0.0525704646286626
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCN,Decorin,15372,156,0.95 [0.50-1.82],0.8876322651936788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTD,Deoxycytidylate deaminase,13289,138,1.03 [0.87-1.22],0.7515050191693593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN1,Dynactin subunit 1,15780,157,0.94 [0.76-1.16],0.5559830910469482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN2,Dynactin subunit 2,15572,159,0.95 [0.81-1.10],0.4928520447190583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTN6,Dynactin subunit 6,15248,155,0.92 [0.74-1.13],0.4256793668777887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCTPP1,dCTP pyrophosphatase 1,15635,156,0.94 [0.60-1.47],0.7931865248330415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCUN1D1,DCN1-like protein 1,13169,137,1.04 [0.85-1.28],0.6903089125809807
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCUN1D2,DCN1-like protein 2,13103,139,0.97 [0.79-1.19],0.7969752888323385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DCXR,L-xylulose reductase,15681,158,1.03 [0.80-1.34],0.8015165155353473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDA1,DET1- and DDB1-associated protein 1,13163,138,0.86 [0.56-1.33],0.5022365178947276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",15572,159,1.21 [0.90-1.63],0.2065855301694606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDC,Aromatic-L-amino-acid decarboxylase,15613,156,1.09 [0.82-1.45],0.5357019446997804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDHD2,Phospholipase DDHD2,13571,143,1.07 [0.84-1.36],0.5922773873856846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDI2,Protein DDI1 homolog 2,13289,138,0.89 [0.72-1.09],0.2536076230583405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDR1,Epithelial discoidin domain-containing receptor 1,15780,160,1.21 [0.67-2.18],0.5315850747651593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDT,D-dopachrome decarboxylase,13569,142,1.04 [0.71-1.52],0.8516076012386141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX1,ATP-dependent RNA helicase DDX1,13524,142,1.13 [0.86-1.49],0.3832934808094154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX25,ATP-dependent RNA helicase DDX25,13194,139,1.01 [0.68-1.51],0.9577376019179032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX39A,ATP-dependent RNA helicase DDX39A,13206,139,1.91 [1.04-3.50],0.0370612000549368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX4,Probable ATP-dependent RNA helicase DDX4,13206,139,1.24 [0.98-1.57],0.0741093236391981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX53,Probable ATP-dependent RNA helicase DDX53,13194,139,0.85 [0.53-1.35],0.4864735668480018
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDX58,Antiviral innate immune response receptor RIG-I,15268,155,1.08 [0.86-1.36],0.4939754534457311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",15623,160,1.04 [0.90-1.20],0.5984526362302944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFA1_DEFA1B,Neutrophil defensin 1,15293,149,0.83 [0.61-1.12],0.2175474887976159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB103A_DEFB103B,Beta-defensin 103,13109,138,1.35 [1.01-1.81],0.0403845987854249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB104A_DEFB104B,Beta-defensin 104,13169,137,1.08 [0.82-1.40],0.5906391584093842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB116,Beta-defensin 116,13169,137,0.89 [0.71-1.13],0.3539584707253508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB118,Beta-defensin 118,13169,137,0.85 [0.61-1.19],0.3375185964218098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DEFB4A_DEFB4B,Beta-defensin 4A,15422,158,1.06 [0.97-1.17],0.2088599709597429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DENND2B,DENN domain-containing protein 2B,13163,138,1.21 [0.94-1.57],0.1385081823182165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DENR,Density-regulated protein,13206,139,0.99 [0.75-1.31],0.9540424142252806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DFFA,DNA fragmentation factor subunit alpha,15813,160,1.04 [0.85-1.27],0.721202317302853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGCR6,Protein DGCR6,13169,137,0.77 [0.50-1.17],0.2217566170406422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGKA,Diacylglycerol kinase alpha,13206,139,1.04 [0.77-1.41],0.7776043511920128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DGKZ,Diacylglycerol kinase zeta,15330,154,0.83 [0.55-1.25],0.3672888398004247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHODH,Dihydroorotate dehydrogenase,13163,138,1.04 [0.75-1.45],0.8165148100757538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHPS,Deoxyhypusine synthase,13509,145,0.82 [0.54-1.24],0.3426227832665388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,13545,141,1.10 [0.80-1.50],0.5678395979158068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIABLO,"Diablo homolog, mitochondrial",15578,156,0.98 [0.86-1.11],0.7104509650870917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIPK1C,Divergent protein kinase domain 1C,13194,139,0.86 [0.57-1.29],0.45238249360192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DIPK2B,Divergent protein kinase domain 2B,13289,138,1.30 [0.71-2.35],0.3940945736942467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK1,Dickkopf-related protein 1,15780,160,1.21 [0.96-1.52],0.1100841889942851
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK3,Dickkopf-related protein 3,15834,160,0.78 [0.48-1.26],0.3081938625870148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKK4,Dickkopf-related protein 4,15499,157,0.75 [0.54-1.04],0.0816492124499266
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DKKL1,Dickkopf-like protein 1,15572,159,0.90 [0.77-1.04],0.1579440422616026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLG4,Disks large homolog 4,13545,141,1.02 [0.81-1.27],0.8787963137719488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLGAP5,Disks large-associated protein 5,13571,143,1.05 [0.81-1.37],0.7115581309431487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLK1,Protein delta homolog 1,15834,160,1.18 [0.92-1.53],0.1975492446239898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLL1,Delta-like protein 1,15681,158,1.39 [0.86-2.25],0.1794666889376245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DLL4,Delta-like protein 4,13218,134,1.14 [1.00-1.30],0.0568170379155876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DMD,Dystrophin,13218,134,1.00 [0.73-1.38],0.9925480063619296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DMP1,Dentin matrix acidic phosphoprotein 1,13218,134,0.81 [0.64-1.02],0.0670938239092993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA1,DnaJ homolog subfamily A member 1,13103,139,1.31 [1.01-1.69],0.0438551038304302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA2,DnaJ homolog subfamily A member 2,15756,160,0.98 [0.83-1.16],0.8005418767956027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJA4,DnaJ homolog subfamily A member 4,13545,141,1.12 [0.91-1.39],0.2778567423526532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB1,DnaJ homolog subfamily B member 1,15572,159,1.06 [0.91-1.24],0.4637722307516669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB14,DnaJ homolog subfamily B member 14,13524,142,1.07 [0.84-1.35],0.5997176251569376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB2,DnaJ homolog subfamily B member 2,13289,138,1.01 [0.75-1.35],0.9652688197758532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB6,DnaJ homolog subfamily B member 6,13159,137,1.03 [0.85-1.25],0.7574919741593904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJB8,DnaJ homolog subfamily B member 8,15372,156,1.06 [0.84-1.34],0.6339572381858845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC21,DnaJ homolog subfamily C member 21,13545,141,1.10 [0.73-1.65],0.648716385728978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC6,Putative tyrosine-protein phosphatase auxilin,13218,134,1.03 [0.85-1.26],0.7462640875025044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNAJC9,DnaJ homolog subfamily C member 9,13524,142,1.10 [0.90-1.34],0.3693316353461326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNER,Delta and Notch-like epidermal growth factor-related receptor,15615,156,1.13 [0.64-2.00],0.6666358553538623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNLZ,DNL-type zinc finger protein,13169,137,0.95 [0.79-1.14],0.579408002222863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNM1,Dynamin-1,13524,142,1.07 [0.92-1.23],0.3813879224426324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNM3,Dynamin-3,13571,143,0.97 [0.72-1.29],0.8157102225344017
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNMBP,Dynamin-binding protein,15529,157,0.96 [0.76-1.20],0.7000017817116859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNPEP,Aspartyl aminopeptidase,13545,141,1.05 [0.80-1.38],0.7124832366034457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,15689,156,1.04 [0.80-1.36],0.7672847667470487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOC2B,Double C2-like domain-containing protein beta,13194,139,0.61 [0.35-1.06],0.0793471562731139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOCK9,Dedicator of cytokinesis protein 9,13169,137,1.02 [0.89-1.17],0.7432662947018075
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOK1,Docking protein 1,13545,141,1.02 [0.91-1.15],0.7220060938109135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOK2,Docking protein 2,15635,156,0.98 [0.88-1.10],0.777072469248091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP1,Dipeptidase 1,15499,157,1.10 [0.83-1.47],0.5042446184802057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP2,Dipeptidase 2,15572,159,0.82 [0.51-1.35],0.4402213408765868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP10,Inactive dipeptidyl peptidase 10,15623,160,0.89 [0.59-1.35],0.5811974970786489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP4,Dipeptidyl peptidase 4,15311,153,1.43 [0.89-2.30],0.1366174631855583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP6,Dipeptidyl aminopeptidase-like protein 6,15572,159,0.88 [0.57-1.34],0.542738723045268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPP7,Dipeptidyl peptidase 2,15498,156,0.97 [0.76-1.23],0.792357092492453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPT,Dermatopontin,15834,160,0.98 [0.59-1.65],0.9521898226380388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPY30,Protein dpy-30 homolog,15732,156,1.10 [0.88-1.38],0.3872916912526412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DRAXIN,Draxin,15529,157,0.91 [0.65-1.27],0.5722053863832848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DRG2,Developmentally-regulated GTP-binding protein 2,15572,159,1.05 [0.82-1.34],0.7134756967400053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSC2,Desmocollin-2,15464,160,1.35 [0.91-2.01],0.1325817678151195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSCAM,Down syndrome cell adhesion molecule,13571,143,1.02 [0.65-1.60],0.9350073362276012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG2,Desmoglein-2,15634,160,1.07 [0.64-1.79],0.8034698101680523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG3,Desmoglein-3,15732,156,1.25 [0.82-1.90],0.3052119420663032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSG4,Desmoglein-4,15516,158,1.19 [0.90-1.58],0.2097000370784889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTD1,D-aminoacyl-tRNA deacylase 1,13289,138,1.00 [0.83-1.20],0.998335380737727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTNB,Dystrobrevin beta,13491,145,1.14 [0.80-1.63],0.4689403804583406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTX2,Probable E3 ubiquitin-protein ligase DTX2,13194,139,1.18 [0.97-1.43],0.1007738529494977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTX3,Probable E3 ubiquitin-protein ligase DTX3,15572,159,1.51 [0.86-2.65],0.1539234279630142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DTYMK,Thymidylate kinase,13588,144,1.09 [0.87-1.36],0.4770369410212368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUOX2,Dual oxidase 2,15372,156,0.89 [0.71-1.10],0.2700377604081398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP13,Dual specificity protein phosphatase 13 isoform A,13509,145,1.13 [0.78-1.64],0.5191130905775232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP29,Dual specificity phosphatase 29,13194,139,1.18 [0.97-1.45],0.1015474347353091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUSP3,Dual specificity protein phosphatase 3,15248,155,1.09 [0.94-1.27],0.2503825192155877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",13524,142,1.04 [0.89-1.22],0.5914319216241126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DXO,Decapping and exoribonuclease protein,13545,141,1.04 [0.74-1.47],0.8108946112578939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,13509,145,0.97 [0.69-1.35],0.8466854505875343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT1,Dynein light chain Tctex-type 1,13194,139,1.03 [0.84-1.25],0.7930322454009554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT3,Dynein light chain Tctex-type 3,13509,145,1.17 [0.82-1.66],0.37848639591509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,15529,157,1.03 [0.88-1.19],0.7360051076413292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EBI3_IL27,Interleukin-27,15757,157,0.88 [0.56-1.39],0.5806129897326588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECE1,Endothelin-converting enzyme 1,15248,155,0.76 [0.50-1.13],0.1770384447104139
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",13588,144,0.91 [0.73-1.13],0.4066628981459129
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECHS1,"Enoyl-CoA hydratase, mitochondrial",13218,134,1.05 [0.88-1.24],0.5957991936051876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECI2,Enoyl-CoA delta isomerase 2,13163,138,1.01 [0.78-1.30],0.9663965463802088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECM1,Extracellular matrix protein 1,13216,137,1.23 [0.77-1.96],0.3941630911173482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECSCR,Endothelial cell-specific chemotaxis regulator,13169,137,1.18 [0.90-1.55],0.2378875552010489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDA2R,Tumor necrosis factor receptor superfamily member 27,15780,157,1.24 [0.82-1.88],0.3094073575625539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDAR,Tumor necrosis factor receptor superfamily member EDAR,15623,160,1.12 [0.97-1.30],0.1237632003876449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDDM3B,Epididymal secretory protein E3-beta,13509,145,1.02 [0.70-1.48],0.9370463471508106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,13163,138,1.01 [0.65-1.56],0.971616976074418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDF1,Endothelial differentiation-related factor 1,13571,143,1.01 [0.81-1.26],0.93067144977116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,15372,156,1.52 [1.05-2.21],0.0253993707617049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDN1,Endothelin-1,13218,134,1.54 [0.89-2.69],0.1251974466687614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDNRB,Endothelin receptor type B,13206,139,1.10 [0.80-1.52],0.5405686452763017
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EEF1D,Elongation factor 1-delta,13588,144,0.95 [0.79-1.12],0.5257702164135041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFCAB14,EF-hand calcium-binding domain-containing protein 14,13524,142,1.73 [1.12-2.68],0.0129935800456869
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFCAB2,Dynein regulatory complex protein 8,13310,143,1.24 [0.81-1.88],0.3209629521117245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,15641,155,1.31 [0.82-2.10],0.2514527664881375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFHD1,EF-hand domain-containing protein D1,13571,143,1.07 [0.68-1.67],0.7645857332973489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNA1,Ephrin-A1,15607,159,1.32 [0.78-2.23],0.2984637818736425
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNA4,Ephrin-A4,15502,157,1.24 [0.75-2.06],0.4038085357970721
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EFNB2,Ephrin-B2,13194,139,0.92 [0.69-1.21],0.5416048850912905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGF,Pro-epidermal growth factor,15612,156,1.03 [0.90-1.18],0.7045380905449887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFL7,Epidermal growth factor-like protein 7,15268,155,1.10 [0.78-1.56],0.5820120867206025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFLAM,Pikachurin,13524,142,0.99 [0.59-1.66],0.9691062248468169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGFR,Epidermal growth factor receptor,15834,160,1.10 [0.46-2.60],0.8362085412725463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EGLN1,Egl nine homolog 1,15623,160,1.00 [0.78-1.28],0.9862615552685984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EHBP1,EH domain-binding protein 1,13588,144,0.98 [0.79-1.21],0.860035426630235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EHD3,EH domain-containing protein 3,13218,134,1.02 [0.88-1.17],0.8299746264014601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",13545,141,1.17 [0.90-1.52],0.2350210022142889
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",13485,141,1.01 [0.87-1.17],0.8786624475055955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,13163,138,0.93 [0.73-1.20],0.5876153003936342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,13218,134,1.15 [0.80-1.67],0.4515180350665687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4B,Eukaryotic translation initiation factor 4B,15529,157,1.07 [0.85-1.37],0.55593079154332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4E,Eukaryotic translation initiation factor 4E,13206,139,1.03 [0.87-1.24],0.7116158187637482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,15635,156,1.00 [0.81-1.24],0.9668060360638164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,15813,160,0.99 [0.86-1.14],0.881336526006587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,13571,143,0.95 [0.75-1.22],0.7110481809911704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF5,Eukaryotic translation initiation factor 5,13163,138,0.99 [0.69-1.42],0.9432015218750264
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EIF5A,Eukaryotic translation initiation factor 5A-1,15330,154,1.37 [0.90-2.09],0.1458912848488489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELAC1,Zinc phosphodiesterase ELAC protein 1,13571,143,1.08 [0.90-1.30],0.3982868694166166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELAVL4,ELAV-like protein 4,13169,137,1.03 [0.86-1.23],0.773061290609106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELN,Elastin,13588,144,1.44 [0.91-2.27],0.116064650495059
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOA,Elongin-A,15572,159,0.95 [0.73-1.25],0.7287826813195537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOB,Elongin-B,13163,138,0.97 [0.65-1.45],0.8798450187999736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENAH,Protein enabled homolog,15330,154,1.48 [1.14-1.92],0.0028935062775079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENDOU,Poly(U)-specific endoribonuclease,12561,136,1.34 [0.99-1.81],0.0603422320081193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENG,Endoglin,15834,160,1.25 [0.55-2.82],0.5953563547917411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO1,Alpha-enolase,15602,159,0.99 [0.83-1.18],0.8714851261808916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO2,Gamma-enolase,15780,160,1.00 [0.81-1.23],0.9903915407964152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENO3,Beta-enolase,13218,134,0.95 [0.70-1.29],0.7452249274442805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENOPH1,Enolase-phosphatase E1,13509,145,1.05 [0.81-1.35],0.7136399856862623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,13163,138,0.75 [0.40-1.39],0.3539806372406825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPEP,Glutamyl aminopeptidase,13163,138,0.94 [0.64-1.40],0.7733666242736755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,15834,160,1.08 [0.68-1.72],0.7340675757536835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,15718,156,0.92 [0.67-1.28],0.6340145517136906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,13218,134,1.15 [0.73-1.82],0.5416212665548006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,15184,150,0.95 [0.80-1.11],0.500521878612732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENSA,Alpha-endosulfine,13509,145,1.05 [0.79-1.41],0.7253242778686606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,15268,155,1.22 [0.89-1.68],0.2211817172629259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,15372,156,1.06 [0.54-2.08],0.8708242453286629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,15372,156,1.48 [0.84-2.62],0.1761723605907178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTR1,Endosome-associated-trafficking regulator 1,13218,134,0.87 [0.64-1.18],0.3581871568329473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EP300,Histone acetyltransferase p300,13206,139,0.68 [0.38-1.19],0.1771406138964731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPB41L5,Band 4.1-like protein 5,13194,139,1.03 [0.82-1.31],0.777680194998382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPCAM,Epithelial cell adhesion molecule,15646,156,0.86 [0.75-1.00],0.0488378437593371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPGN,Epigen,13509,145,1.03 [0.76-1.40],0.8378880904054784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA1,Ephrin type-A receptor 1,15689,156,1.16 [0.77-1.76],0.4796808384016008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA10,Ephrin type-A receptor 10,15248,155,0.99 [0.79-1.24],0.9193213263847044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA2,Ephrin type-A receptor 2,15090,152,1.42 [0.90-2.25],0.129027801918335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA4,Ephrin type-A receptor 4,13289,138,1.03 [0.57-1.84],0.933942745620618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB4,Ephrin type-B receptor 4,15834,160,1.36 [0.77-2.41],0.2909269470365346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB6,Ephrin type-B receptor 6,15499,157,1.13 [0.71-1.81],0.6018495136344273
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHX2,Bifunctional epoxide hydrolase 2,15372,156,0.86 [0.67-1.10],0.2247606058500605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPN1,Epsin-1,13310,143,0.91 [0.62-1.34],0.6250310567625279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPO,Erythropoietin,15623,160,1.13 [0.97-1.32],0.1085049854109202
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPPK1,Epiplakin,13218,134,1.04 [0.84-1.30],0.6956982153438065
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,15755,156,1.32 [0.84-2.07],0.2329218428360464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB2,Receptor tyrosine-protein kinase erbB-2,15681,158,1.01 [0.58-1.75],0.97444320136651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB3,Receptor tyrosine-protein kinase erbB-3,15583,156,2.88 [1.46-5.67],0.0023034624575561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBB4,Receptor tyrosine-protein kinase erbB-4,15681,158,0.93 [0.52-1.65],0.8012370465673061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERBIN,Erbin,15572,159,1.03 [0.90-1.18],0.7092075066320737
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERC2,ERC protein 2,13194,139,0.96 [0.78-1.20],0.7394402062647929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERCC1,DNA excision repair protein ERCC-1,13103,139,1.31 [0.92-1.88],0.1367955241159235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EREG,Proepiregulin,15499,157,1.16 [0.98-1.37],0.0853003955111473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERI1,3'-5' exoribonuclease 1,13310,143,0.85 [0.52-1.39],0.526604621099592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERMAP,Erythroid membrane-associated protein,13206,139,1.32 [0.93-1.87],0.1141356882680077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,13509,145,0.90 [0.59-1.37],0.6175045999080637
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERP29,Endoplasmic reticulum resident protein 29,13289,138,1.02 [0.89-1.17],0.7543937376743945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERP44,Endoplasmic reticulum resident protein 44,15552,159,1.28 [0.75-2.19],0.3656965854956508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,13163,138,0.81 [0.55-1.19],0.279900770909242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESAM,Endothelial cell-selective adhesion molecule,15834,160,1.65 [1.09-2.52],0.0189592789030327
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESM1,Endothelial cell-specific molecule 1,15640,155,0.69 [0.45-1.04],0.0779778207462783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESPL1,Separin,13103,139,1.09 [0.84-1.43],0.518232937942704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESR1,Estrogen receptor,13206,139,1.27 [1.04-1.55],0.0194469709077825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ESYT2,Extended synaptotagmin-2,13545,141,1.01 [0.83-1.23],0.8973692883137006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVI2B,Protein EVI2B,13103,139,1.14 [0.80-1.62],0.47300398336456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVI5,Ecotropic viral integration site 5 protein homolog,13206,139,1.02 [0.85-1.22],0.8093170459462842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EVPL,Envoplakin,13310,143,1.41 [0.91-2.17],0.1218943205866385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EXOSC10,Exosome component 10,13163,138,1.21 [0.97-1.49],0.0851842524010595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EXTL1,Exostosin-like 1,13163,138,1.09 [0.80-1.48],0.5936172766733046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EZR,Ezrin,15780,160,1.22 [0.69-2.16],0.4887756783088243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F10,Coagulation factor X,13597,143,1.49 [0.91-2.46],0.114205487928607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F11,Coagulation factor XI,13413,138,1.18 [0.74-1.87],0.4845692324380848
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F11R,Junctional adhesion molecule A,15634,160,1.04 [0.82-1.33],0.7491387566053376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F12,Coagulation factor XII,13612,142,1.03 [0.71-1.52],0.8606446236347371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F13B,Coagulation factor XIII B chain,13534,141,2.12 [1.13-3.98],0.0195688936271545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F2,Prothrombin,13612,142,0.68 [0.23-2.00],0.4834619288854255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F2R,Proteinase-activated receptor 1,15693,156,1.21 [0.95-1.54],0.1176412840430227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F3,Tissue factor,15686,155,1.05 [0.64-1.75],0.8412688380409207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F7,Coagulation factor VII,15646,155,1.26 [0.78-2.02],0.3393066523115666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",F9,Coagulation factor IX,15650,155,1.60 [0.74-3.48],0.2328116017850606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP1,"Fatty acid-binding protein, liver",15640,155,1.12 [0.97-1.30],0.1214032478642739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP2,"Fatty acid-binding protein, intestinal",15635,156,1.15 [0.96-1.37],0.1207361015033131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP3,"Fatty acid-binding protein, heart",13588,144,1.21 [0.87-1.68],0.2494419550383487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP4,"Fatty acid-binding protein, adipocyte",15834,160,1.28 [0.97-1.68],0.0820970030875121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP5,Fatty acid-binding protein 5,15736,160,1.09 [0.89-1.32],0.4137912698440522
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP6,Gastrotropin,15351,155,1.12 [0.86-1.44],0.4010280711652154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FABP9,Fatty acid-binding protein 9,15623,160,1.05 [0.82-1.35],0.6872958357760754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FADD,FAS-associated death domain protein,15635,156,1.00 [0.83-1.20],0.9663778563683636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM13A,Protein FAM13A,13524,142,1.00 [0.79-1.27],0.9933089352585324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM171A2,Protein FAM171A2,13571,143,1.03 [0.94-1.13],0.5433005707789406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM171B,Protein FAM171B,13509,145,1.17 [0.69-1.98],0.5517977571642001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM172A,Cotranscriptional regulator FAM172A,13218,134,1.07 [0.83-1.40],0.5904322171354035
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM20A,Pseudokinase FAM20A,13588,144,1.69 [0.98-2.90],0.0568410588265757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3B,Protein FAM3B,15572,159,0.89 [0.61-1.31],0.5640760831970089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3C,Protein FAM3C,15613,156,1.78 [1.11-2.85],0.0157391248437908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3D,Protein FAM3D,13524,142,1.03 [0.85-1.25],0.7488057119906294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAP,Prolyl endopeptidase FAP,15834,160,1.30 [0.78-2.16],0.3168396500918974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FARSA,Phenylalanine--tRNA ligase alpha subunit,13194,139,1.13 [0.91-1.41],0.2790894743158206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAS,Tumor necrosis factor receptor superfamily member 6,15777,160,1.34 [0.95-1.89],0.0970969178331783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FASLG,Tumor necrosis factor ligand superfamily member 6,15813,160,0.65 [0.45-0.93],0.0181023471967187
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBLN2,Fibulin-2,13569,142,0.99 [0.58-1.68],0.9708775410165766
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBN2,Fibrillin-2,13194,139,0.95 [0.72-1.24],0.6946128528666424
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FBP1,"Fructose-1,6-bisphosphatase 1",15635,156,1.05 [0.87-1.27],0.6063958344619368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,13588,144,1.22 [0.98-1.51],0.0719306186442834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCAR,Immunoglobulin alpha Fc receptor,15623,160,1.04 [0.77-1.41],0.7779590300236908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,13571,143,1.64 [0.85-3.15],0.1380692157714255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCER2,Low affinity immunoglobulin epsilon Fc receptor,15634,160,1.22 [0.91-1.63],0.1871848859613148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,15548,155,1.10 [0.86-1.41],0.4670316867678459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,15268,155,0.82 [0.64-1.07],0.1393589184658234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,15620,155,1.11 [0.83-1.49],0.4668852116912459
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCN1,Ficolin-1,13574,142,1.00 [0.75-1.31],0.9761329695553036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCN2,Ficolin-2,15554,155,1.50 [1.04-2.18],0.0315509504613311
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL1,Fc receptor-like protein 1,15635,156,1.22 [0.89-1.69],0.2157233908036461
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL2,Fc receptor-like protein 2,15738,158,1.07 [0.79-1.45],0.6621721713564239
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL3,Fc receptor-like protein 3,15330,154,0.99 [0.76-1.30],0.9701393957493198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL5,Fc receptor-like protein 5,15634,160,0.89 [0.69-1.14],0.34808685290602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL6,Fc receptor-like protein 6,15623,160,0.96 [0.78-1.18],0.7009836180241379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRLB,Fc receptor-like B,15268,155,0.87 [0.67-1.12],0.2806174208780114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FDX1,"Adrenodoxin, mitochondrial",13163,138,1.12 [0.89-1.41],0.3322417934225201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FDX2,"Ferredoxin-2, mitochondrial",13163,138,1.05 [0.80-1.37],0.7490873239553365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FEN1,Flap endonuclease 1,15268,155,0.79 [0.61-1.03],0.085087869581912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FES,Tyrosine-protein kinase Fes/Fps,15268,155,1.15 [0.87-1.51],0.3285007317556706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FETUB,Fetuin-B,15650,155,1.16 [0.77-1.76],0.4707740146707335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGA,Fibrinogen alpha chain,13277,139,1.65 [0.99-2.75],0.0562027812161584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",13571,143,1.01 [0.83-1.23],0.9057873288416622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF12,Fibroblast growth factor 12,13206,139,0.98 [0.69-1.39],0.9028460739257652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF16,Fibroblast growth factor 16,13206,139,0.90 [0.64-1.28],0.5756038871255924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF19,Fibroblast growth factor 19,15718,156,1.17 [0.97-1.40],0.0996264385127164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF2,Fibroblast growth factor 2,15623,160,1.09 [0.89-1.34],0.3952502739101506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF20,Fibroblast growth factor 20,13206,139,1.06 [0.74-1.50],0.7657407147826205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF21,Fibroblast growth factor 21,15757,157,1.12 [1.00-1.26],0.0485299698578151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF23,Fibroblast growth factor 23,15754,157,1.06 [0.87-1.29],0.5708538371199924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF3,Fibroblast growth factor 3,13206,139,1.33 [0.87-2.03],0.1807093459489076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF5,Fibroblast growth factor 5,15330,154,1.63 [1.10-2.42],0.01479195194138
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF6,Fibroblast growth factor 6,13206,139,1.09 [0.78-1.52],0.6097305487475498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF7,Fibroblast growth factor 7,13103,139,1.02 [0.84-1.24],0.8155639215581084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF9,Fibroblast growth factor 9,13079,139,1.27 [0.87-1.84],0.2104649320227488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP1,Fibroblast growth factor-binding protein 1,15681,158,1.10 [0.70-1.72],0.6893056701322406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP2,Fibroblast growth factor-binding protein 2,13569,142,0.89 [0.64-1.23],0.47070747407434
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFBP3,Fibroblast growth factor-binding protein 3,13545,141,0.97 [0.63-1.50],0.8994616713787056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFR2,Fibroblast growth factor receptor 2,15681,158,1.65 [0.87-3.10],0.1225379853151187
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGFR4,Fibroblast growth factor receptor 4,13289,138,0.88 [0.65-1.20],0.4269782160915836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGL1,Fibrinogen-like protein 1,13597,143,1.15 [0.89-1.49],0.2711433082345661
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGR,Tyrosine-protein kinase Fgr,15248,155,0.97 [0.76-1.25],0.8253550637514875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FH,"Fumarate hydratase, mitochondrial",13169,137,0.86 [0.68-1.07],0.1738944227785585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FHIP2A,FHF complex subunit HOOK interacting protein 2A,13163,138,0.82 [0.57-1.19],0.29971293584965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FHIT,Bis(5'-adenosyl)-triphosphatase,15248,155,1.07 [0.88-1.29],0.5012562131616736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FIS1,Mitochondrial fission 1 protein,15632,156,0.98 [0.82-1.17],0.8152165447734894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,13571,143,1.06 [0.90-1.24],0.5027988434480893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,15683,157,0.97 [0.85-1.10],0.6187227539562165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,15529,157,1.15 [0.84-1.57],0.385170165693515
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,15529,157,1.01 [0.87-1.17],0.9146151941103748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,15218,155,1.01 [0.75-1.36],0.9475230441072314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FKBPL,FK506-binding protein-like,13524,142,1.11 [0.85-1.44],0.454739170236943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLI1,Friend leukemia integration 1 transcription factor,15268,155,1.08 [0.95-1.24],0.2179391007451431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,15529,157,0.90 [0.55-1.48],0.6789460208100615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT1,Vascular endothelial growth factor receptor 1,15542,159,0.89 [0.47-1.67],0.7182737426338399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT3,Receptor-type tyrosine-protein kinase FLT3,15268,155,1.16 [0.75-1.79],0.5137828437584141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT3LG,Fms-related tyrosine kinase 3 ligand,15813,160,1.34 [0.88-2.03],0.167175839343047
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FLT4,Vascular endothelial growth factor receptor 3,15681,158,1.03 [0.68-1.56],0.8855318670867312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMNL1,Formin-like protein 1,15248,155,0.97 [0.77-1.22],0.7666154484927902
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMR1,Synaptic functional regulator FMR1,15268,155,1.10 [0.74-1.65],0.6335112810788347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FN1,Fibronectin,13612,142,1.14 [0.63-2.09],0.6601825138942192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNDC1,Fibronectin type III domain-containing protein 1,13545,141,1.22 [0.86-1.73],0.2666206237027875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,13509,145,1.35 [0.93-1.95],0.1164516399994033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLH1,Glutamate carboxypeptidase 2,13206,139,1.09 [0.96-1.23],0.1737317636578644
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR1,Folate receptor alpha,15597,157,1.07 [0.65-1.78],0.7851137779519602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR2,Folate receptor beta,15780,160,1.20 [0.74-1.94],0.4569470414266167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOLR3,Folate receptor gamma,15631,157,0.99 [0.91-1.07],0.7291877480557207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOS,Proto-oncogene c-Fos,13079,139,1.14 [0.72-1.81],0.5743277228478318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOSB,Protein fosB,15248,155,1.02 [0.71-1.46],0.9117214974690216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXJ3,Forkhead box protein J3,13206,139,1.28 [0.93-1.74],0.1260675901063506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXO1,Forkhead box protein O1,15623,160,1.03 [0.87-1.21],0.7395054924847574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FOXO3,Forkhead box protein O3,15268,155,1.08 [0.94-1.23],0.3011320049278196
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRMD4B,FERM domain-containing protein 4B,13163,138,0.95 [0.75-1.20],0.6467086951614406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRMD7,FERM domain-containing protein 7,13194,139,0.68 [0.41-1.11],0.119793401754303
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FRZB,Secreted frizzled-related protein 3,15469,156,1.02 [0.61-1.71],0.9469809396193204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSHB,Follitropin subunit beta,13218,134,1.36 [1.07-1.72],0.0103613619805729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FST,Follistatin,15693,156,1.17 [0.90-1.52],0.2307433292453027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSTL1,Follistatin-related protein 1,13218,134,0.93 [0.45-1.92],0.8382553816177065
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FSTL3,Follistatin-related protein 3,15612,154,1.27 [0.80-2.02],0.3112326638362637
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FTCD,Formimidoyltransferase-cyclodeaminase,13527,141,1.01 [0.84-1.22],0.8915246678431409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUCA1,Tissue alpha-L-fucosidase,15732,160,1.01 [0.85-1.20],0.946085167832934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUOM,Fucose mutarotase,13289,138,1.19 [0.93-1.53],0.1669949000293451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FURIN,Furin,15681,158,1.13 [0.75-1.69],0.5654595387779469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUS,RNA-binding protein FUS,15242,155,1.26 [0.89-1.77],0.1914245612808619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",13285,142,0.98 [0.76-1.26],0.8783211391493481
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,15780,160,0.74 [0.54-1.01],0.0564043002793362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FUT8,"Alpha-(1,6)-fucosyltransferase",15529,157,1.06 [0.83-1.35],0.629030343149204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FXN,"Frataxin, mitochondrial",15780,157,1.01 [0.83-1.22],0.9436176713797564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FXYD5,FXYD domain-containing ion transport regulator 5,15330,154,1.08 [0.88-1.34],0.4548953546810973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FYB1,FYN-binding protein 1,15611,159,1.00 [0.86-1.17],0.9700934119852808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FZD10,Frizzled-10,13194,139,1.18 [0.94-1.46],0.1485575106458814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FZD8,Frizzled-8,13169,137,1.00 [0.69-1.46],0.998974401419608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABARAP,Gamma-aminobutyric acid receptor-associated protein,13509,145,0.98 [0.71-1.34],0.8818686758685739
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,13310,143,1.10 [0.88-1.37],0.3960274392702247
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,13169,137,0.82 [0.61-1.09],0.1752225889171639
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAD1,Glutamate decarboxylase 1,13103,139,1.21 [0.65-2.24],0.5541170618513085
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAD2,Glutamate decarboxylase 2,13206,139,0.92 [0.64-1.31],0.6309627059584617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,13310,143,0.88 [0.61-1.26],0.4774082852007486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,13218,134,1.02 [0.75-1.39],0.885946623230341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAGE2A,G antigen 2A,13103,139,1.45 [1.23-1.72],1.3516748485399891e-05
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAL,Galanin peptides,15718,156,0.75 [0.60-0.94],0.0113981636888978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,15572,159,1.31 [0.80-2.13],0.2818592178476918
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,15780,157,1.00 [0.57-1.74],0.997348166514932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,15330,154,1.11 [0.79-1.56],0.5611319163465105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,13588,144,1.66 [0.91-3.03],0.0986250280392661
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GALNT7,N-acetylgalactosaminyltransferase 7,15572,159,0.87 [0.45-1.70],0.6870031642825899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAMT,Guanidinoacetate N-methyltransferase,13163,138,1.13 [0.77-1.68],0.5261028791125615
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13000,137,0.98 [0.61-1.58],0.9406261281882252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GART,Trifunctional purine biosynthetic protein adenosine-3,13571,143,0.93 [0.50-1.73],0.8166248671737029
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAS2,Growth arrest-specific protein 2,13310,143,1.10 [0.84-1.44],0.4833419350624165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAS6,Growth arrest-specific protein 6,15720,160,0.97 [0.57-1.66],0.9237488088369048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GASK1A,Golgi-associated kinase 1A,13163,138,1.08 [0.74-1.58],0.6876897153723571
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GAST,Gastrin,13545,141,1.17 [1.04-1.31],0.0080771673860784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13103,139,0.76 [0.41-1.43],0.3998317850040815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",13218,134,1.00 [0.81-1.23],0.9715762021460256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBA,Lysosomal acid glucosylceramidase,13194,139,1.05 [0.78-1.40],0.7544211261665015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP1,Guanylate-binding protein 1,13519,141,1.05 [0.82-1.34],0.7157058140116025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP2,Guanylate-binding protein 2,15330,154,0.81 [0.64-1.03],0.0878243151073899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP4,Guanylate-binding protein 4,15248,155,1.06 [0.80-1.41],0.6721012311514012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GBP6,Guanylate-binding protein 6,13163,138,0.85 [0.57-1.27],0.4227261083329864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GC,Vitamin D-binding protein,13612,142,1.37 [0.76-2.49],0.2957806528903145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCC1,GRIP and coiled-coil domain-containing protein 1,13545,141,1.02 [0.88-1.18],0.7929601774878715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCG,Pro-glucagon,15268,155,1.07 [0.96-1.21],0.2297475299157961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,12961,136,1.18 [0.88-1.57],0.2756241471275715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCLM,Glutamate--cysteine ligase regulatory subunit,13163,138,0.89 [0.61-1.29],0.5305893430552759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",15572,159,1.05 [0.70-1.57],0.8270072475870207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDF15,Growth/differentiation factor 15,15834,160,1.33 [1.03-1.72],0.0278163235951701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDF2,Growth/differentiation factor 2,15635,156,0.95 [0.64-1.41],0.7942834086030408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GDNF,Glial cell line-derived neurotrophic factor,15248,155,1.10 [0.76-1.60],0.6003224126681789
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GET3,ATPase GET3,13588,144,0.99 [0.75-1.30],0.9434498632708104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFAP,Glial fibrillary acidic protein,15248,155,1.42 [1.04-1.93],0.0260775121815163
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFER,FAD-linked sulfhydryl oxidase ALR,15268,155,1.04 [0.84-1.30],0.7117397867865609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,15268,155,1.02 [0.92-1.14],0.6816001740500672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA1,GDNF family receptor alpha-1,15757,157,1.85 [1.14-3.02],0.0134002534009368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA2,GDNF family receptor alpha-2,15572,159,1.20 [0.62-2.33],0.5820776819760012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRA3,GDNF family receptor alpha-3,15482,156,0.96 [0.58-1.59],0.8834785071258503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFRAL,GDNF family receptor alpha-like,13139,137,1.08 [0.83-1.40],0.5817265792934336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGA1,ADP-ribosylation factor-binding protein GGA1,15248,155,1.15 [0.97-1.37],0.1059521871163707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGACT,Gamma-glutamylaminecyclotransferase,13588,144,1.02 [0.81-1.27],0.8863770460740539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGCT,Gamma-glutamylcyclotransferase,13566,144,1.02 [0.74-1.42],0.8978174072474081
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGH,Gamma-glutamyl hydrolase,15336,150,1.16 [0.77-1.76],0.4785024143082629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGT1,Glutathione hydrolase 1 proenzyme,15607,159,1.16 [0.88-1.53],0.3026525103321865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GGT5,Glutathione hydrolase 5 proenzyme,15529,157,0.61 [0.34-1.11],0.1046153001118748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GH1,Somatotropin,15613,156,0.97 [0.89-1.05],0.4119062938988662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GH2,Growth hormone variant,15268,155,1.11 [1.03-1.19],0.005054043114302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHR,Growth hormone receptor,13289,138,1.18 [0.68-2.07],0.5565148965879616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHRHR,Growth hormone-releasing hormone receptor,15248,155,0.96 [0.74-1.24],0.7502595523024905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GHRL,Appetite-regulating hormone,15635,156,1.15 [0.95-1.39],0.1469892820540719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GID8,Glucose-induced degradation protein 8 homolog,13571,143,1.18 [0.78-1.76],0.431078194905625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIGYF2,GRB10-interacting GYF protein 2,13571,143,0.98 [0.79-1.20],0.816969985399678
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIMAP7,GTPase IMAP family member 7,13289,138,0.88 [0.53-1.47],0.6335047096013309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIMAP8,GTPase IMAP family member 8,13103,139,1.30 [1.00-1.70],0.0486208076285982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIP,Gastric inhibitory polypeptide,13218,134,1.20 [0.84-1.72],0.3175968903110505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPC2,PDZ domain-containing protein GIPC2,13545,141,1.17 [0.68-2.01],0.5695013573322101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPC3,PDZ domain-containing protein GIPC3,13524,142,1.08 [0.91-1.27],0.380437772321634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPR,Gastric inhibitory polypeptide receptor,13206,139,1.12 [0.83-1.52],0.4511008995013669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIT1,ARF GTPase-activating protein GIT1,13206,139,0.99 [0.84-1.17],0.9197427912278536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GJA8,Gap junction alpha-8 protein,13103,139,0.93 [0.71-1.23],0.6250908281515544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GKN1,Gastrokine-1,14946,150,1.34 [0.80-2.25],0.2619931378306167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLA,Alpha-galactosidase A,13257,138,1.01 [0.65-1.58],0.947447344109124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLB1,Beta-galactosidase,15529,157,0.97 [0.68-1.37],0.8439170530991604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLI2,Zinc finger protein GLI2,13206,139,1.38 [0.96-1.97],0.0802645639813056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLO1,Lactoylglutathione lyase,15372,156,1.11 [0.87-1.40],0.4033479294900386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLOD4,Glyoxalase domain-containing protein 4,15607,156,1.07 [0.73-1.57],0.7253171068730643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLP1R,Glucagon-like peptide 1 receptor,13169,137,0.71 [0.43-1.16],0.1692823608020903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLRX,Glutaredoxin-1,15548,156,1.00 [0.78-1.27],0.989646009635362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",13289,138,1.04 [0.87-1.24],0.6892900880073617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,15248,155,0.82 [0.59-1.15],0.2534741159041495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLYR1,Putative oxidoreductase GLYR1,13509,145,1.10 [0.88-1.39],0.4017225954395178
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GM2A,Ganglioside GM2 activator,13264,140,1.24 [0.87-1.78],0.2393016088618631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMFG,Glia maturation factor gamma,13588,144,1.07 [0.86-1.33],0.5439652282260642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMPR,GMP reductase 1,15813,160,1.06 [0.81-1.38],0.6874695777086715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GMPR2,GMP reductase 2,13289,138,1.02 [0.80-1.29],0.8964923214702831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNAS,Neuroendocrine secretory protein 55,13571,143,1.01 [0.85-1.21],0.8831846522474274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,15268,155,1.08 [0.87-1.33],0.4900152288120808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,13194,139,0.92 [0.66-1.28],0.6104403901463317
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNLY,Granulysin,15634,160,0.84 [0.64-1.11],0.216863351655687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNPDA1,Glucosamine-6-phosphate isomerase 1,13218,134,0.51 [0.27-0.95],0.0354455322306306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNPDA2,Glucosamine-6-phosphate isomerase 2,13289,138,1.22 [0.79-1.90],0.3654741822732026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOLGA3,Golgin subfamily A member 3,13571,143,1.05 [0.85-1.28],0.6698017150805071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOLM2,Protein GOLM2,15780,160,0.77 [0.41-1.45],0.4140556704681184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,15623,160,1.02 [0.89-1.17],0.8109489582628449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GORASP2,Golgi reassembly-stacking protein 2,13524,142,1.24 [0.89-1.72],0.2059524409642196
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GOT1,"Aspartate aminotransferase, cytoplasmic",13569,142,1.03 [0.70-1.52],0.8715600896435975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP1BA,Platelet glycoprotein Ib alpha chain,15556,155,1.15 [0.74-1.78],0.5389774440064763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP1BB,Platelet glycoprotein Ib beta chain,13163,138,1.15 [0.90-1.46],0.2730575604832386
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,15173,152,0.86 [0.72-1.04],0.1135572576261148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP5,Platelet glycoprotein V,13289,138,1.48 [0.93-2.37],0.1018023871017588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GP6,Platelet glycoprotein VI,15611,159,1.06 [0.91-1.25],0.4361245112689397
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPA33,Cell surface A33 antigen,15572,159,0.90 [0.81-1.00],0.0569445510885746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPC1,Glypican-1,15780,157,1.48 [0.92-2.40],0.1083386167206475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPC5,Glypican-5,15529,157,1.08 [0.84-1.39],0.5348867746841168
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPD1,Glycerol-3-phosphate dehydrogenase,13509,145,1.11 [0.82-1.50],0.4971420666916073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPHA2,Glycoprotein hormone alpha-2,13524,142,1.03 [0.76-1.41],0.8476454054949533
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPI,Glucose-6-phosphate isomerase,13597,143,0.95 [0.68-1.32],0.7416848943165695
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,13524,142,1.02 [0.81-1.28],0.8764898206298389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPKOW,G-patch domain and KOW motifs-containing protein,15248,155,0.69 [0.39-1.22],0.2030716420578308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPNMB,Transmembrane glycoprotein NMB,15216,155,1.44 [0.86-2.39],0.1612563602198469
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR101,Probable G-protein coupled receptor 101,13169,137,0.82 [0.61-1.12],0.222350619449818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR158,Probable G-protein coupled receptor 158,13571,143,0.95 [0.61-1.47],0.8162412782268198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR15L,Protein GPR15L,13524,142,1.37 [1.08-1.76],0.0108472911960589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPR37,Prosaposin receptor GPR37,15372,156,1.27 [1.02-1.58],0.0301675634746852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPRC5C,G-protein coupled receptor family C group 5 member C,13509,145,1.07 [0.82-1.39],0.60607766301854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRAP2,GRB2-related adapter protein 2,15635,156,1.01 [0.91-1.13],0.814656650336147
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,13588,144,1.05 [0.83-1.34],0.673087973218784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRIK2,"Glutamate receptor ionotropic, kainate 2",13571,143,1.25 [0.89-1.77],0.2011117158271398
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",13169,137,0.87 [0.63-1.19],0.3797548622948997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRK5,G protein-coupled receptor kinase 5,15372,156,1.17 [0.92-1.49],0.1883345480599858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRN,Progranulin,15558,159,0.89 [0.50-1.59],0.700050524966024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRP,Gastrin-releasing peptide,13218,134,1.04 [0.76-1.43],0.804578677444205
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRPEL1,"GrpE protein homolog 1, mitochondrial",15572,159,1.19 [0.96-1.47],0.1214587165242629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GRSF1,G-rich sequence factor 1,13034,139,1.09 [0.90-1.33],0.3882345177537352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSAP,Gamma-secretase-activating protein,15268,155,0.95 [0.80-1.12],0.5305991992939354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSN,Gelsolin,13544,143,0.71 [0.30-1.67],0.4312492419554963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSR,"Glutathione reductase, mitochondrial",13518,142,1.43 [0.70-2.91],0.3225876452889633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTA1,Glutathione S-transferase A1,15615,156,1.00 [0.85-1.19],0.9560762912528712
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTA3,Glutathione S-transferase A3,15268,155,1.01 [0.84-1.22],0.8752472779874007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTM4,Glutathione S-transferase Mu 4,13163,138,0.88 [0.68-1.13],0.3157106188409448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTP1,Glutathione S-transferase P,15155,154,0.90 [0.73-1.12],0.3600003122510834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSTT2B,Glutathione S-transferase theta-2B,13545,141,1.00 [0.94-1.07],0.8852404264475149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,13310,143,1.22 [1.04-1.44],0.0160717192088958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GTPBP2,GTP-binding protein 2,13194,139,1.08 [0.88-1.32],0.468657759157001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUCA2A,Guanylin,15560,159,1.48 [0.97-2.26],0.0708656716658552
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUCY2C,Heat-stable enterotoxin receptor,13310,143,0.99 [0.82-1.19],0.8966014743502068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUK1,Guanylate kinase,13163,138,1.00 [0.68-1.47],0.9891781192019966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GUSB,Beta-glucuronidase,15699,160,1.03 [0.82-1.30],0.7915531372910707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GYS1,"Glycogen [starch] synthase, muscle",15372,156,1.06 [0.91-1.24],0.4342202704876406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMA,Granzyme A,15813,160,0.97 [0.64-1.45],0.8714998132532656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMB,Granzyme B,15623,160,0.91 [0.72-1.14],0.4009418461015436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMH,Granzyme H,15372,156,0.89 [0.72-1.09],0.2649801519394298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",H2AP,Huntingtin-interacting protein M,13103,139,0.99 [0.71-1.37],0.9297390903895998
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",13163,138,1.17 [0.96-1.43],0.1184566429179867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",15740,157,0.91 [0.75-1.09],0.3090173697992403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAO1,Hydroxyacid oxidase 1,15780,157,1.02 [0.92-1.14],0.6457017836328929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HARS1,"Histidine--tRNA ligase, cytoplasmic",15634,160,0.98 [0.82-1.17],0.7896416585614049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAVCR1,Hepatitis A virus cellular receptor 1,15763,157,1.34 [1.08-1.67],0.0082131506656561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HAVCR2,Hepatitis A virus cellular receptor 2,15634,160,1.45 [0.97-2.16],0.071301738571661
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBEGF,Proheparin-binding EGF-like growth factor,15740,157,1.05 [0.87-1.27],0.6060875080416818
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBQ1,Hemoglobin subunit theta-1,15780,157,0.90 [0.71-1.14],0.3891819698787918
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HBZ,Hemoglobin subunit zeta,13588,144,1.01 [0.87-1.18],0.8541097560724269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HCG22,Protein PBMUCL2,13163,138,1.06 [0.80-1.40],0.6746240095804883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HCLS1,Hematopoietic lineage cell-specific protein,15813,160,0.92 [0.72-1.18],0.5041394292621824
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDAC8,Histone deacetylase 8,13206,139,1.13 [0.92-1.40],0.2436965642273835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDAC9,Histone deacetylase 9,13169,137,1.09 [0.87-1.38],0.4529951464640519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDDC2,5'-deoxynucleotidase HDDC2,13524,142,1.17 [0.83-1.65],0.3795910436767351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGF,Hepatoma-derived growth factor,15762,156,1.07 [0.93-1.24],0.3381624869499812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGFL2,Hepatoma-derived growth factor-related protein 2,13545,141,1.08 [0.84-1.37],0.5546077725888875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEBP1,Heme-binding protein 1,15372,156,1.19 [0.97-1.47],0.0998930281355124
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEG1,Protein HEG homolog 1,13289,138,1.34 [0.73-2.45],0.3470714141265261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEPACAM2,HEPACAM family member 2,13545,141,1.04 [0.70-1.54],0.8491953550611058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEPH,Hephaestin,13588,144,1.50 [0.80-2.79],0.2043449010128863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HEXIM1,Protein HEXIM1,15623,160,1.01 [0.85-1.20],0.9108261717584872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGF,Hepatocyte growth factor,15813,160,1.37 [0.92-2.02],0.1175531753586381
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGFAC,Hepatocyte growth factor activator,13466,142,0.83 [0.48-1.44],0.5162027831356073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,15268,155,1.03 [0.86-1.24],0.7325816305970071
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HHEX,Hematopoietically-expressed homeobox protein HHEX,13545,141,1.15 [0.93-1.41],0.1979747193078536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIF1A,Hypoxia-inducible factor 1-alpha,13206,139,1.18 [0.98-1.42],0.0880459186763477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIP1,Huntingtin-interacting protein 1,13163,138,0.76 [0.45-1.28],0.3040012254451003
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HIP1R,Huntingtin-interacting protein 1-related protein,13527,141,0.95 [0.65-1.39],0.7966624864887907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HJV,Hemojuvelin,13571,143,1.32 [0.97-1.78],0.0730300553923217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HK2,Hexokinase-2,15372,156,1.36 [0.85-2.20],0.2022161456985991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",13571,143,0.67 [0.41-1.08],0.0996191465004422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",15573,160,1.21 [0.83-1.77],0.3279948071607431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",15623,160,0.92 [0.55-1.53],0.7548515766325121
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMBS,Porphobilinogen deaminase,15780,157,0.93 [0.69-1.26],0.6578165457274718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMCN2,Hemicentin-2,13263,138,0.94 [0.71-1.25],0.6726137795817995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",13218,134,0.97 [0.70-1.35],0.8560122880735983
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",13163,138,1.13 [0.81-1.57],0.488301058869986
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMMR,Hyaluronan mediated motility receptor,13085,139,1.35 [1.03-1.76],0.0301314695652359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMOX1,Heme oxygenase 1,15460,156,0.92 [0.67-1.25],0.5851775731357192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HMOX2,Heme oxygenase 2,15248,155,1.03 [0.77-1.40],0.8291211436162573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNF1A,Hepatocyte nuclear factor 1-alpha,13194,139,0.92 [0.73-1.18],0.5208132826382186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNMT,Histamine N-methyltransferase,15448,157,1.06 [0.78-1.44],0.7062309840161174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,15321,154,1.10 [0.92-1.31],0.3155422780894079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,13571,143,1.11 [0.82-1.51],0.4902485847550685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPCAL1,Hippocalcin-like protein 1,15813,160,1.01 [0.83-1.21],0.9559384559692432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPGDS,Hematopoietic prostaglandin D synthase,15268,155,1.40 [0.99-1.99],0.0569664960106825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HPSE,Heparanase,13385,141,1.09 [0.92-1.30],0.327507440246288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRAS,GTPase Hras,13293,143,1.09 [0.95-1.25],0.2346861424153717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,13218,134,0.68 [0.40-1.14],0.1406732779394128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HRG,Histidine-rich glycoprotein,13534,141,1.42 [0.85-2.36],0.1779431573602609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS1BP3,HCLS1-binding protein 3,13218,134,1.10 [0.91-1.32],0.3305772695951257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,15572,159,1.37 [0.95-1.96],0.08963671364981
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,15780,157,1.19 [0.81-1.76],0.3778700908033759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,13206,139,1.12 [0.65-1.91],0.6840374796968625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSBP1,Heat shock factor-binding protein 1,13218,134,0.92 [0.78-1.10],0.3647743331975713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,15623,160,0.73 [0.51-1.03],0.0746032004997613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,13545,141,0.96 [0.74-1.24],0.7346885613658298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSD17B3,Testosterone 17-beta-dehydrogenase 3,13163,138,0.74 [0.50-1.07],0.111102768966495
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,13218,134,1.18 [0.84-1.66],0.3489341351774594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSP90B1,Endoplasmin,15170,151,1.06 [0.87-1.29],0.5544008957859167
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPA1A,Heat shock 70 kDa protein 1A,15689,156,0.95 [0.78-1.16],0.615520580259399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPA2,Heat shock-related 70 kDa protein 2,13509,145,1.28 [0.83-1.98],0.2679009731663595
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPB1,Heat shock protein beta-1,15375,155,1.07 [0.86-1.32],0.5348642670892967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPB6,Heat shock protein beta-6,15780,157,1.07 [0.72-1.57],0.746953040618785
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,15487,153,1.49 [0.86-2.59],0.154665932743411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTR1A,5-hydroxytryptamine receptor 1A,13169,137,0.84 [0.66-1.07],0.1575301205148778
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTR1B,5-hydroxytryptamine receptor 1B,13169,137,0.93 [0.62-1.38],0.7040540833185629
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HTRA2,"Serine protease HTRA2, mitochondrial",15681,158,1.00 [0.80-1.26],0.9838070042551708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HYAL1,Hyaluronidase-1,15514,154,1.77 [1.00-3.15],0.0514173753979596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HYOU1,Hypoxia up-regulated protein 1,15834,160,1.46 [0.76-2.79],0.2552518311047106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICA1,Islet cell autoantigen 1,15330,154,1.04 [0.87-1.25],0.6478092452689491
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM1,Intercellular adhesion molecule 1,15557,155,1.22 [0.76-1.98],0.4103503367905078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM2,Intercellular adhesion molecule 2,15834,160,0.89 [0.57-1.40],0.6164996175754195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM3,Intercellular adhesion molecule 3,15834,160,1.08 [0.61-1.89],0.7956746846023858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM4,Intercellular adhesion molecule 4,15623,160,0.79 [0.61-1.03],0.0801079475169094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICAM5,Intercellular adhesion molecule 5,15635,156,1.06 [0.77-1.45],0.729396316984698
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ICOSLG,ICOS ligand,15572,159,1.18 [0.57-2.46],0.6506166552210263
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ID4,DNA-binding protein inhibitor ID-4,13310,143,1.01 [0.72-1.43],0.933603542077556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDI2,Isopentenyl-diphosphate delta-isomerase 2,15248,155,0.93 [0.68-1.28],0.6707122416629355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDO1,"Indoleamine 2,3-dioxygenase 1",13218,134,0.98 [0.76-1.27],0.8851309212094294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDS,Iduronate 2-sulfatase,15813,160,1.64 [0.32-8.51],0.553098440113127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IDUA,Alpha-L-iduronidase,15780,157,1.00 [0.73-1.35],0.9800343473393044
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,13199,141,1.26 [0.85-1.86],0.2561938047986052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,13310,143,0.97 [0.72-1.33],0.87118886359831
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,13310,143,1.01 [0.66-1.55],0.9540152477057028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNAR1,Interferon alpha/beta receptor 1,13524,142,1.66 [0.99-2.78],0.0524640735042696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNG,Interferon gamma,15330,154,1.10 [0.97-1.24],0.1374209118743108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNGR1,Interferon gamma receptor 1,15718,156,1.21 [0.60-2.46],0.5909274019881483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNGR2,Interferon gamma receptor 2,15529,157,0.91 [0.69-1.20],0.5053705685381049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNL1,Interferon lambda-1,15248,155,0.94 [0.68-1.29],0.6846275924147016
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNL2,Interferon lambda-2,13169,137,1.16 [0.94-1.43],0.1736026667433488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNLR1,Interferon lambda receptor 1,15623,160,0.93 [0.63-1.36],0.6908148479694026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFNW1,Interferon omega-1,13163,138,0.56 [0.31-0.99],0.047908700395339
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFT20,Intraflagellar transport protein 20 homolog,13194,139,1.23 [0.87-1.74],0.2328816831472718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGBP1,Immunoglobulin-binding protein 1,13571,143,1.04 [0.80-1.34],0.786955695316725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,13169,137,0.90 [0.62-1.29],0.5486418492357448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,13569,142,0.64 [0.34-1.21],0.1720970646755586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF1R,Insulin-like growth factor 1 receptor,15572,159,0.95 [0.50-1.79],0.8683610565406047
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,13163,138,1.07 [0.77-1.48],0.7060095401201665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2R,Cation-independent mannose-6-phosphate receptor,15634,160,1.61 [0.89-2.94],0.1169987295305483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP1,Insulin-like growth factor-binding protein 1,15807,160,1.01 [0.90-1.13],0.9062200053316696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP2,Insulin-like growth factor-binding protein 2,15802,160,0.97 [0.78-1.20],0.776390357442261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP3,Insulin-like growth factor-binding protein 3,15672,155,0.97 [0.57-1.64],0.9070285767363278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP4,Insulin-like growth factor-binding protein 4,15420,157,1.18 [0.83-1.67],0.3478152610274904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP6,Insulin-like growth factor-binding protein 6,15551,155,1.01 [0.60-1.70],0.9765596134539646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBP7,Insulin-like growth factor-binding protein 7,15834,160,1.17 [0.75-1.84],0.484842802477242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFBPL1,Insulin-like growth factor-binding protein-like 1,15635,156,0.77 [0.50-1.18],0.2265305581385622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGFL4,Insulin growth factor-like family member 4,13206,139,1.21 [1.05-1.41],0.0096379482706176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGHMBP2,DNA-binding protein SMUBP-2,13163,138,1.00 [0.76-1.33],0.9752408248689252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGLC2,Immunoglobulin lambda constant 2,13588,142,0.82 [0.38-1.78],0.6219795324892754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGLON5,IgLON family member 5,13103,139,1.08 [0.92-1.26],0.3525060794598991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF21,Immunoglobulin superfamily member 21,13218,134,0.81 [0.51-1.27],0.352118000688978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF3,Immunoglobulin superfamily member 3,15572,159,0.95 [0.64-1.43],0.8201798626951095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF8,Immunoglobulin superfamily member 8,15635,156,1.27 [0.81-2.01],0.2945440606645451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGSF9,Protein turtle homolog A,13588,144,1.10 [0.91-1.33],0.3348176362458513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IKBKG,NF-kappa-B essential modulator,15623,160,0.96 [0.83-1.12],0.6317172871393775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IKZF2,Zinc finger protein Helios,15268,155,1.04 [0.91-1.20],0.5353293040862525
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10,Interleukin-10,15330,154,1.08 [0.92-1.26],0.3671149536645903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RA,Interleukin-10 receptor subunit alpha,15330,154,0.93 [0.72-1.20],0.5843596222291221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RB,Interleukin-10 receptor subunit beta,15718,156,1.19 [0.73-1.95],0.4907085231006716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL11,Interleukin-11,15330,154,0.81 [0.62-1.05],0.1093738006526806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12A_IL12B,Interleukin-12,15572,159,0.95 [0.79-1.14],0.5610112634598382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12B,Interleukin-12 subunit beta,15813,160,0.87 [0.67-1.12],0.2779675229627564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12RB1,Interleukin-12 receptor subunit beta-1,15330,154,1.05 [0.72-1.54],0.8009158914896641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL12RB2,Interleukin-12 receptor subunit beta-2,13206,139,1.02 [0.70-1.51],0.9050722031264772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13,Interleukin-13,15330,154,1.00 [0.76-1.33],0.9752193821168296
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA1,Interleukin-13 receptor subunit alpha-1,15434,153,1.48 [0.75-2.92],0.2588146471440172
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA2,Interleukin-13 receptor subunit alpha-2,13169,137,0.66 [0.38-1.17],0.1540367989431019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL15,Interleukin-15,15623,160,1.45 [0.97-2.15],0.0670873138995236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL15RA,Interleukin-15 receptor subunit alpha,15330,154,0.99 [0.66-1.49],0.9511009514971444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL16,Pro-interleukin-16,15813,160,0.95 [0.68-1.32],0.7457278365081028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17A,Interleukin-17A,15315,154,1.11 [0.80-1.53],0.5383382531854681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17C,Interleukin-17C,15330,154,0.89 [0.71-1.11],0.3079347019216893
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17D,Interleukin-17D,15330,154,1.09 [0.73-1.64],0.6633596000587682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17F,Interleukin-17F,15330,154,1.06 [0.90-1.25],0.4928861095405625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17RA,Interleukin-17 receptor A,15634,160,1.14 [0.83-1.56],0.4271815938849524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL17RB,Interleukin-17 receptor B,15415,157,0.89 [0.69-1.16],0.3983957246911727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18,Interleukin-18,15585,154,1.30 [0.98-1.73],0.0727001803663019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18BP,Interleukin-18-binding protein,15672,155,1.20 [0.76-1.91],0.4375999549762719
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18R1,Interleukin-18 receptor 1,15813,160,1.06 [0.70-1.60],0.789805586418901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL18RAP,Interleukin-18 receptor accessory protein,15425,156,1.09 [1.01-1.18],0.0252180429947232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL19,Interleukin-19,15243,156,1.14 [0.93-1.39],0.2033078841270804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1A,Interleukin-1 alpha,15330,154,1.01 [0.78-1.32],0.925556648863578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1B,Interleukin-1 beta,15253,154,1.14 [0.89-1.45],0.2923408920004624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1R1,Interleukin-1 receptor type 1,15607,159,1.35 [0.72-2.52],0.3522850157030336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1R2,Interleukin-1 receptor type 2,15614,155,1.42 [0.68-2.98],0.3513450469301974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RAP,Interleukin-1 receptor accessory protein,15634,160,1.26 [0.92-1.72],0.1565907946881479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RL1,Interleukin-1 receptor-like 1,15777,160,1.01 [0.75-1.37],0.928221842435452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RL2,Interleukin-1 receptor-like 2,15330,154,1.24 [0.87-1.76],0.2356739431191511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL1RN,Interleukin-1 receptor antagonist protein,15608,156,1.13 [0.89-1.44],0.3129319360535214
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2,Interleukin-2,15330,154,1.25 [0.79-1.99],0.3378188811189431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20,Interleukin-20,15330,154,1.16 [0.91-1.48],0.2378388772321056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20RA,Interleukin-20 receptor subunit alpha,15330,154,1.03 [0.76-1.41],0.831798562127336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL20RB,Interleukin-20 receptor subunit beta,13206,139,1.23 [0.86-1.76],0.2550755781516863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL21R,Interleukin-21 receptor,13206,139,0.98 [0.73-1.32],0.8864623375984313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL22,Interleukin-22,13509,145,1.14 [0.91-1.43],0.2469330952091253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL22RA1,Interleukin-22 receptor subunit alpha-1,15330,154,0.99 [0.71-1.38],0.9400996869329268
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL24,Interleukin-24,15330,154,1.11 [0.84-1.47],0.460742902028331
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL25,Interleukin-25,13059,139,1.09 [0.68-1.74],0.7113665529682728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RA,Interleukin-2 receptor subunit alpha,15525,158,1.10 [0.77-1.56],0.6125762281393741
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RB,Interleukin-2 receptor subunit beta,15330,154,0.98 [0.67-1.42],0.9090465333815896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RG,Cytokine receptor common subunit gamma,13509,145,0.93 [0.61-1.43],0.7422569124363136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL3,Interleukin-3,13103,139,0.90 [0.70-1.15],0.4062126399111494
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL31,Interleukin-31,13206,139,0.88 [0.65-1.20],0.4250589900261078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL31RA,Interleukin-31 receptor subunit alpha,13156,137,1.36 [0.92-2.01],0.1252103605423203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL32,Interleukin-32,15623,160,0.90 [0.64-1.25],0.5215585391079338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL33,Interleukin-33,15330,154,1.56 [1.09-2.23],0.0156792433867808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL34,Interleukin-34,15222,154,0.98 [0.66-1.46],0.9394704930174136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL36A,Interleukin-36 alpha,13206,139,1.17 [0.93-1.47],0.1726963579181328
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL36G,Interleukin-36 gamma,13156,138,0.98 [0.77-1.25],0.8627609309875878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL3RA,Interleukin-3 receptor subunit alpha,15330,154,1.01 [0.64-1.59],0.956333870933664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL4,Interleukin-4,15330,154,0.92 [0.80-1.06],0.2617362806558598
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL4R,Interleukin-4 receptor subunit alpha,15623,160,1.20 [0.82-1.76],0.3539631045864557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5,Interleukin-5,15330,154,1.02 [0.93-1.12],0.6591556803599448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5RA,Interleukin-5 receptor subunit alpha,15623,160,0.89 [0.68-1.15],0.3680067025681784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6,Interleukin-6,15572,159,1.03 [0.85-1.25],0.74412442966633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6R,Interleukin-6 receptor subunit alpha,15523,155,1.54 [1.01-2.33],0.0439956271253794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL6ST,Interleukin-6 receptor subunit beta,15635,156,1.88 [0.90-3.94],0.0925265239410248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL7,Interleukin-7,15623,160,1.00 [0.80-1.24],0.9760649395387292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL7R,Interleukin-7 receptor subunit alpha,15634,160,1.05 [0.81-1.37],0.6971136579435369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL9,Interleukin-9,13310,143,1.13 [0.89-1.44],0.309901025504455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,15230,155,1.06 [0.84-1.35],0.6185952820608833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMMT,MICOS complex subunit MIC60,13509,145,1.16 [0.84-1.61],0.3682673383167961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPA1,Inositol monophosphatase 1,15529,157,0.97 [0.77-1.22],0.7871282945911775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPACT,Protein IMPACT,13545,141,1.00 [0.76-1.33],0.9822370787441508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMPG1,Interphotoreceptor matrix proteoglycan 1,13169,137,1.12 [0.67-1.86],0.6678769420488775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ING1,Inhibitor of growth protein 1,15218,155,0.71 [0.50-1.01],0.0597780694666232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INHBB,Inhibin beta B chain,13289,138,1.00 [0.72-1.38],0.9831990439901114
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INHBC,Inhibin beta C chain,15634,160,1.05 [0.76-1.46],0.761531344716978
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP1,Inositol polyphosphate 1-phosphatase,15572,159,0.97 [0.75-1.26],0.8294385483199336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",13218,134,0.93 [0.70-1.25],0.6516954013201706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",13571,143,0.87 [0.58-1.29],0.4777108698771841
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",15572,159,1.00 [0.87-1.16],0.986196963314148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL3,Insulin-like 3,13545,141,0.98 [0.75-1.28],0.8925180075158967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL4,Early placenta insulin-like peptide,13509,145,0.96 [0.72-1.30],0.8149811198225692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSL5,Insulin-like peptide INSL5,13524,142,1.06 [0.90-1.26],0.461272297335135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INSR,Insulin receptor,13206,139,1.27 [0.48-3.33],0.6283512034123104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IPCEF1,Interactor protein for cytohesin exchange factors 1,15502,157,1.08 [0.92-1.26],0.351008484669238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IQGAP2,Ras GTPase-activating-like protein IQGAP2,15572,159,0.89 [0.69-1.15],0.3730775693042097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",15372,156,0.94 [0.79-1.10],0.4277635475215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAK1,Interleukin-1 receptor-associated kinase 1,15330,154,1.00 [0.81-1.22],0.9633979405496926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IRAK4,Interleukin-1 receptor-associated kinase 4,15623,160,1.04 [0.91-1.19],0.5294738859771022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,15021,153,1.10 [0.75-1.61],0.6415594577336214
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISM1,Isthmin-1,15623,160,1.19 [0.84-1.68],0.316928590373134
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ISM2,Isthmin-2,13569,142,0.88 [0.60-1.30],0.5261369732811716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IST1,IST1 homolog,13435,142,1.04 [0.89-1.23],0.5964642701053853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA11,Integrin alpha-11,15623,160,1.04 [0.70-1.55],0.8580638244287997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA2,Integrin alpha-2,13289,138,1.32 [0.80-2.16],0.2799857254778441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA5,Integrin alpha-5,15634,160,0.92 [0.52-1.62],0.7738554519262182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGA6,Integrin alpha-6,15623,160,0.98 [0.76-1.27],0.8906678539570079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAL,Integrin alpha-L,13206,139,1.05 [0.72-1.53],0.802891427280204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAM,Integrin alpha-M,15634,160,0.80 [0.52-1.25],0.3335562295116377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAV,Integrin alpha-V,15780,157,1.45 [0.62-3.38],0.3949274605010169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGAX,Integrin alpha-X,13310,143,0.94 [0.70-1.28],0.6975443248349421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1,Integrin beta-1,15594,155,0.83 [0.43-1.60],0.5769200565974382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1BP1,Integrin beta-1-binding protein 1,15268,155,1.22 [0.87-1.71],0.2410747812037799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB1BP2,Integrin beta-1-binding protein 2,15372,156,0.99 [0.87-1.12],0.8779402194707169
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB2,Integrin beta-2,15533,160,0.94 [0.57-1.52],0.7876186579429145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB5,Integrin beta-5,15681,158,0.96 [0.66-1.39],0.8141945317985502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB6,Integrin beta-6,15330,154,1.11 [0.69-1.80],0.6672418637864046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGB7,Integrin beta-7,15780,157,1.05 [0.77-1.42],0.768117761077926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITGBL1,Integrin beta-like protein 1,13569,142,0.73 [0.45-1.18],0.1948225675677632
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,13612,142,0.57 [0.24-1.34],0.196178846779596
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,15672,155,1.07 [0.73-1.55],0.7317752017522876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,13612,142,1.47 [0.86-2.52],0.1571852920463682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,13509,145,0.97 [0.68-1.37],0.8601631260622149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITM2A,Integral membrane protein 2A,15623,160,0.96 [0.75-1.22],0.7235710252611784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPA,Inosine triphosphate pyrophosphatase,13163,138,0.98 [0.77-1.25],0.8460629765071791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",13218,134,1.11 [0.90-1.37],0.3323196168475729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",13169,137,1.11 [0.81-1.53],0.5017314636535026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",15248,155,0.81 [0.60-1.10],0.1707093367393973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IZUMO1,Izumo sperm-egg fusion protein 1,13103,139,1.08 [0.80-1.46],0.6183212593419861
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JAM2,Junctional adhesion molecule B,15780,160,1.68 [0.99-2.85],0.0552825758825507
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JAM3,Junctional adhesion molecule C,13289,138,1.04 [0.76-1.43],0.7927534891229115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JCHAIN,Immunoglobulin J chain,15330,154,0.97 [0.76-1.23],0.8103704021188443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13103,139,0.98 [0.72-1.32],0.873821620697126
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JPT2,Jupiter microtubule associated homolog 2,13524,142,1.13 [0.94-1.35],0.2014865913404493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",JUN,Transcription factor AP-1,15330,154,1.05 [0.82-1.35],0.6735760375268132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,15572,159,0.85 [0.63-1.14],0.2669971906220513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KAZN,Kazrin,13524,142,1.01 [0.87-1.18],0.884208110799211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNC4,Potassium voltage-gated channel subfamily C member 4,13169,137,0.98 [0.73-1.31],0.8822194771739829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNH2,Potassium voltage-gated channel subfamily H member 2,13194,139,0.83 [0.65-1.07],0.1557496407172332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCNIP4,Kv channel-interacting protein 4,15248,155,1.12 [0.88-1.43],0.3578946594944665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCTD5,BTB/POZ domain-containing protein KCTD5,13292,140,0.83 [0.56-1.23],0.3517122295637027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KDM3A,Lysine-specific demethylase 3A,13206,139,1.10 [0.95-1.27],0.1896776712606825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KDR,Vascular endothelial growth factor receptor 2,15681,158,1.34 [0.77-2.31],0.301819971705621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KEL,Kell blood group glycoprotein,15248,155,0.96 [0.65-1.44],0.8541865811143193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KHDC3L,KH domain-containing protein 3,13103,139,1.22 [1.02-1.46],0.0262455201072006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KHK,Ketohexokinase,13218,134,1.04 [0.80-1.34],0.7786571493254245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA0319,Dyslexia-associated protein KIAA0319,13545,141,0.81 [0.47-1.38],0.4357018167284182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA1549,UPF0606 protein KIAA1549,13310,143,1.10 [0.89-1.37],0.3838899348593216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA1549L,UPF0606 protein KIAA1549L,13310,143,0.87 [0.49-1.55],0.6376326977231104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIAA2013,Uncharacterized protein KIAA2013,13509,145,0.92 [0.69-1.24],0.5920492130618549
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF1C,Kinesin-like protein KIF1C,13163,138,1.16 [0.79-1.71],0.4497198743696486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF20B,Kinesin-like protein KIF20B,13169,137,1.03 [0.84-1.27],0.757709006464523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIF22,Kinesin-like protein KIF22,13163,138,1.00 [0.88-1.15],0.9659285271871384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIFBP,KIF-binding protein,15572,159,1.00 [0.85-1.19],0.9775419000215738
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,13509,145,0.96 [0.79-1.16],0.6375749349450466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,15268,155,0.92 [0.76-1.11],0.3792726329048702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,13524,142,0.96 [0.87-1.05],0.3491775555748754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,15268,155,1.03 [0.92-1.17],0.5949834235895077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13103,139,1.11 [0.95-1.30],0.190391296038499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIRREL1,Kin of IRRE-like protein 1,13169,137,1.00 [0.76-1.30],0.9732923796809708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIRREL2,Kin of IRRE-like protein 2,15248,155,1.03 [0.72-1.47],0.8669062106402314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIT,Mast/stem cell growth factor receptor Kit,15650,155,1.13 [0.70-1.83],0.6176069825980648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KITLG,Kit ligand,15635,156,0.75 [0.51-1.09],0.1333318483992374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLB,Beta-klotho,15248,155,0.95 [0.78-1.15],0.59000696944008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLF4,Krueppel-like factor 4,13169,137,1.32 [0.92-1.89],0.1299854303927662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLHL41,Kelch-like protein 41,13571,143,1.28 [0.98-1.68],0.0748311443608418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK1,Kallikrein-1,15477,156,0.96 [0.86-1.08],0.4854655024932538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK10,Kallikrein-10,15633,157,1.13 [0.79-1.60],0.5041666981072697
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK11,Kallikrein-11,15526,157,1.17 [0.73-1.88],0.5046907184956443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK12,Kallikrein-12,15268,155,1.01 [0.92-1.12],0.8125394955217511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK13,Kallikrein-13,15302,154,1.14 [0.82-1.59],0.4251400425547351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK14,Kallikrein-14,15780,157,1.31 [0.98-1.77],0.0720825148603148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK15,Kallikrein-15,13491,145,0.98 [0.71-1.34],0.8898886634733154
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK3,Prostate-specific antigen,13569,142,1.00 [0.75-1.32],0.973395822410614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK4,Kallikrein-4,15780,157,0.88 [0.70-1.12],0.3001720584835855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK6,Kallikrein-6,15665,158,1.14 [0.71-1.83],0.5918984564449916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK7,Kallikrein-7,12920,134,1.18 [0.78-1.78],0.4430023432548646
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK8,Kallikrein-8,15115,151,1.24 [0.82-1.86],0.311805235287141
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLKB1,Plasma kallikrein,13344,139,2.24 [1.22-4.11],0.0089997464056832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRB1,Killer cell lectin-like receptor subfamily B member 1,15813,160,1.10 [0.75-1.62],0.6125015496565833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,13169,137,0.86 [0.63-1.17],0.3314506136558635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRD1,Natural killer cells antigen CD94,15813,160,1.15 [0.85-1.57],0.3550982302992227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRF1,Killer cell lectin-like receptor subfamily F member 1,13206,139,1.03 [0.71-1.51],0.869716909515349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLRK1,NKG2-D type II integral membrane protein,13545,141,1.03 [0.72-1.47],0.8889760038190267
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT14,"Keratin, type I cytoskeletal 14",14754,152,1.25 [0.79-2.00],0.343087269260891
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT17,"Keratin, type I cytoskeletal 17",13163,138,0.82 [0.53-1.29],0.3931310289274864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT18,"Keratin, type I cytoskeletal 18",15572,159,0.99 [0.83-1.19],0.9270160319820218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT19,"Keratin, type I cytoskeletal 19",15603,159,1.03 [0.83-1.27],0.7846700399168527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT5,"Keratin, type II cytoskeletal 5",15248,155,1.15 [0.87-1.53],0.3286340832923047
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT6C,"Keratin, type II cytoskeletal 6C",13163,138,1.06 [0.73-1.54],0.7609913146658567
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KRT8,"Keratin, type II cytoskeletal 8",13169,137,0.69 [0.48-1.00],0.0489798009403885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KYAT1,Kynurenine--oxoglutarate transaminase 1,15604,156,1.07 [0.84-1.37],0.5708499798624224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KYNU,Kynureninase,15813,160,1.32 [0.99-1.77],0.0572217157328823
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",L1CAM,Neural cell adhesion molecule L1,15681,158,1.05 [0.64-1.72],0.8480668775183082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,13588,144,1.09 [0.91-1.29],0.3543422865858385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LACRT,Extracellular glycoprotein lacritin,13488,145,0.97 [0.71-1.34],0.86287345284773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LACTB2,Endoribonuclease LACTB2,15635,156,1.03 [0.83-1.27],0.7864608619574349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAG3,Lymphocyte activation gene 3 protein,15572,159,0.74 [0.52-1.06],0.1035283990388462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,15640,155,1.37 [0.98-1.93],0.0695721469550537
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,15529,157,1.08 [0.94-1.24],0.2909917932969579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMA1,Laminin subunit alpha-1,13163,138,0.84 [0.60-1.18],0.3155194589891971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMA4,Laminin subunit alpha-4,15718,156,1.38 [0.92-2.07],0.1154471259694072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMB1,Laminin subunit beta-1,13218,134,0.85 [0.49-1.47],0.5675915056479128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP1,Lysosome-associated membrane glycoprotein 1,13206,141,0.95 [0.52-1.73],0.8671835834522252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP2,Lysosome-associated membrane glycoprotein 2,15159,154,1.17 [0.54-2.54],0.6991624446589803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMP3,Lysosome-associated membrane glycoprotein 3,15783,159,1.09 [0.84-1.42],0.5118446453526325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMTOR5,Ragulator complex protein LAMTOR5,13509,145,1.15 [0.81-1.63],0.4406607798438877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAP3,Cytosol aminopeptidase,15330,154,0.90 [0.67-1.21],0.4783441989030728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LARP1,La-related protein 1,13509,145,1.06 [0.84-1.34],0.6107544702162797
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAT,Linker for activation of T-cells family member 1,15813,160,1.09 [0.91-1.31],0.3553850823820759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAT2,Linker for activation of T-cells family member 2,15572,159,1.02 [0.91-1.14],0.778229065589759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LATS1,Serine/threonine-protein kinase LATS1,13206,139,1.05 [0.87-1.27],0.6245072823124451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAYN,Layilin,15499,157,1.06 [0.69-1.63],0.8021135661037873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LBP,Lipopolysaccharide-binding protein,15672,155,1.01 [0.79-1.28],0.942926360869145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LBR,Delta(14)-sterol reductase LBR,15780,160,0.97 [0.79-1.19],0.7923613173931153
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCAT,Phosphatidylcholine-sterol acyltransferase,13597,143,1.80 [0.87-3.73],0.1138695190352294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCN15,Lipocalin-15,13571,143,0.97 [0.75-1.25],0.8033731226437617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCN2,Neutrophil gelatinase-associated lipocalin,15116,144,1.18 [0.80-1.74],0.4151644138101562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LCP1,Plastin-2,13569,142,0.98 [0.70-1.37],0.9106825327946568
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LDLR,Low-density lipoprotein receptor,15686,159,1.45 [1.12-1.88],0.0050434022977049
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LDLRAP1,Low density lipoprotein receptor adapter protein 1,13571,143,1.05 [0.89-1.24],0.5595289242724857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LECT2,Leukocyte cell-derived chemotaxin-2,13588,144,1.20 [0.95-1.51],0.1316627841461527
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEFTY2,Left-right determination factor 2,15757,157,0.82 [0.63-1.06],0.1222345447470847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEG1,Protein LEG1 homolog,12819,136,0.88 [0.68-1.12],0.2999764290051319
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LELP1,Late cornified envelope-like proline-rich protein 1,13169,137,0.97 [0.77-1.21],0.7797897800898791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEO1,RNA polymerase-associated protein LEO1,13571,143,1.17 [0.73-1.87],0.5220154541883882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEP,Leptin,15635,156,1.17 [0.93-1.46],0.1856918843374351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LEPR,Leptin receptor,15635,156,0.93 [0.59-1.48],0.7651773589907402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LETM1,Mitochondrial proton/calcium exchanger protein,13571,143,1.15 [0.86-1.54],0.329827323743578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS1,Galectin-1,15635,156,1.17 [0.77-1.78],0.4572312816040589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS3,Galectin-3,15680,160,1.54 [0.97-2.45],0.0645000931402001
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS3BP,Galectin-3-binding protein,13612,142,0.81 [0.47-1.41],0.458711108367546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS4,Galectin-4,15640,155,1.10 [0.85-1.44],0.4645239188994727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS7_LGALS7B,Galectin-7,15611,156,1.38 [1.01-1.87],0.0412323172308106
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS8,Galectin-8,15780,160,1.02 [0.82-1.29],0.8330486775116924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGALS9,Galectin-9,15636,156,1.15 [0.75-1.78],0.523929725993306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LGMN,Legumain,15718,156,1.10 [0.75-1.63],0.6161630732946493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LHB,Lutropin subunit beta,15268,155,1.00 [0.85-1.17],0.9656231147523312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,15665,156,0.99 [0.78-1.25],0.9015750707318284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIF,Leukemia inhibitory factor,15248,155,1.15 [0.91-1.47],0.2483200717067055
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIFR,Leukemia inhibitory factor receptor,15623,160,0.79 [0.44-1.40],0.4185769977537705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,15634,160,1.09 [0.74-1.61],0.6550035088418603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,13569,142,1.05 [0.92-1.20],0.4573003021465909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,13163,138,0.88 [0.63-1.23],0.4510038628931354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,15613,156,1.38 [0.88-2.17],0.1554278796456019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,13588,144,1.03 [0.83-1.28],0.79023060011353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,15834,160,1.54 [0.93-2.56],0.092880683872899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,15745,160,1.20 [0.80-1.81],0.3869170230641775
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,15330,154,1.16 [0.84-1.62],0.367777765331631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,15834,160,1.11 [0.91-1.37],0.3009557742044396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LIPF,Gastric triacylglycerol lipase,13218,134,1.01 [0.76-1.34],0.9305096625678082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMNB1,Lamin-B1,13498,142,0.95 [0.73-1.24],0.7106809890860948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMNB2,Lamin-B2,13545,141,1.39 [0.81-2.38],0.2286656159882906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMOD1,Leiomodin-1,13571,143,1.30 [0.88-1.91],0.1868651598512237
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LMOD2,Leiomodin-2,13169,137,1.12 [0.89-1.41],0.3271063049992236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LONP1,"Lon protease homolog, mitochondrial",13218,134,1.00 [0.83-1.21],0.9999844608895576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPA,Apolipoprotein(a),13266,139,0.95 [0.87-1.04],0.3073753295908875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPCAT2,Lysophosphatidylcholine acyltransferase 2,15572,159,0.83 [0.56-1.23],0.3504120664185242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPL,Lipoprotein lipase,15635,156,1.02 [0.75-1.39],0.8845851927549218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPO,Lactoperoxidase,15155,152,0.77 [0.60-0.98],0.0374163210651447
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPP,Lipoma-preferred partner,13163,138,1.09 [0.85-1.38],0.5069535916372047
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,13163,138,0.96 [0.75-1.23],0.7502223329925534
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,13194,139,0.82 [0.57-1.20],0.308433022251358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRG1,Leucine-rich alpha-2-glycoprotein,13612,142,0.86 [0.47-1.60],0.6379648591752074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,15740,157,1.40 [0.94-2.10],0.1014459523771776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,13157,139,1.45 [0.95-2.22],0.0817063595701236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP1,Prolow-density lipoprotein receptor-related protein 1,15572,159,1.50 [0.90-2.48],0.1174317075070926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP11,Low-density lipoprotein receptor-related protein 11,15635,156,1.24 [0.83-1.86],0.2994051052945483
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP2,Low-density lipoprotein receptor-related protein 2,13194,139,0.91 [0.57-1.44],0.684024390580416
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRP2BP,LRP2-binding protein,13194,139,1.05 [0.88-1.26],0.60542380676661
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,15780,160,1.26 [1.02-1.55],0.0309845053300774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC25,Leucine-rich repeat-containing protein 25,15572,159,1.05 [0.74-1.49],0.7784278948389056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC37A2,Leucine-rich repeat-containing protein 37A2,13524,142,1.01 [0.69-1.47],0.9701734080899616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC38,Leucine-rich repeat-containing protein 38,13194,139,0.98 [0.71-1.36],0.9005034009493574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRC59,Leucine-rich repeat-containing protein 59,13588,144,1.01 [0.72-1.43],0.937501647727088
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,13509,145,0.96 [0.69-1.34],0.8325002911432989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRRN1,Leucine-rich repeat neuronal protein 1,15330,154,1.20 [0.82-1.74],0.3417948180230257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,13194,139,1.08 [0.75-1.56],0.6685228404389287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,13571,143,1.08 [0.61-1.91],0.7830137361338685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSM1,U6 snRNA-associated Sm-like protein LSm1,15268,155,0.73 [0.54-0.99],0.0440260517453425
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSM8,U6 snRNA-associated Sm-like protein LSm8,13310,143,1.09 [0.93-1.28],0.2773034162891097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LSP1,Lymphocyte-specific protein 1,15623,160,0.99 [0.70-1.39],0.954827013541938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTA,Lymphotoxin-alpha,15623,160,0.96 [0.67-1.36],0.8087230153301403
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTA4H,Leukotriene A-4 hydrolase,15780,157,1.03 [0.82-1.31],0.7859985971815104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTB,Lymphotoxin-beta,13509,145,1.35 [0.93-1.94],0.1117685578967769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBP2,Latent-transforming growth factor beta-binding protein 2,15834,160,0.99 [0.63-1.54],0.9516886529270624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBP3,Latent-transforming growth factor beta-binding protein 3,15268,155,1.14 [0.90-1.43],0.2756549962192316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTBR,Tumor necrosis factor receptor superfamily member 3,15554,155,1.16 [0.69-1.96],0.5766675682275184
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LTO1,Protein LTO1 homolog,15330,154,1.08 [0.78-1.50],0.6502578577203868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LUZP2,Leucine zipper protein 2,13509,145,1.29 [0.95-1.74],0.1027474449475825
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LXN,Latexin,15452,156,0.82 [0.66-1.03],0.0896715474185854
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY6D,Lymphocyte antigen 6D,15549,156,1.35 [0.93-1.97],0.1150534917973627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY75,Lymphocyte antigen 75,15623,160,1.07 [0.75-1.53],0.7143678771500821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY9,T-lymphocyte surface antigen Ly-9,15477,156,0.74 [0.44-1.25],0.2600543944788412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY96,Lymphocyte antigen 96,15529,157,1.18 [0.79-1.74],0.4219219556188486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYAR,Cell growth-regulating nucleolar protein,15268,155,1.13 [0.90-1.43],0.2968943347634784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYN,Tyrosine-protein kinase Lyn,15572,159,1.01 [0.86-1.19],0.9125232791480958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD1,Ly6/PLAUR domain-containing protein 1,15248,155,1.07 [0.88-1.30],0.5032417264523104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD3,Ly6/PLAUR domain-containing protein 3,15559,156,1.10 [0.73-1.63],0.6539905904966765
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPD8,Ly6/PLAUR domain-containing protein 8,15268,155,1.07 [0.82-1.39],0.6305499632301171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYPLA2,Acyl-protein thioesterase 2,13169,137,1.10 [0.96-1.25],0.180511437277256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,13194,139,1.02 [0.87-1.19],0.8126952949920645
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,13612,142,1.76 [0.79-3.93],0.1695522347080709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYZL2,Lysozyme-like protein 2,13103,139,1.48 [1.05-2.09],0.0263960137651068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LZTFL1,Leucine zipper transcription factor-like protein 1,13289,138,1.05 [0.84-1.32],0.6741831161454352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",M6PR,Cation-dependent mannose-6-phosphate receptor,13218,134,0.85 [0.55-1.31],0.4560925112861599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,15478,157,0.99 [0.74-1.32],0.9442493561050171
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAEA,E3 ubiquitin-protein transferase MAEA,15268,155,0.70 [0.47-1.03],0.0707309913618551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAG,Myelin-associated glycoprotein,13194,139,1.15 [0.81-1.63],0.4433307029307036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAGEA3,Melanoma-associated antigen 3,13310,143,1.02 [0.84-1.23],0.8582688335544642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAGED1,Melanoma-associated antigen D1,15268,155,1.02 [0.76-1.37],0.9019684571664556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAMDC2,MAM domain-containing protein 2,13588,144,0.66 [0.40-1.07],0.0902322663644814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAMDC4,Apical endosomal glycoprotein,13509,145,1.05 [0.79-1.39],0.75129497439383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",13218,134,0.88 [0.46-1.68],0.702725156924008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAN2B2,Epididymis-specific alpha-mannosidase,13588,144,1.07 [0.82-1.40],0.6049445318711526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13103,139,0.93 [0.67-1.29],0.6759829215245666
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANF,Mesencephalic astrocyte-derived neurotrophic factor,15718,156,0.99 [0.89-1.12],0.9257221121339798
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANSC1,MANSC domain-containing protein 1,15681,158,1.44 [0.87-2.38],0.1592861589051484
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MANSC4,MANSC domain-containing protein 4,13163,138,1.05 [0.81-1.36],0.7214447857870718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,13169,137,0.74 [0.44-1.25],0.2621612861060516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,13163,138,0.89 [0.68-1.19],0.4382239448506467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2,Microtubule-associated protein 2,13545,141,1.17 [0.84-1.64],0.356167276662676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,13524,142,1.09 [0.85-1.39],0.4915656355826466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,15623,160,0.98 [0.86-1.13],0.7936696313014339
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,15268,155,0.99 [0.85-1.14],0.8762859324519087
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,15499,157,0.99 [0.87-1.12],0.8791063898422478
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK13,Mitogen-activated protein kinase 13,13103,139,0.98 [0.68-1.41],0.8990662036996914
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK9,Mitogen-activated protein kinase 9,15623,160,1.01 [0.73-1.39],0.9631811789694558
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPKAPK2,MAP kinase-activated protein kinase 2,13310,143,1.06 [0.86-1.32],0.5750419996592555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPRE3,Microtubule-associated protein RP/EB family member 3,13103,139,1.05 [0.94-1.16],0.3887864995117301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPT,Microtubule-associated protein tau,15248,155,1.01 [0.77-1.33],0.9437912415559724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MARCO,Macrophage receptor MARCO,15635,156,1.41 [0.83-2.42],0.2061976034078486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MARS1,"Methionine--tRNA ligase, cytoplasmic",13257,138,1.02 [0.84-1.23],0.8718900286634201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MASP1,Mannan-binding lectin serine protease 1,15499,157,0.67 [0.37-1.20],0.1758405705901574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MATN2,Matrilin-2,15669,156,1.17 [0.74-1.86],0.4966123317184384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MATN3,Matrilin-3,15502,157,0.99 [0.63-1.56],0.9597363099708054
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAVS,Mitochondrial antiviral-signaling protein,15268,155,0.96 [0.82-1.12],0.6188217157579516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAX,Protein max,15248,155,1.03 [0.90-1.18],0.6815668207815928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MB,Myoglobin,15834,160,0.98 [0.74-1.31],0.8890021475662938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MBL2,Mannose-binding protein C,13411,138,1.00 [0.86-1.16],0.9818370669268784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCAM,Cell surface glycoprotein MUC18,15672,155,1.13 [0.75-1.71],0.5597905406732203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",13571,143,0.83 [0.56-1.23],0.3472428633257927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCEMP1,Mast cell-expressed membrane protein 1,13206,139,1.12 [0.94-1.32],0.2039671554585513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCFD2,Multiple coagulation factor deficiency protein 2,15578,156,0.98 [0.71-1.35],0.8876988227951732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MCTS1,Malignant T-cell-amplified sequence 1,13524,142,1.10 [0.60-2.01],0.7515937925907091
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,15529,157,1.03 [0.84-1.25],0.8004917040289118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDH1,"Malate dehydrogenase, cytoplasmic",13516,142,1.04 [0.71-1.52],0.8287626272897127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDK,Midkine,15632,158,1.20 [0.93-1.55],0.1639126554138569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDM1,Nuclear protein MDM1,13194,139,0.77 [0.45-1.32],0.3469228911179204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",13218,134,1.03 [0.86-1.23],0.7877584828468611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MED18,Mediator of RNA polymerase II transcription subunit 18,15268,155,1.05 [0.87-1.27],0.6005354173556348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MED21,Mediator of RNA polymerase II transcription subunit 21,13163,138,1.01 [0.74-1.39],0.936994461866242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF10,Multiple epidermal growth factor-like domains protein 10,15640,155,1.09 [0.76-1.56],0.6324702935598249
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF11,Multiple epidermal growth factor-like domains protein 11,13163,138,0.84 [0.49-1.43],0.5189614797909938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEGF9,Multiple epidermal growth factor-like domains protein 9,15777,160,2.18 [1.20-3.96],0.0105515807651291
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MELTF,Melanotransferrin,13588,144,1.15 [0.66-1.99],0.6170119826117149
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MENT,Protein MENT,13289,138,1.06 [0.50-2.28],0.8748140093574852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEP1A,Meprin A subunit alpha,13524,142,1.19 [0.95-1.49],0.1393005075144482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEP1B,Meprin A subunit beta,15635,156,0.94 [0.83-1.05],0.2667717140400265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MEPE,Matrix extracellular phosphoglycoprotein,15640,155,1.24 [0.71-2.16],0.447840943934642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MERTK,Tyrosine-protein kinase Mer,15813,160,1.48 [0.89-2.48],0.1321995991609033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MESD,LRP chaperone MESD,15634,160,1.01 [0.90-1.13],0.8315584423467961
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MET,Hepatocyte growth factor receptor,15688,159,1.61 [0.80-3.24],0.183281234128852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP1,Methionine aminopeptidase 1,15248,155,1.25 [0.81-1.92],0.3217684055853717
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",15623,160,1.06 [0.90-1.25],0.495363943582143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",METAP2,Methionine aminopeptidase 2,15757,157,1.09 [0.86-1.39],0.4659973924342505
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3,Microfibril-associated glycoprotein 3,15372,156,1.04 [0.79-1.36],0.7977514838999418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3L,Microfibrillar-associated protein 3-like,13194,139,0.87 [0.66-1.14],0.313299661514395
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP4,Microfibril-associated glycoprotein 4,13289,138,0.75 [0.45-1.27],0.2822314288823373
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP5,Microfibrillar-associated protein 5,15834,160,1.09 [0.78-1.54],0.6103899542465313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFGE8,Lactadherin,15634,160,1.34 [0.98-1.82],0.0687143144266473
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MGLL,Monoglyceride lipase,15693,156,0.98 [0.83-1.15],0.7813272073834836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MGMT,Methylated-DNA--protein-cysteine methyltransferase,15623,160,0.98 [0.88-1.10],0.7230446853013098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MIA,Melanoma-derived growth regulatory protein,15681,158,1.02 [0.69-1.49],0.9374169068320548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MICALL2,MICAL-like protein 2,13194,139,1.08 [0.86-1.35],0.5324938425571952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,15623,160,0.97 [0.89-1.06],0.5272534402502007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MIF,Macrophage migration inhibitory factor,15610,160,1.03 [0.85-1.27],0.7411305046939669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MILR1,Allergin-1,15330,154,1.05 [0.79-1.40],0.7228553772395314
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,13509,145,1.01 [0.87-1.17],0.9040968601288452
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MINK1,Misshapen-like kinase 1,13545,141,1.00 [0.84-1.18],0.9561257430691144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MITD1,MIT domain-containing protein 1,15529,157,1.01 [0.88-1.17],0.8711132251330506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MKI67,Proliferation marker protein Ki-67,13206,139,0.91 [0.60-1.39],0.6576817144077101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MLLT1,Protein ENL,13103,139,1.02 [0.83-1.27],0.8355670205860852
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MLN,Promotilin,15623,160,1.02 [0.87-1.19],0.8046337644991242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MME,Neprilysin,15572,159,1.18 [1.00-1.39],0.0462195655044282
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP1,Interstitial collagenase,15044,149,1.14 [0.97-1.34],0.1102610827303674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP10,Stromelysin-2,15629,155,0.82 [0.64-1.04],0.0973405622429748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP12,Macrophage metalloelastase,15661,156,1.19 [0.91-1.56],0.2134949983033549
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP13,Collagenase 3,15248,155,0.85 [0.55-1.33],0.4812929625540062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP15,Matrix metalloproteinase-15,13588,144,0.80 [0.54-1.19],0.2725855968730868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP3,Stromelysin-1,15634,160,1.17 [0.88-1.56],0.2826891276917046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP7,Matrilysin,15345,156,1.29 [0.95-1.76],0.1047328640651102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP8,Neutrophil collagenase,15759,160,1.09 [0.91-1.31],0.3416474736967098
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMP9,Matrix metalloproteinase-9,15611,159,1.11 [0.89-1.39],0.3664429895889856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",13163,138,0.89 [0.63-1.25],0.5114400068292853
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MN1,Transcriptional activator MN1,13194,139,1.04 [0.80-1.35],0.7955660848265856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNAT1,CDK-activating kinase assembly factor MAT1,13310,143,1.13 [0.81-1.58],0.4585709204052726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNDA,Myeloid cell nuclear differentiation antigen,15615,156,0.93 [0.80-1.08],0.3199534762863331
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MOCS2,Molybdopterin synthase catalytic subunit,13289,138,1.06 [0.83-1.35],0.6275008959171089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MOG,Myelin-oligodendrocyte glycoprotein,15780,157,1.25 [0.81-1.95],0.3141983482363623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORC3,MORC family CW-type zinc finger protein 3,13545,141,0.94 [0.53-1.66],0.8286674318968655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORF4L1,Mortality factor 4-like protein 1,13310,143,0.92 [0.61-1.39],0.6940492296260101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORF4L2,Mortality factor 4-like protein 2,13103,139,0.93 [0.60-1.47],0.766169713556827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORN4,MORN repeat-containing protein 4,13103,139,0.94 [0.76-1.17],0.6046080892176573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPHOSPH8,M-phase phosphoprotein 8,15372,156,1.05 [0.87-1.27],0.6037386855091019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPI,Mannose-6-phosphate isomerase,15572,159,1.06 [0.90-1.24],0.5071619441473357
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,15693,156,0.99 [0.83-1.19],0.9202164401235912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPO,Myeloperoxidase,15634,160,0.92 [0.68-1.24],0.5862486844729928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MPRIP,Myosin phosphatase Rho-interacting protein,13484,144,0.94 [0.66-1.35],0.7540720483667074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRC1,Macrophage mannose receptor 1,13597,143,1.59 [0.91-2.76],0.1010046083895457
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRI1,Methylthioribose-1-phosphate isomerase,13194,139,1.16 [0.92-1.48],0.2134806844907028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL24,"39S ribosomal protein L24, mitochondrial",13163,138,1.25 [0.91-1.70],0.1616439203154565
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL28,"39S ribosomal protein L28, mitochondrial",13571,143,1.05 [0.71-1.56],0.807665294672304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL46,"39S ribosomal protein L46, mitochondrial",15248,155,0.89 [0.52-1.52],0.6721019029086839
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL52,"39S ribosomal protein L52, mitochondrial",13085,139,1.60 [0.90-2.82],0.1071680059776842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",13571,143,0.95 [0.76-1.19],0.6741835747636425
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MRPS16,"28S ribosomal protein S16, mitochondrial",13206,139,1.20 [0.76-1.90],0.44213457668209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSLN,Mesothelin,15554,159,1.13 [0.88-1.45],0.3353239978939145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSLNL,Mesothelin-like protein,13194,139,0.60 [0.37-0.97],0.0385549324317165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSMB,Beta-microseminoprotein,15593,159,1.20 [0.98-1.48],0.0829229159765289
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSR1,Macrophage scavenger receptor types I and II,15780,160,1.18 [0.86-1.60],0.3030197364059876
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSRA,Mitochondrial peptide methionine sulfoxide reductase,15681,158,1.04 [0.86-1.26],0.6816767716064519
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MST1,Hepatocyte growth factor-like protein,13387,142,1.26 [0.91-1.74],0.1677297740731966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MSTN,Growth/differentiation factor 8,15372,156,1.08 [0.82-1.43],0.5728546958638245
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTDH,Protein LYRIC,13206,139,1.12 [0.93-1.33],0.2241696285790381
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",13545,141,0.61 [0.30-1.24],0.1693625742252159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,13310,143,0.96 [0.83-1.11],0.5727574542796565
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTIF3,"Translation initiation factor IF-3, mitochondrial",13524,142,1.09 [0.91-1.30],0.3663765640070996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTPN,Myotrophin,15372,156,0.66 [0.40-1.08],0.0990534445137421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTR,Methionine synthase,13163,138,1.27 [1.04-1.54],0.0180177552217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTSS1,Protein MTSS 1,13524,142,1.04 [0.90-1.21],0.5685231522091019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTSS2,Protein MTSS 2,13509,145,1.01 [0.86-1.19],0.8734180253945083
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MTUS1,Microtubule-associated tumor suppressor 1,13310,143,1.03 [0.78-1.36],0.8178700275401333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC13,Mucin-13,15248,155,0.82 [0.61-1.09],0.1768920485338704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC16,Mucin-16,15572,159,0.98 [0.91-1.06],0.6679196642601863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUC2,Mucin-2,13569,142,1.06 [0.89-1.27],0.4938587412851435
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MUCL3,Mucin-like protein 3,13103,139,1.03 [0.73-1.46],0.859462623864888
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MVK,Mevalonate kinase,15330,154,1.06 [0.88-1.27],0.5440074281978156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MXRA8,Matrix remodeling-associated protein 8,13289,138,0.85 [0.50-1.45],0.5431965411163653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYBPC1,"Myosin-binding protein C, slow-type",13588,144,1.05 [0.82-1.35],0.6889534836285162
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYBPC2,"Myosin-binding protein C, fast-type",13218,134,0.92 [0.74-1.15],0.4760153442591602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,13571,143,0.91 [0.72-1.16],0.4620995116215305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYDGF,Myeloid-derived growth factor,13588,144,1.06 [0.90-1.23],0.4869896856142084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH4,Myosin-4,13163,138,0.80 [0.53-1.20],0.2701936774026287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH7B,Myosin-7B,13103,139,1.17 [0.85-1.61],0.3270776483648293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYH9,Myosin-9,13569,142,1.05 [0.91-1.21],0.5087081511730012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",13163,138,1.16 [0.83-1.63],0.3893848577366553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL3,Myosin light chain 3,13218,134,0.98 [0.77-1.26],0.8966157189419838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL4,Myosin light chain 4,13218,134,0.95 [0.69-1.31],0.7756819647240261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYL6B,Myosin light chain 6B,13194,139,1.16 [1.00-1.34],0.0495230161152875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",13194,139,0.91 [0.60-1.38],0.6518047583785638
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYO6,Unconventional myosin-VI,13571,143,0.87 [0.55-1.37],0.5381794940081195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYO9B,Unconventional myosin-IXb,15330,154,0.89 [0.71-1.12],0.3164419017689895
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOC,Myocilin,15634,160,0.97 [0.71-1.31],0.8210930840061499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM1,Myomesin-1,13169,137,0.74 [0.49-1.13],0.16796565656879
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM2,Myomesin-2,13163,138,0.76 [0.51-1.13],0.1712328399019463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYOM3,Myomesin-3,13289,138,1.02 [0.85-1.22],0.8458655216762143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MZB1,Marginal zone B- and B1-cell-specific protein,15694,156,0.94 [0.70-1.25],0.6565710093419965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MZT1,Mitotic-spindle organizing protein 1,15268,155,1.00 [0.77-1.30],0.9991263387412938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAA10,N-alpha-acetyltransferase 10,13163,138,0.92 [0.67-1.27],0.632991545854279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAA80,N-alpha-acetyltransferase 80,13194,139,1.07 [0.93-1.23],0.3208975991447405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAAA,N-acylethanolamine-hydrolyzing acid amidase,15453,157,0.91 [0.72-1.16],0.4590687625809962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NACC1,Nucleus accumbens-associated protein 1,13509,145,0.93 [0.69-1.25],0.6177110105851603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NADK,NAD kinase,15635,156,0.86 [0.66-1.13],0.2747974525728455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGA,Alpha-N-acetylgalactosaminidase,13184,137,1.16 [0.93-1.45],0.1780821381511643
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGK,N-acetyl-D-glucosamine kinase,13191,134,0.90 [0.67-1.20],0.4629162156379685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,13289,138,1.81 [0.83-3.97],0.1375163400819811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAMPT,Nicotinamide phosphoribosyltransferase,15268,155,0.91 [0.69-1.21],0.5218938997120341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAP1L4,Nucleosome assembly protein 1-like 4,13506,142,0.92 [0.63-1.34],0.6596654205072034
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NAPRT,Nicotinate phosphoribosyltransferase,13545,141,0.99 [0.61-1.62],0.9799400929912012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NARS1,"Asparagine--tRNA ligase, cytoplasmic",13571,143,1.06 [0.76-1.49],0.7231615058909542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBL1,Neuroblastoma suppressor of tumorigenicity 1,15681,158,0.84 [0.49-1.44],0.518398885363694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBN,Nibrin,15330,154,0.89 [0.66-1.20],0.4535411536988812
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAM1,Neural cell adhesion molecule 1,15672,155,1.08 [0.65-1.80],0.7741576337404683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAM2,Neural cell adhesion molecule 2,15634,160,1.37 [0.82-2.30],0.2328489183909901
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCAN,Neurocan core protein,15780,160,1.00 [0.69-1.46],0.986876647459558
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCF2,Neutrophil cytosol factor 2,15599,160,0.93 [0.79-1.10],0.4190312516356486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCK2,Cytoplasmic protein NCK2,15718,156,1.00 [0.88-1.14],0.99978787877322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCLN,Nicalin,15330,154,1.11 [0.90-1.39],0.3342491303444349
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCR1,Natural cytotoxicity triggering receptor 1,15600,160,1.07 [0.72-1.59],0.7353076102019382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,13524,142,1.56 [0.98-2.48],0.0601440465711185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NCS1,Neuronal calcium sensor 1,15780,157,1.68 [1.03-2.73],0.0371007354866667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDRG1,Protein NDRG1,15248,155,1.08 [0.90-1.29],0.3939726562918241
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,13509,145,1.11 [0.89-1.37],0.3666478110606299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,13181,138,1.25 [0.80-1.95],0.3202451757254856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,13524,142,1.06 [0.89-1.26],0.5368689208976176
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",15268,155,1.00 [0.84-1.19],0.9984064405592696
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEB,Nebulin,13163,138,0.77 [0.47-1.28],0.3152144797813593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECAP2,Adaptin ear-binding coat-associated protein 2,13163,138,0.95 [0.74-1.23],0.694916511040192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN1,Nectin-1,13206,139,0.86 [0.51-1.46],0.5819733723849453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN2,Nectin-2,15613,156,1.28 [0.78-2.11],0.325243965337367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN4,Nectin-4,15681,158,1.03 [0.64-1.66],0.9088501529510448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,13206,139,1.27 [0.89-1.80],0.189990727554453
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEDD9,Enhancer of filamentation 1,13206,139,1.01 [0.63-1.62],0.9709148570435272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEFL,Neurofilament light polypeptide,15198,154,1.15 [0.82-1.61],0.429776624009979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEK7,Serine/threonine-protein kinase Nek7,13310,143,0.96 [0.77-1.20],0.7139157206891731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NELL1,Protein kinase C-binding protein NELL1,15681,158,0.89 [0.64-1.25],0.514853116147855
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NELL2,Protein kinase C-binding protein NELL2,15718,156,0.83 [0.50-1.38],0.4769044505517846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NENF,Neudesin,13509,145,1.10 [0.97-1.25],0.1401055114377835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEO1,Neogenin,13571,143,1.66 [0.88-3.15],0.1205985451755587
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NEXN,Nexilin,13597,143,0.93 [0.73-1.17],0.5241066794549925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFASC,Neurofascin,15813,160,0.76 [0.45-1.27],0.2890749875681488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFAT5,Nuclear factor of activated T-cells 5,13206,139,1.00 [0.83-1.21],0.961627463031944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",15623,160,1.00 [0.86-1.15],0.966538043985201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",15330,154,1.12 [0.89-1.42],0.3458552311521793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFE2,Transcription factor NF-E2 45 kDa subunit,13218,134,0.91 [0.73-1.14],0.423801984060813
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFIC,Nuclear factor 1 C-type,13571,143,1.16 [0.84-1.58],0.3662031473676147
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKB1,Nuclear factor NF-kappa-B p105 subunit,13163,138,0.98 [0.79-1.23],0.8889552592691259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKB2,Nuclear factor NF-kappa-B p100 subunit,13310,143,0.86 [0.62-1.20],0.3771099357317504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFKBIE,NF-kappa-B inhibitor epsilon,15268,155,0.95 [0.70-1.28],0.7277204844732417
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",13524,142,1.07 [0.91-1.25],0.4131507996462039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFX1,Transcriptional repressor NF-X1,13163,138,1.10 [0.87-1.39],0.4317984704086094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NFYA,Nuclear transcription factor Y subunit alpha,13163,138,0.81 [0.51-1.29],0.3835532772015849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGF,Beta-nerve growth factor,15529,157,0.79 [0.25-2.46],0.685370379063462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGFR,Tumor necrosis factor receptor superfamily member 16,13588,144,0.81 [0.46-1.44],0.4770534865832428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NGRN,Neugrin,13545,141,0.87 [0.41-1.86],0.729131147225928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NHLRC3,NHL repeat-containing protein 3,12961,135,1.54 [0.91-2.59],0.1064074517370192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NID1,Nidogen-1,15626,155,1.02 [0.71-1.46],0.9175885611286246
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NID2,Nidogen-2,15634,160,1.10 [0.91-1.32],0.3237462763369321
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NINJ1,Ninjurin-1,15268,155,1.22 [1.02-1.48],0.0340391836059945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NIT1,Deaminated glutathione amidase,13218,134,1.05 [0.75-1.48],0.7691552390072995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NIT2,Omega-amidase NIT2,13545,143,1.05 [0.85-1.29],0.648288193179651
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN1,Neuroligin-1,13194,139,0.99 [0.78-1.26],0.9439165828583728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN2,Neuroligin-2,13169,137,0.68 [0.45-1.03],0.0701613497711962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NME1,Nucleoside diphosphate kinase A,13206,139,1.03 [0.49-2.16],0.9343004690859366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NME3,Nucleoside diphosphate kinase 3,15669,156,0.91 [0.50-1.66],0.7532576034737553
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMI,N-myc-interactor,13458,145,1.10 [0.89-1.36],0.3846197831051278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,15529,157,0.92 [0.75-1.12],0.3935127912657322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMRK2,Nicotinamide riboside kinase 2,13103,139,1.14 [0.82-1.59],0.4485222382221958
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,13571,143,0.99 [0.78-1.26],0.910928886084449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOMO1,Nodal modulator 1,15634,160,1.36 [0.78-2.39],0.2775278582678048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOP56,Nucleolar protein 56,13163,138,1.07 [0.94-1.22],0.3296249630999111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS1,"Nitric oxide synthase, brain",15248,155,0.99 [0.74-1.32],0.9337214206924864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS2,"Nitric oxide synthase, inducible",13163,138,1.02 [0.68-1.54],0.926354589773674
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOS3,"Nitric oxide synthase, endothelial",15248,155,1.05 [0.81-1.36],0.719823398783732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH1,Neurogenic locus notch homolog protein 1,15834,160,1.99 [0.83-4.79],0.1221967811704552
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH2,Neurogenic locus notch homolog protein 2,13569,142,1.17 [0.56-2.45],0.6726589538572378
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH3,Neurogenic locus notch homolog protein 3,15834,160,0.79 [0.53-1.17],0.243194942196104
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPC2,NPC intracellular cholesterol transporter 2,13355,140,1.35 [0.83-2.19],0.2282146908043383
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPDC1,Neural proliferation differentiation and control protein 1,15635,156,1.30 [0.82-2.05],0.2638924432809826
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPHS1,Nephrin,13206,139,1.47 [0.99-2.16],0.0537540466181548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPHS2,Podocin,13206,139,1.00 [0.86-1.17],0.9730220652839802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPL,N-acetylneuraminate lyase,13588,144,1.49 [1.05-2.11],0.0249205654795362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPPB,Natriuretic peptides B,15372,156,0.95 [0.85-1.06],0.358333507433538
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPPC,C-type natriuretic peptide,15623,160,1.20 [0.88-1.65],0.2478657578907727
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPR1,Atrial natriuretic peptide receptor 1,13163,138,1.13 [0.78-1.64],0.508658541040211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTN,Neuroplastin,15268,155,1.08 [0.93-1.25],0.3034282497352125
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTX1,Neuronal pentraxin-1,15634,160,1.26 [0.91-1.76],0.1661272001674706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTX2,Neuronal pentraxin-2,13569,142,0.89 [0.55-1.44],0.6395260307190388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPTXR,Neuronal pentraxin receptor,15635,156,0.93 [0.61-1.40],0.7239381792170791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NPY,Pro-neuropeptide Y,15780,157,1.11 [0.90-1.36],0.3364659850911637
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRCAM,Neuronal cell adhesion molecule,15635,156,1.03 [0.62-1.71],0.9086244071569668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRGN,Neurogranin,13597,143,1.06 [0.89-1.26],0.5230627368513215
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRN1,Neuritin,13571,143,0.82 [0.49-1.37],0.4519393411358618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRP1,Neuropilin-1,15703,155,1.10 [0.67-1.81],0.7054702375826647
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRP2,Neuropilin-2,15634,160,0.88 [0.54-1.43],0.5970393905559624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRTN,Neurturin,15330,154,0.92 [0.68-1.24],0.5899583658504668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NRXN3,Neurexin-3,13194,139,1.12 [0.73-1.73],0.6007271934415113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NSFL1C,NSFL1 cofactor p47,15780,160,1.02 [0.83-1.25],0.8832545626514298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",13588,144,1.03 [0.83-1.27],0.8057106970826188
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C1A,Cytosolic 5'-nucleotidase 1A,13545,141,1.63 [1.14-2.33],0.0071353934184768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5C3A,Cytosolic 5'-nucleotidase 3A,15598,160,1.03 [0.88-1.20],0.7329146683883703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NT5E,5'-nucleotidase,15681,158,1.12 [0.88-1.42],0.3690795534726899
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTF3,Neurotrophin-3,15623,160,1.00 [0.67-1.49],0.9936895039538252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTF4,Neurotrophin-4,15268,155,0.95 [0.66-1.38],0.7944030551907963
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTRK2,BDNF/NT-3 growth factors receptor,15635,156,1.13 [0.65-1.95],0.670765339122497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTRK3,NT-3 growth factor receptor,15780,160,0.95 [0.50-1.80],0.8731467667644799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NTproBNP,N-terminal prohormone of brain natriuretic peptide,15635,156,0.98 [0.84-1.15],0.8155114597176749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUB1,NEDD8 ultimate buster 1,15623,160,1.01 [0.86-1.19],0.9108719221547468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,13509,145,1.06 [0.91-1.23],0.4618565093820369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUCB2,Nucleobindin-2,15752,156,1.17 [0.81-1.69],0.4013655403457143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDC,Nuclear migration protein nudC,15813,160,0.97 [0.78-1.21],0.7995637594152939
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,13218,134,0.84 [0.43-1.65],0.6052430741823278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,13163,138,0.89 [0.64-1.26],0.5196372840459859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT16,U8 snoRNA-decapping enzyme,13501,142,1.07 [0.89-1.28],0.4793076501564033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],15572,159,0.91 [0.71-1.17],0.4811851122041493
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUDT5,ADP-sugar pyrophosphatase,15634,160,1.13 [0.87-1.47],0.3537974883176226
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUMB,Protein numb homolog,13206,139,1.08 [0.88-1.31],0.4632297210970892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NUP50,Nuclear pore complex protein Nup50,13163,138,1.06 [0.68-1.65],0.7841361855239928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPE4,NXPE family member 4,13163,138,0.74 [0.43-1.26],0.2652515933039752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPH1,Neurexophilin-1,15248,155,0.87 [0.58-1.29],0.4801188484877513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NXPH3,Neurexophilin-3,13206,139,1.63 [0.94-2.83],0.0793260268457725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OBP2B,Odorant-binding protein 2b,15475,157,0.95 [0.77-1.17],0.6203007423110583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OCLN,Occludin,13571,143,1.20 [0.84-1.71],0.3088153051807524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ODAM,Odontogenic ameloblast-associated protein,15222,154,1.13 [0.88-1.45],0.350857532541301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OFD1,Oral-facial-digital syndrome 1 protein,13310,143,0.86 [0.66-1.12],0.2657382923556429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGA,Protein O-GlcNAcase,13524,142,1.10 [0.87-1.37],0.4241296030114885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGFR,Opioid growth factor receptor,15572,159,1.03 [0.68-1.58],0.8805008140203608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGN,Mimecan,15634,160,1.01 [0.70-1.44],0.975005544271706
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,13310,143,1.19 [0.96-1.47],0.1187421282712979
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OLFM4,Olfactomedin-4,12790,135,1.08 [0.95-1.24],0.2437043817768585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OLR1,Oxidized low-density lipoprotein receptor 1,15477,153,1.12 [0.89-1.40],0.3461783665263702
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMD,Osteomodulin,15718,156,1.06 [0.78-1.45],0.7047205378164856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMG,Oligodendrocyte-myelin glycoprotein,15572,159,0.89 [0.71-1.11],0.3115704705651734
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OMP,Olfactory marker protein,13169,137,0.99 [0.72-1.37],0.9740284958488108
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPHN1,Oligophrenin-1,13545,141,1.00 [0.86-1.16],0.9965297253307082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPLAH,5-oxoprolinase,13218,134,0.99 [0.78-1.26],0.9580550577631578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OPTC,Opticin,15572,159,1.20 [0.90-1.61],0.2171323570041977
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ORM1,Alpha-1-acid glycoprotein 1,13565,142,1.88 [0.88-4.05],0.1050107084871524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSBPL2,Oxysterol-binding protein-related protein 2,13545,141,0.87 [0.57-1.33],0.5166928532961966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSCAR,Osteoclast-associated immunoglobulin-like receptor,15669,156,1.29 [0.84-1.99],0.2456528496023914
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSM,Oncostatin-M,15543,160,1.09 [0.91-1.32],0.3536415493223881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSMR,Oncostatin-M-specific receptor subunit beta,15703,155,2.25 [1.17-4.30],0.0146926551127111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OSTN,Osteocrin,13194,139,0.81 [0.52-1.25],0.3381947031884381
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTOA,Otoancorin,13169,137,1.06 [0.80-1.42],0.6689572706673366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTUD6B,Deubiquitinase OTUD6B,13524,142,1.11 [0.85-1.45],0.4636094270443619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OTUD7B,OTU domain-containing protein 7B,13571,143,1.08 [0.85-1.38],0.5207742866441142
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",13218,134,1.19 [0.94-1.50],0.1467263972681648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",OXT,Oxytocin-neurophysin 1,15780,160,0.99 [0.89-1.09],0.798698641376387
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",P4HB,Protein disulfide-isomerase,15558,156,1.22 [0.85-1.74],0.2844954658886583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PACS2,Phosphofurin acidic cluster sorting protein 2,13163,138,1.08 [0.84-1.41],0.5437153394274569
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI2,Protein-arginine deiminase type-2,15330,154,1.20 [0.98-1.48],0.0746983681579573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI4,Protein-arginine deiminase type-4,15222,154,0.94 [0.77-1.15],0.5543649266023611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAEP,Glycodelin,15529,157,0.84 [0.76-0.94],0.0014562486635075
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,13571,143,1.03 [0.91-1.18],0.6114855208989913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",13310,143,1.20 [0.88-1.62],0.2452198090835748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,15372,156,0.95 [0.73-1.22],0.6717747804929685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAGR1,PAXIP1-associated glutamate-rich protein 1,13218,134,0.97 [0.67-1.41],0.87538482064898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13079,139,1.22 [0.92-1.61],0.1600576260699464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAK4,Serine/threonine-protein kinase PAK 4,15248,155,1.11 [0.88-1.38],0.3756124357109404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALLD,Palladin,13206,139,0.99 [0.66-1.47],0.9541670727568288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM,Paralemmin-1,13460,142,1.83 [1.11-3.02],0.0187521742132353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM2,Paralemmin-2,13545,141,1.52 [1.04-2.22],0.02898121206397
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PALM3,Paralemmin-3,13163,138,1.06 [0.87-1.29],0.5610389605452941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAM,Peptidyl-glycine alpha-amidating monooxygenase,15750,160,1.38 [0.82-2.32],0.2240223376468894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAMR1,Inactive serine protease PAMR1,15634,160,1.39 [0.84-2.28],0.1982978771794707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAPPA,Pappalysin-1,15330,154,0.87 [0.64-1.18],0.3619313712486731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARD3,Partitioning defective 3 homolog,13310,143,1.13 [0.93-1.37],0.2338426298586916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARK7,Parkinson disease protein 7,15634,160,1.08 [0.83-1.39],0.576504167339502
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARP1,Poly [ADP-ribose] polymerase 1,15623,160,0.94 [0.72-1.23],0.6756451385915077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PAXX,Protein PAXX,13289,138,0.93 [0.65-1.33],0.6950083280135182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBK,Lymphokine-activated killer T-cell-originated protein kinase,13103,139,1.70 [1.04-2.77],0.0348070147510523
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBLD,Phenazine biosynthesis-like domain-containing protein,15248,155,1.15 [0.88-1.51],0.3069664755441642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,13524,142,0.96 [0.57-1.62],0.8755694885890232
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCARE,Photoreceptor cilium actin regulator,13169,137,1.16 [0.99-1.34],0.0592412691628236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,13259,138,0.99 [0.70-1.41],0.9711917648215046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCBP2,Poly(rC)-binding protein 2,13571,143,1.08 [0.86-1.34],0.506539187931297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH1,Protocadherin-1,15763,159,1.47 [0.83-2.63],0.1873225605546097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH12,Protocadherin-12,13571,143,1.37 [0.75-2.49],0.3006816939479456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH17,Protocadherin-17,15635,156,0.84 [0.55-1.27],0.4097734161086628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH7,Protocadherin-7,13524,142,1.53 [1.07-2.19],0.0188136243874573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDH9,Protocadherin-9,13524,142,1.10 [0.69-1.77],0.6792583050597688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCDHB15,Protocadherin beta-15,13509,145,0.84 [0.56-1.27],0.4148440669167763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCNA,Proliferating cell nuclear antigen,13103,139,0.95 [0.73-1.23],0.6862012113990723
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCSK7,Proprotein convertase subtilisin/kexin type 7,13509,145,1.46 [1.11-1.92],0.0072029537524255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCSK9,Proprotein convertase subtilisin/kexin type 9,15834,160,1.09 [0.76-1.56],0.6291325417625412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PCYT2,Ethanolamine-phosphate cytidylyltransferase,13524,142,1.07 [0.87-1.31],0.5398565935003111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDAP1,28 kDa heat- and acid-stable phosphoprotein,13588,144,1.09 [0.93-1.28],0.2879517109057792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1,Programmed cell death protein 1,15758,157,1.04 [0.75-1.45],0.8229495563550655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1LG2,Programmed cell death 1 ligand 2,15572,159,0.95 [0.61-1.49],0.8382516724436111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD5,Programmed cell death protein 5,15780,160,1.03 [0.82-1.30],0.7892368616140333
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD6,Programmed cell death protein 6,15635,156,0.99 [0.81-1.21],0.9253247705568752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCL2,Phosducin-like protein 2,13103,139,1.16 [0.90-1.50],0.26007214224767
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13103,139,1.16 [0.92-1.47],0.2154311945355705
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",13163,138,0.89 [0.67-1.19],0.430152463212989
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",13289,138,1.00 [0.86-1.17],0.9988894182694308
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFA,Platelet-derived growth factor subunit A,15834,160,1.13 [0.93-1.37],0.2051627951165394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFB,Platelet-derived growth factor subunit B,15718,156,1.11 [0.94-1.30],0.2289549252317039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFC,Platelet-derived growth factor C,15268,155,1.08 [0.67-1.75],0.7512547111071438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFRA,Platelet-derived growth factor receptor alpha,15635,156,0.91 [0.56-1.50],0.7254861743723757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDGFRB,Platelet-derived growth factor receptor beta,15834,160,0.84 [0.57-1.24],0.3841406812647949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA2,Protein disulfide-isomerase A2,13103,139,0.70 [0.44-1.11],0.1324661742228038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA3,Protein disulfide-isomerase A3,13289,138,1.02 [0.55-1.92],0.9431421768712528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA4,Protein disulfide-isomerase A4,13569,142,1.09 [0.84-1.41],0.5177020149747658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDIA5,Protein disulfide-isomerase A5,13103,139,1.01 [0.78-1.32],0.931554650230028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDLIM5,PDZ and LIM domain protein 5,13571,143,1.01 [0.88-1.15],0.893291586994293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDLIM7,PDZ and LIM domain protein 7,15718,156,0.96 [0.85-1.07],0.4254434490188884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",15268,155,1.11 [0.87-1.41],0.3867924789339716
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDRG1,p53 and DNA damage-regulated protein 1,13194,139,1.30 [1.04-1.64],0.0239846256519741
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13103,139,1.03 [0.80-1.33],0.8323250178225465
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDZD2,PDZ domain-containing protein 2,13163,138,0.92 [0.69-1.21],0.5430972808001151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,13206,139,1.19 [0.85-1.65],0.3163519050412928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEAR1,Platelet endothelial aggregation receptor 1,15834,160,1.10 [0.59-2.04],0.7625843558423041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEBP1,Phosphatidylethanolamine-binding protein 1,15634,160,1.06 [0.84-1.34],0.6146584984754784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECAM1,Platelet endothelial cell adhesion molecule,15634,160,0.97 [0.61-1.54],0.8885003601829999
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECR,Peroxisomal trans-2-enoyl-CoA reductase,13218,134,1.35 [0.83-2.19],0.229665988472405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PENK,Proenkephalin-A,13289,138,1.29 [0.77-2.16],0.3409535479847517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PEPD,Xaa-Pro dipeptidase,13597,143,1.41 [0.75-2.64],0.2862221308608497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PER3,Period circadian protein homolog 3,13206,139,1.02 [0.89-1.18],0.7362727767461148
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PF4,Platelet factor 4,13515,140,1.08 [0.92-1.27],0.3516508874733927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN2,Prefoldin subunit 2,15248,155,1.00 [0.77-1.29],0.9937068815393753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN4,Prefoldin subunit 4,13103,139,1.15 [0.89-1.48],0.2727971275952174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFDN6,Prefoldin subunit 6,13194,139,0.99 [0.77-1.26],0.9300867722990742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",15552,159,0.98 [0.82-1.18],0.829945867334608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGA4,Pepsin A-4,13597,143,0.94 [0.73-1.20],0.6022244093262634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",13588,144,1.10 [0.83-1.47],0.4963309187095733
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGF,Placenta growth factor,15813,160,1.25 [0.78-2.00],0.3571800218982877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP1,Peptidoglycan recognition protein 1,15745,160,1.12 [0.81-1.55],0.4823281819467432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,13434,138,1.18 [0.71-1.99],0.5216907928756828
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGLYRP4,Peptidoglycan recognition protein 4,13163,138,0.90 [0.68-1.18],0.4400349126591621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGM2,Phosphoglucomutase-2,13194,139,1.16 [0.94-1.44],0.176029950482607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PGR,Progesterone receptor,13206,139,1.15 [1.03-1.30],0.0153685574908774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHACTR2,Phosphatase and actin regulator 2,13571,143,1.06 [0.92-1.22],0.392047865606159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHLDB1,Pleckstrin homology-like domain family B member 1,13524,142,0.99 [0.73-1.33],0.9379992659469556
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHLDB2,Pleckstrin homology-like domain family B member 2,13103,139,1.00 [0.84-1.19],0.9923431502867448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,15529,157,0.97 [0.60-1.59],0.9193806687335082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,13289,138,1.15 [0.78-1.69],0.4888700275212455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PI16,Peptidase inhibitor 16,13597,143,1.81 [0.94-3.49],0.0741004671618128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PI3,Elafin,15420,159,1.15 [0.89-1.49],0.2714507362399062
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",13571,143,1.01 [0.83-1.24],0.910959306358354
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIGR,Polymeric immunoglobulin receptor,15436,158,1.17 [0.80-1.71],0.4074546671142574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,15623,160,1.01 [0.81-1.27],0.9140583887093404
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,15634,160,1.30 [0.76-2.24],0.3370777063030971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,13206,139,0.96 [0.72-1.28],0.7877635140593869
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PILRA,Paired immunoglobulin-like type 2 receptor alpha,15634,160,1.29 [0.92-1.82],0.1375774094817193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PILRB,Paired immunoglobulin-like type 2 receptor beta,15635,156,1.26 [0.97-1.63],0.0840351409252955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,13289,138,0.84 [0.66-1.07],0.1540196154822217
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PITHD1,PITH domain-containing protein 1,13079,139,1.14 [0.96-1.35],0.1382372793483095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKD1,Polycystin-1,13588,144,1.32 [0.71-2.44],0.3758060880372305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKD2,Polycystin-2,13163,138,0.99 [0.75-1.30],0.926830822369146
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKLR,Pyruvate kinase PKLR,15664,156,0.99 [0.81-1.22],0.9381759394260916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PKN3,Serine/threonine-protein kinase N3,13310,143,1.05 [0.86-1.28],0.6189382049740209
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G10,Group 10 secretory phospholipase A2,15529,157,0.90 [0.71-1.13],0.3618625291109479
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G15,Phospholipase A2 group XV,15681,158,0.90 [0.53-1.55],0.7102699227445746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G1B,Phospholipase A2,15802,159,0.72 [0.52-1.01],0.0556459295415949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G2A,"Phospholipase A2, membrane associated",15602,159,1.01 [0.79-1.28],0.9405716999871292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G4A,Cytosolic phospholipase A2,15718,156,0.95 [0.81-1.12],0.5425576155305429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLA2G7,Platelet-activating factor acetylhydrolase,15634,160,1.07 [0.67-1.69],0.7855123276411944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAT,Tissue-type plasminogen activator,15777,160,0.90 [0.68-1.19],0.4800133136911341
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAU,Urokinase-type plasminogen activator,15634,160,1.12 [0.72-1.75],0.6080988938467259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLAUR,Urokinase plasminogen activator surface receptor,15538,154,1.55 [0.93-2.59],0.095769270607306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLB1,"Phospholipase B1, membrane-associated",13545,141,1.17 [0.89-1.54],0.2491548287502472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",13206,139,1.04 [0.75-1.44],0.8154317674940699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",13545,141,1.03 [0.87-1.21],0.736256177970815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLEKHO1,Pleckstrin homology domain-containing family O member 1,13545,141,1.07 [0.85-1.35],0.5599523820969938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLG,Plasminogen,13250,138,1.75 [0.95-3.23],0.0715039598559353
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLIN1,Perilipin-1,15248,155,1.44 [1.03-2.02],0.0314648038251006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLIN3,Perilipin-3,15635,156,0.97 [0.70-1.35],0.8625375129670189
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLPBP,Pyridoxal phosphate homeostasis protein,15635,156,1.03 [0.84-1.26],0.8090651649445454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLSCR3,Phospholipid scramblase 3,13525,140,0.98 [0.75-1.29],0.9044399867278484
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLTP,Phospholipid transfer protein,15772,160,0.95 [0.64-1.41],0.8055576586018406
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXDC1,Plexin domain-containing protein 1,15268,155,1.22 [0.86-1.71],0.2640659729546374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXDC2,Plexin domain-containing protein 2,13545,141,1.25 [0.71-2.20],0.4344678310524288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNA4,Plexin-A4,15623,160,1.02 [0.86-1.21],0.7810317967986771
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNB2,Plexin-B2,15758,160,0.98 [0.54-1.77],0.9385058364227412
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PLXNB3,Plexin-B3,15580,156,1.18 [0.88-1.58],0.2730717007325765
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,15565,156,0.94 [0.87-1.01],0.0872355562387926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMCH,Pro-MCH,13163,138,1.16 [0.98-1.36],0.0807899033538242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMM2,Phosphomannomutase 2,13163,138,1.16 [0.89-1.51],0.2620139003121225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMS1,PMS1 protein homolog 1,13194,139,0.93 [0.67-1.29],0.6712535419439911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PMVK,Phosphomevalonate kinase,15225,155,0.98 [0.87-1.12],0.8103206416075965
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIP,Pancreatic triacylglycerol lipase,13597,143,0.84 [0.64-1.10],0.1993479329426751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIPRP1,Inactive pancreatic lipase-related protein 1,13545,141,0.91 [0.74-1.13],0.4090637422083616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIPRP2,Pancreatic lipase-related protein 2,15640,155,1.05 [1.00-1.11],0.0741316145293221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNMA1,Paraneoplastic antigen Ma1,13218,134,1.13 [0.85-1.51],0.3908497107517299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNMA2,Paraneoplastic antigen Ma2,13169,137,1.02 [0.70-1.48],0.9185462850211182
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",15330,154,1.03 [0.92-1.15],0.5802140041107722
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PODXL,Podocalyxin,15572,159,0.68 [0.28-1.67],0.3997169104421368
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PODXL2,Podocalyxin-like protein 2,15681,158,1.39 [0.84-2.32],0.2002538619027731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POF1B,Protein POF1B,13206,139,1.27 [0.93-1.74],0.1289437174423573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2A,DNA-directed RNA polymerase II subunit RPB1,13206,139,1.13 [0.67-1.93],0.6446649171799594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",15572,159,0.97 [0.64-1.47],0.8748571603350858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POMC,Pro-opiomelanocortin,13218,134,0.96 [0.75-1.23],0.7246555494654324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON1,Serum paraoxonase/arylesterase 1,13597,143,0.54 [0.31-0.95],0.03139090581808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON2,Serum paraoxonase/arylesterase 2,15372,156,1.36 [0.90-2.06],0.1426466478420586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PON3,Serum paraoxonase/lactonase 3,15718,156,1.27 [0.74-2.20],0.3826534456478133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POSTN,Periostin,13569,142,0.94 [0.62-1.43],0.7683604874887943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPBP,Platelet basic protein,13506,141,1.19 [0.98-1.44],0.0748128532341474
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPCDC,Phosphopantothenoylcysteine decarboxylase,15780,160,0.84 [0.63-1.13],0.2516776013922528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIB,Peptidyl-prolyl cis-trans isomerase B,15634,160,1.05 [0.91-1.21],0.5242748149677676
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIE,Peptidyl-prolyl cis-trans isomerase E,13310,143,0.91 [0.69-1.20],0.5219997395084441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",13569,142,1.13 [0.88-1.44],0.33717924508634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPL,Periplakin,13206,139,1.33 [0.87-2.05],0.1910707000540863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1A,Protein phosphatase 1A,15268,155,0.73 [0.44-1.20],0.212241528053269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1B,Protein phosphatase 1B,13206,139,1.19 [0.97-1.44],0.0902423325151077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPM1F,Protein phosphatase 1F,13588,144,1.03 [0.76-1.40],0.8316608759114599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPME1,Protein phosphatase methylesterase 1,15572,159,0.99 [0.79-1.24],0.9275555689832984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,13509,145,1.05 [0.87-1.27],0.5980650173925357
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,15681,158,0.95 [0.82-1.11],0.5318518699461221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,13310,143,1.08 [0.89-1.32],0.437876067286838
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,13571,143,1.08 [0.89-1.31],0.4556250259425694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,13571,143,1.15 [0.77-1.71],0.5004214954037897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R2,Protein phosphatase inhibitor 2,15635,156,1.05 [0.88-1.25],0.5736356406493193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP1R9B,Neurabin-2,15813,160,0.93 [0.80-1.08],0.3504262572038211
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,13524,142,1.05 [0.92-1.20],0.4926779576874497
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPP3R1,Calcineurin subunit B type 1,15529,157,0.97 [0.69-1.35],0.8456836114791113
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPT1,Palmitoyl-protein thioesterase 1,13194,139,1.11 [0.93-1.33],0.2410220526552393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PPY,Pancreatic prohormone,15618,158,0.98 [0.85-1.13],0.7987669762134774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PQBP1,Polyglutamine-binding protein 1,15268,155,0.99 [0.77-1.28],0.946214916822808
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRAME,Melanoma antigen preferentially expressed in tumors,13103,139,1.63 [0.96-2.76],0.0718527193732724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRAP1,Proline-rich acidic protein 1,13569,142,1.10 [0.75-1.62],0.6203475069905802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRC1,Protein regulator of cytokinesis 1,13509,145,1.06 [0.79-1.43],0.6784707386311748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRCP,Lysosomal Pro-X carboxypeptidase,15724,159,0.89 [0.57-1.39],0.6070518907756053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX1,Peroxiredoxin-1,15203,151,0.86 [0.72-1.02],0.0815071493862471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX2,Peroxiredoxin-2,13366,141,1.00 [0.78-1.29],0.99318846142953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",15330,154,1.08 [0.89-1.31],0.4429746936067578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX5,"Peroxiredoxin-5, mitochondrial",15813,160,0.98 [0.81-1.20],0.861894274192913
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRDX6,Peroxiredoxin-6,15780,157,0.92 [0.73-1.16],0.4723109747660581
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PREB,Prolactin regulatory element-binding protein,15330,154,0.96 [0.59-1.56],0.8620747666175749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRELP,Prolargin,15640,155,1.04 [0.55-1.94],0.9109787756737614
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG2,Bone marrow proteoglycan,13569,142,1.03 [0.76-1.40],0.8351255217326166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG3,Proteoglycan 3,13569,142,0.90 [0.66-1.24],0.5232440109146408
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,15330,154,1.14 [0.89-1.46],0.3096155266883924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,13194,139,1.08 [0.67-1.75],0.7566802002644094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,15635,156,0.99 [0.84-1.17],0.9001418687899599
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,13522,141,1.01 [0.84-1.22],0.8930850945229971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKCQ,Protein kinase C theta type,15330,154,1.10 [0.81-1.49],0.539353585042605
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKD2,Serine/threonine-protein kinase D2,13163,138,1.09 [0.80-1.49],0.5834833947072745
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKG1,cGMP-dependent protein kinase 1,13289,138,0.95 [0.83-1.08],0.4195171859489531
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,15268,155,1.15 [0.93-1.42],0.1910517724127503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRL,Prolactin,15780,160,0.88 [0.73-1.06],0.1759822790585119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRND,Prion-like protein doppel,13545,141,1.19 [0.89-1.59],0.2365883558244456
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROC,Vitamin K-dependent protein C,15650,155,1.18 [0.68-2.07],0.5538393970898677
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROCR,Endothelial protein C receptor,13163,138,0.50 [0.28-0.91],0.0230563420149206
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROK1,Prokineticin-1,15623,160,0.77 [0.62-0.95],0.0143195538950763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PROS1,Vitamin K-dependent protein S,13612,142,1.75 [0.98-3.12],0.06018012576982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR4,Proline-rich protein 4,13208,138,0.97 [0.76-1.23],0.7907450904369693
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR5,Proline-rich protein 5,13206,139,0.89 [0.62-1.28],0.5426696952011971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRRT3,Proline-rich transmembrane protein 3,13218,134,1.28 [0.82-2.01],0.2749519730515415
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS2,Trypsin-2,15672,155,1.20 [0.91-1.57],0.1996476117031356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS22,Brain-specific serine protease 4,13206,139,1.37 [0.92-2.02],0.1179931168984802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS27,Serine protease 27,15578,156,1.10 [0.77-1.55],0.6056486328775279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS53,Serine protease 53,13545,141,1.26 [0.83-1.91],0.2865736638818631
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRSS8,Prostasin,15585,155,1.18 [0.84-1.66],0.3444141868250995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,15248,155,0.99 [0.87-1.13],0.9000397396809402
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTG,Protogenin,15780,157,1.15 [0.66-1.99],0.6216732155957111
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRTN3,Myeloblastin,15228,155,0.92 [0.67-1.26],0.6047216180773509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRUNE2,Protein prune homolog 2,13310,143,1.24 [0.74-2.07],0.4184734228498796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSAP,Prosaposin,13449,141,1.35 [0.80-2.27],0.2582304187277132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSAPL1,Proactivator polypeptide-like 1,13524,142,1.05 [0.77-1.44],0.7576655249026278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSCA,Prostate stem cell antigen,13524,142,1.08 [1.01-1.16],0.0207790769411607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSG1,Pregnancy-specific beta-1-glycoprotein 1,15529,157,1.09 [0.95-1.24],0.215953177314967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSIP1,PC4 and SFRS1-interacting protein,15623,160,1.05 [0.85-1.29],0.6513704717074846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMA1,Proteasome subunit alpha type-1,15268,155,0.90 [0.66-1.24],0.5350198437780052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMC3,26S proteasome regulatory subunit 6A,13103,139,1.27 [0.75-2.12],0.3722426108360647
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD1,26S proteasome non-ATPase regulatory subunit 1,13571,143,0.89 [0.65-1.24],0.50535920615143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD5,26S proteasome non-ATPase regulatory subunit 5,13194,139,1.16 [0.91-1.49],0.2289446481055204
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMD9,26S proteasome non-ATPase regulatory subunit 9,15572,159,0.94 [0.73-1.21],0.6460500425186032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSME1,Proteasome activator complex subunit 1,15508,157,0.94 [0.65-1.36],0.7324264767817454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSME2,Proteasome activator complex subunit 2,15457,157,0.93 [0.64-1.35],0.6894370548450641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMG3,Proteasome assembly chaperone 3,15623,160,0.98 [0.75-1.28],0.8973920801262155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSMG4,Proteasome assembly chaperone 4,13206,139,1.04 [0.79-1.37],0.7593102628822984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSPN,Persephin,15623,160,1.01 [0.88-1.15],0.9160477906423428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSRC1,Proline/serine-rich coiled-coil protein 1,15268,155,1.17 [0.93-1.47],0.1704784951345554
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,12792,135,1.02 [0.87-1.19],0.8318594616440156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",15248,155,0.91 [0.56-1.45],0.679991467467804
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGDS,Prostaglandin-H2 D-isomerase,15502,154,1.14 [0.69-1.87],0.6056246073019498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGES2,Prostaglandin E synthase 2,13101,137,1.17 [0.87-1.56],0.3015930101386832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTGR1,Prostaglandin reductase 1,13588,144,0.91 [0.74-1.11],0.3402674074980063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTH,Parathyroid hormone,13194,139,1.18 [0.97-1.45],0.1012303427173768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,15623,160,1.20 [0.87-1.65],0.261905967232966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTK7,Inactive tyrosine-protein kinase 7,15248,155,1.28 [0.90-1.81],0.1724227667383508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTN,Pleiotrophin,15372,156,1.20 [0.91-1.58],0.1902683400652269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTP4A3,Protein tyrosine phosphatase type IVA 3,13206,139,1.05 [0.78-1.41],0.7463802384776856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,15529,157,0.97 [0.81-1.16],0.744354052809286
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,15693,156,0.97 [0.83-1.14],0.7400276183125225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,13178,139,1.14 [0.78-1.66],0.4936649460565243
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRB,Receptor-type tyrosine-protein phosphatase beta,13588,144,1.24 [0.73-2.10],0.4305571319461829
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRC,Receptor-type tyrosine-protein phosphatase C,13569,142,0.73 [0.36-1.49],0.3880072978830622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRF,Receptor-type tyrosine-protein phosphatase F,15834,160,1.15 [0.72-1.86],0.5572652046080115
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRH,Receptor-type tyrosine-protein phosphatase H,13524,142,1.25 [0.90-1.72],0.1817442505107668
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,13524,142,1.02 [0.51-2.05],0.9529433572937952
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRM,Receptor-type tyrosine-protein phosphatase mu,15592,160,1.09 [0.62-1.92],0.7723252627596221
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,15469,157,1.36 [0.88-2.12],0.1677724654080903
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRR,Receptor-type tyrosine-protein phosphatase R,13545,141,1.16 [0.75-1.80],0.5154504882882063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRS,Receptor-type tyrosine-protein phosphatase S,15834,160,1.25 [0.71-2.20],0.4360281867643834
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,13588,144,1.04 [0.64-1.69],0.874727047536035
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,13289,138,1.08 [0.83-1.41],0.5740105010866099
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTS,6-pyruvoyl tetrahydrobiopterin synthase,15181,153,1.17 [0.92-1.48],0.2142181021550369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTTG1,Securin,13310,143,1.16 [0.82-1.63],0.4040014703021555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PTX3,Pentraxin-related protein PTX3,15623,160,0.82 [0.64-1.06],0.1315712155780988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PVALB,Parvalbumin alpha,15716,157,0.95 [0.85-1.08],0.4473730445043117
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PVR,Poliovirus receptor,15780,160,1.05 [0.72-1.53],0.7939968512518759
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PXDNL,Peroxidasin-like protein,13509,145,1.11 [0.87-1.41],0.3880937109554278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PXN,Paxillin,15248,155,1.15 [0.90-1.48],0.2583414505442788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PYDC1,Pyrin domain-containing protein 1,13218,134,1.00 [0.68-1.47],0.9926539437259742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PYY,Peptide YY,13163,138,1.03 [0.86-1.23],0.7466708050804827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PZP,Pregnancy zone protein,13612,142,1.12 [0.89-1.40],0.3394935748301912
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QDPR,Dihydropteridine reductase,15567,156,1.01 [0.74-1.39],0.9476936704484212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QPCT,Glutaminyl-peptide cyclotransferase,15645,159,1.12 [0.66-1.90],0.6803649466524833
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",QSOX1,Sulfhydryl oxidase 1,13324,139,0.96 [0.65-1.42],0.8325345030229956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB10,Ras-related protein Rab-10,13588,144,1.13 [0.85-1.50],0.4142036131484063
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB11FIP3,Rab11 family-interacting protein 3,13588,144,1.02 [0.88-1.19],0.7546039622270564
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB27B,Ras-related protein Rab-27B,13588,144,1.04 [0.86-1.26],0.6865318646288907
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB2B,Ras-related protein Rab-2B,13509,145,1.09 [0.85-1.40],0.4980099316273411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB33A,Ras-related protein Rab-33A,13163,138,0.93 [0.72-1.19],0.5410829309254127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB37,Ras-related protein Rab-37,15330,154,1.15 [0.99-1.33],0.0709674845475959
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB39B,Ras-related protein Rab-39B,13163,138,0.92 [0.75-1.12],0.3936677385324393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,13169,137,1.02 [0.77-1.34],0.9119808004826836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB44,Ras-related protein Rab-44,13509,145,0.65 [0.41-1.03],0.0649387111547585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB6A,Ras-related protein Rab-6A,15623,160,0.95 [0.71-1.27],0.7218905822144919
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB6B,Ras-related protein Rab-6B,15248,155,1.23 [0.95-1.58],0.1096693421830087
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABEP1,Rab GTPase-binding effector protein 1,13289,138,1.00 [0.81-1.23],0.9747635383802298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABEPK,Rab9 effector protein with kelch motifs,15268,155,1.09 [0.87-1.35],0.4476370097417634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RABGAP1L,Rab GTPase-activating protein 1-like,15330,154,1.02 [0.81-1.29],0.8767355535470355
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAC3,Ras-related C3 botulinum toxin substrate 3,13194,139,0.59 [0.41-0.85],0.0041023427461746
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAD23B,UV excision repair protein RAD23 homolog B,15268,155,1.21 [0.91-1.61],0.1870216838329326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAD51,DNA repair protein RAD51 homolog 1,13310,143,1.12 [0.88-1.44],0.3585794101768381
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RALB,Ras-related protein Ral-B,13206,139,1.31 [0.77-2.24],0.3177712154203145
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RALY,RNA-binding protein Raly,13509,145,0.84 [0.59-1.19],0.3223931758912362
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANBP1,Ran-specific GTPase-activating protein,13218,134,1.12 [0.83-1.53],0.4600950172532803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANBP2,E3 SUMO-protein ligase RanBP2,13169,137,0.68 [0.41-1.14],0.1405013820770304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RANGAP1,Ran GTPase-activating protein 1,15268,155,1.06 [0.81-1.37],0.6821558108307882
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAP1A,Ras-related protein Rap-1A,13206,139,1.10 [0.90-1.34],0.3681185862267579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAPGEF2,Rap guanine nucleotide exchange factor 2,13310,143,1.03 [0.76-1.40],0.8328507073044006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RARRES1,Retinoic acid receptor responder protein 1,15268,155,0.98 [0.65-1.49],0.9239549107523672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RARRES2,Retinoic acid receptor responder protein 2,15703,155,1.02 [0.75-1.37],0.921698702591748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASA1,Ras GTPase-activating protein 1,15248,155,0.56 [0.36-0.89],0.0128485700668906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13103,139,1.34 [0.95-1.89],0.0898809525548849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RASSF2,Ras association domain-containing protein 2,15268,155,0.99 [0.77-1.27],0.9085382284572948
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBFOX3,RNA binding protein fox-1 homolog 3,13571,143,1.52 [1.07-2.16],0.018944098227776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBKS,Ribokinase,15260,157,0.93 [0.70-1.23],0.5985536200164641
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM17,Splicing factor 45,13571,143,1.04 [0.85-1.28],0.6774416617205774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM19,Probable RNA-binding protein 19,13163,138,0.76 [0.51-1.13],0.1781009377951451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBM25,RNA-binding protein 25,13103,139,1.21 [0.87-1.68],0.2683280485090279
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP1,Retinol-binding protein 1,13194,139,1.11 [0.91-1.35],0.2950417429758242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP2,Retinol-binding protein 2,15572,159,1.03 [0.85-1.23],0.7800446383223284
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP5,Retinol-binding protein 5,15572,159,1.16 [0.91-1.47],0.2306002708912392
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBP7,Retinoid-binding protein 7,13524,142,1.04 [0.81-1.35],0.7413417849477648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBPMS,RNA-binding protein with multiple splicing,13206,139,1.18 [0.97-1.44],0.103177115155962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RBPMS2,RNA-binding protein with multiple splicing 2,13218,134,0.97 [0.82-1.14],0.6749526107983118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RCC1,Regulator of chromosome condensation,13509,145,0.95 [0.69-1.30],0.7307573228959439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RCOR1,REST corepressor 1,15372,156,1.14 [0.87-1.49],0.3538179949215158
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,13218,134,0.48 [0.21-1.08],0.0749305755519513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REEP4,Receptor expression-enhancing protein 4,13571,143,0.97 [0.75-1.26],0.8446521590253881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG1A,Lithostathine-1-alpha,15536,155,1.35 [1.03-1.75],0.02794002649345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG1B,Lithostathine-1-beta,15834,160,1.23 [0.98-1.55],0.071106577215093
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG3A,Regenerating islet-derived protein 3-alpha,15834,160,1.15 [0.92-1.44],0.2173528818252589
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG3G,Regenerating islet-derived protein 3-gamma,13509,145,0.90 [0.60-1.35],0.621684486796755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REG4,Regenerating islet-derived protein 4,15669,156,1.36 [1.01-1.83],0.0397086200886014
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RELB,Transcription factor RelB,13206,139,1.14 [0.87-1.50],0.3329815062393382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RELT,Tumor necrosis factor receptor superfamily member 19L,15634,160,1.41 [0.84-2.37],0.1970632504942557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REN,Renin,15635,156,0.93 [0.75-1.15],0.5019828249507028
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REPS1,RalBP1-associated Eps domain-containing protein 1,13206,139,1.05 [0.69-1.57],0.8302638270775033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REST,RE1-silencing transcription factor,13103,139,1.07 [0.70-1.64],0.7547900107012927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,15572,159,1.17 [0.84-1.63],0.3453513444972242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RETN,Resistin,15587,160,1.21 [0.86-1.69],0.2750370353221151
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",REXO2,"Oligoribonuclease, mitochondrial",13163,138,1.12 [0.84-1.50],0.4486874660633897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RFC4,Replication factor C subunit 4,13509,145,0.75 [0.35-1.63],0.4720896327522313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGCC,Regulator of cell cycle RGCC,13571,143,1.10 [0.89-1.36],0.3575329082319662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,13310,143,1.04 [0.82-1.30],0.7548034940966655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGMA,Repulsive guidance molecule A,15780,160,1.16 [0.73-1.82],0.5329189397280878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGMB,RGM domain family member B,15780,160,1.64 [0.95-2.83],0.0736760890011563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGS10,Regulator of G-protein signaling 10,13571,143,1.11 [0.86-1.44],0.4122778782001609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RGS8,Regulator of G-protein signaling 8,15330,154,0.96 [0.77-1.20],0.73035376334399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RHOC,Rho-related GTP-binding protein RhoC,15422,157,1.00 [0.89-1.13],0.9888088493310166
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RICTOR,Rapamycin-insensitive companion of mTOR,13206,139,1.24 [0.95-1.62],0.1142395061014488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,13289,138,0.94 [0.67-1.32],0.7392907607662379
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RILP,Rab-interacting lysosomal protein,15740,157,1.02 [0.81-1.28],0.8750642466216274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RILPL2,RILP-like protein 2,13588,144,1.00 [0.85-1.17],0.9676317014006136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,13163,138,0.87 [0.66-1.13],0.2984201571077185
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RLN1,Prorelaxin H1,13571,143,0.90 [0.75-1.09],0.2991396962362859
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RLN2,Prorelaxin H2,13269,138,0.91 [0.81-1.02],0.116785028232256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE1,Ribonuclease pancreatic,13597,143,1.23 [0.63-2.43],0.547133968494815
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE10,Inactive ribonuclease-like protein 10,13218,134,1.11 [0.80-1.54],0.516328548472617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE3,Eosinophil cationic protein,15558,156,1.02 [0.90-1.16],0.7057514238877305
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE4,Ribonuclease 4,13146,140,1.64 [0.95-2.85],0.0774647015199057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASE6,Ribonuclease K6,13495,142,1.30 [0.77-2.20],0.3299206828039588
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASEH2A,Ribonuclease H2 subunit A,13571,143,1.17 [0.89-1.53],0.2739078461929713
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNASET2,Ribonuclease T2,15749,159,1.07 [0.62-1.84],0.7995092951842934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF149,E3 ubiquitin-protein ligase RNF149,13218,134,1.55 [0.90-2.68],0.111219648394471
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF168,E3 ubiquitin-protein ligase RNF168,13206,139,1.20 [0.86-1.67],0.2837149192751119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF31,E3 ubiquitin-protein ligase RNF31,13206,139,1.33 [0.94-1.87],0.1034390366591621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF4,E3 ubiquitin-protein ligase RNF4,13310,143,1.10 [0.89-1.37],0.3829298708160304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF41,E3 ubiquitin-protein ligase NRDP1,15268,155,1.02 [0.83-1.26],0.8216354388109433
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF43,E3 ubiquitin-protein ligase RNF43,13310,143,0.84 [0.61-1.15],0.2665811316953866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF5,E3 ubiquitin-protein ligase RNF5,13218,134,1.05 [0.84-1.32],0.6539147385911164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO1,Roundabout homolog 1,15669,156,1.24 [0.70-2.20],0.457209393196462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO2,Roundabout homolog 2,15780,160,1.71 [0.94-3.08],0.0773393722041742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROBO4,Roundabout homolog 4,13218,134,0.98 [0.38-2.49],0.9628042793583078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,15635,156,1.19 [0.76-1.88],0.4482620432432127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RP2,Protein XRP2,15572,159,1.12 [0.81-1.55],0.4842391906908351
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPA2,Replication protein A 32 kDa subunit,13206,139,1.14 [0.71-1.82],0.597013399503906
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPE,Ribulose-phosphate 3-epimerase,13310,143,1.13 [0.92-1.39],0.2520002406248097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPGR,X-linked retinitis pigmentosa GTPase regulator,13194,139,0.70 [0.45-1.10],0.1184042637803752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPL14,60S ribosomal protein L14,13218,134,0.76 [0.49-1.17],0.2095924964811411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPS10,40S ribosomal protein S10,13163,138,1.00 [0.68-1.45],0.9860544307055056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRAS,Ras-related protein R-Ras,13194,139,1.01 [0.89-1.14],0.8957077187587875
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRM2,Ribonucleoside-diphosphate reductase subunit M2,15268,155,0.92 [0.69-1.24],0.6049614789492003
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,15268,155,1.06 [0.86-1.31],0.5666360502160708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RRP15,RRP15-like protein,13169,137,1.03 [0.86-1.22],0.7738755248266768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RSPO1,R-spondin-1,15529,157,0.94 [0.63-1.39],0.7519812589352822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RSPO3,R-spondin-3,15780,157,0.87 [0.52-1.44],0.5871534059141887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTBDN,Retbindin,15572,159,1.23 [0.77-1.96],0.3838097065731873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTKN2,Rhotekin-2,13163,138,0.83 [0.59-1.18],0.3031337892262988
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",13571,143,1.07 [0.90-1.27],0.4658709486283962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RTN4R,Reticulon-4 receptor,15780,157,1.05 [0.69-1.59],0.8228380474658772
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RUVBL1,RuvB-like 1,15268,155,1.13 [1.00-1.27],0.0554311857085043
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RWDD1,RWD domain-containing protein 1,15780,160,0.99 [0.80-1.23],0.957273215573472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RYR1,Ryanodine receptor 1,13163,138,1.09 [0.69-1.72],0.7007120371514199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A11,Protein S100-A11,15501,155,0.90 [0.66-1.24],0.5292755217824257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A12,Protein S100-A12,15442,157,0.99 [0.82-1.19],0.9284440661846728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A13,Protein S100-A13,13206,139,1.23 [0.79-1.92],0.3513217688497078
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A14,Protein S100-A14,13571,143,0.77 [0.56-1.06],0.1131506924033137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A16,Protein S100-A16,15222,154,0.95 [0.75-1.19],0.6343122847259037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A3,Protein S100-A3,13509,145,0.80 [0.53-1.23],0.3091844118300045
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100A4,Protein S100-A4,15681,158,1.06 [0.83-1.35],0.6251629623831219
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100G,Protein S100-G,13571,143,0.78 [0.53-1.15],0.2080467578867455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",S100P,Protein S100-P,15372,156,1.03 [0.80-1.33],0.8115385044482156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAA4,Serum amyloid A-4 protein,13612,142,1.05 [0.66-1.68],0.8335862785628858
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAFB2,Scaffold attachment factor B2,13571,143,0.95 [0.53-1.70],0.8497821710972401
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAG,S-arrestin,13169,137,0.95 [0.68-1.30],0.7308006483868407
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAMD9L,Sterile alpha motif domain-containing protein 9-like,15623,160,0.96 [0.79-1.16],0.6403824976111681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAP18,Histone deacetylase complex subunit SAP18,13310,143,0.95 [0.76-1.19],0.6351660839544933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SARG,Specifically androgen-regulated gene protein,13540,142,1.02 [0.88-1.18],0.815145596049667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SART1,U4/U6.U5 tri-snRNP-associated protein 1,13163,138,0.89 [0.55-1.43],0.6186747719561652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAT1,Diamine acetyltransferase 1,13163,138,1.00 [0.73-1.38],0.9788371342294242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAT2,Thialysine N-epsilon-acetyltransferase,13310,143,0.84 [0.64-1.09],0.1784890380442583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SATB1,DNA-binding protein SATB1,13571,143,1.30 [0.86-1.96],0.2181506936584718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SBSN,Suprabasin,13542,142,1.32 [0.83-2.10],0.2480398492809322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCAMP3,Secretory carrier-associated membrane protein 3,15572,159,1.00 [0.85-1.18],0.9716183901852216
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARA5,Scavenger receptor class A member 5,15780,160,1.28 [0.79-2.07],0.315631702371377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARB1,Scavenger receptor class B member 1,15248,155,1.14 [0.93-1.41],0.2038579497830881
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARB2,Lysosome membrane protein 2,15234,154,1.09 [0.66-1.80],0.738011037913199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARF1,Scavenger receptor class F member 1,15834,160,1.10 [0.80-1.52],0.543769866547763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCARF2,Scavenger receptor class F member 2,15780,160,1.37 [0.84-2.22],0.2099861698054883
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCG2,Secretogranin-2,15712,156,1.25 [0.80-1.96],0.3334127641899488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCG3,Secretogranin-3,15669,156,1.00 [0.65-1.53],0.994978640442658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB1A1,Uteroglobin,15678,155,0.78 [0.61-0.98],0.0357572194797041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB2A2,Mammaglobin-A,13163,138,0.85 [0.49-1.48],0.5696980517377075
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB3A1,Secretoglobin family 3A member 1,13289,138,0.55 [0.28-1.08],0.0809142552003842
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGB3A2,Secretoglobin family 3A member 2,15693,156,0.98 [0.83-1.16],0.8308451675226294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCGN,Secretagogin,15330,154,1.15 [0.84-1.59],0.3807482815431633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCIN,Adseverin,13169,137,0.94 [0.74-1.18],0.5754782980538147
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCLY,Selenocysteine lyase,15740,157,1.09 [0.82-1.44],0.5571371242280964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN2A,Sodium channel protein type 2 subunit alpha,13169,137,0.87 [0.60-1.25],0.4472721310491487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN2B,Sodium channel subunit beta-2,13194,139,0.91 [0.51-1.64],0.7575595022676002
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN3A,Sodium channel protein type 3 subunit alpha,13194,139,0.86 [0.54-1.34],0.4994445994237037
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN3B,Sodium channel subunit beta-3,13169,137,0.97 [0.68-1.39],0.8836384974596887
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCN4B,Sodium channel subunit beta-4,13218,134,1.25 [0.84-1.86],0.2749856943444649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCP2,Non-specific lipid-transfer protein,15268,155,1.16 [1.00-1.35],0.0562769586030136
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCPEP1,Retinoid-inducible serine carboxypeptidase,13168,134,1.19 [0.86-1.65],0.2823574756755207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRG1,Scrapie-responsive protein 1,13588,144,1.22 [0.69-2.15],0.4909836215776421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRIB,Protein scribble homolog,13218,134,0.96 [0.80-1.15],0.6621457135453972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCRN1,Secernin-1,15623,160,1.03 [0.81-1.31],0.8312396623338455
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SCT,Secretin,13194,139,0.93 [0.64-1.35],0.6946090752420708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDC1,Syndecan-1,15635,156,0.95 [0.66-1.36],0.7858706397942496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDC4,Syndecan-4,15635,156,1.35 [0.99-1.86],0.060215508832441
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDCCAG8,Serologically defined colon cancer antigen 8,13509,145,0.97 [0.85-1.12],0.6951206784690399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDHB,Succinate dehydrogenase,13524,142,1.14 [0.93-1.40],0.197142458486467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SDK2,Protein sidekick-2,13289,138,0.88 [0.56-1.38],0.5865866569037061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEC31A,Protein transport protein Sec31A,13218,134,1.07 [0.86-1.33],0.54771071914079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEL1L,Protein sel-1 homolog 1,13218,134,1.45 [1.00-2.10],0.0477719733836297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELE,E-selectin,15834,160,1.19 [0.90-1.58],0.2160363049409857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELENOP,Selenoprotein P,13612,142,0.93 [0.45-1.94],0.8523974959061462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELL,L-selectin,13612,142,0.75 [0.37-1.52],0.4289955185642951
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELP,P-selectin,15672,155,1.11 [0.87-1.40],0.4098424208329625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELPLG,P-selectin glycoprotein ligand 1,15623,160,1.10 [0.66-1.82],0.7206329107385667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA3F,Semaphorin-3F,15635,156,2.03 [1.18-3.46],0.0099130739376511
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA3G,Semaphorin-3G,13289,138,0.98 [0.67-1.43],0.9136139545289762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA4C,Semaphorin-4C,15572,159,1.16 [0.73-1.84],0.5373023080558703
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA4D,Semaphorin-4D,15780,160,1.13 [0.71-1.81],0.5999986344435877
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA6C,Semaphorin-6C,13206,139,1.12 [0.63-1.99],0.6975430098000526
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEMA7A,Semaphorin-7A,15777,160,0.86 [0.50-1.47],0.5775723621072436
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN3,Neuronal-specific septin-3,13571,143,0.94 [0.75-1.18],0.6028869432589594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN7,Septin-7,13310,143,0.97 [0.71-1.32],0.8443962911556181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN8,Septin-8,13512,141,1.21 [0.76-1.93],0.42786485480038
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEPTIN9,Septin-9,15572,159,0.84 [0.50-1.40],0.503892674379218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA1,Alpha-1-antitrypsin,13357,141,1.20 [0.17-8.67],0.8554779823176084
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA11,Serpin A11,15834,160,0.89 [0.63-1.25],0.508275757903177
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA12,Serpin A12,15208,155,1.04 [0.92-1.17],0.5473943061355137
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA3,Alpha-1-antichymotrypsin,13565,141,1.83 [0.65-5.19],0.2526452707780161
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA4,Kallistatin,13351,140,1.82 [0.93-3.56],0.0816679338147894
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA5,Plasma serine protease inhibitor,13408,140,1.42 [0.92-2.18],0.1148148395740234
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA6,Corticosteroid-binding globulin,13612,142,1.32 [0.59-2.96],0.4935269067750869
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA7,Thyroxine-binding globulin,13612,142,1.36 [0.59-3.15],0.4710709691760041
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINA9,Serpin A9,15489,158,1.10 [0.91-1.33],0.3475637488242672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB1,Leukocyte elastase inhibitor,15587,159,1.00 [0.86-1.17],0.9860322684263256
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB5,Serpin B5,15372,156,1.34 [1.00-1.79],0.0535564398821794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB6,Serpin B6,15728,159,1.05 [0.84-1.32],0.6684179477672814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB8,Serpin B8,15813,160,0.96 [0.75-1.23],0.751081742785724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB9,Serpin B9,15529,157,0.92 [0.61-1.39],0.6922518321788073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINC1,Antithrombin-III,13581,142,3.95 [1.33-11.75],0.0133976795274866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPIND1,Heparin cofactor 2,13581,142,1.85 [1.05-3.27],0.0339116884664748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINE1,Plasminogen activator inhibitor 1,15834,160,1.12 [0.92-1.38],0.2620081647251366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINE2,Glia-derived nexin,13588,144,1.10 [0.86-1.40],0.4387201071976726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINF1,Pigment epithelium-derived factor,13408,141,1.93 [1.07-3.49],0.0286622895158203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINF2,Alpha-2-antiplasmin,13353,139,3.95 [1.30-12.02],0.0154354380731105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPING1,Plasma protease C1 inhibitor,13581,142,3.00 [1.30-6.97],0.0103490574392574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINH1,Serpin H1,13310,143,1.05 [0.93-1.19],0.4561960243073025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINI1,Neuroserpin,13257,138,1.00 [0.60-1.67],0.995812168984066
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINI2,Serpin I2,13524,142,0.90 [0.67-1.20],0.4572262415713116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,15248,155,1.15 [0.93-1.43],0.1951661020358485
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SETMAR,Histone-lysine N-methyltransferase SETMAR,15484,157,1.10 [0.69-1.75],0.6893257406635405
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6,Seizure protein 6 homolog,13194,139,1.11 [0.65-1.88],0.70530828363326
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6L,Seizure 6-like protein,15681,158,1.24 [0.74-2.07],0.4171298307814095
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SEZ6L2,Seizure 6-like protein 2,15572,159,0.78 [0.44-1.40],0.4115391799182033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SF3B4,Splicing factor 3B subunit 4,15572,159,0.92 [0.76-1.11],0.3733532649623119
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFRP1,Secreted frizzled-related protein 1,15472,157,1.13 [0.82-1.56],0.456979608663504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFRP4,Secreted frizzled-related protein 4,13289,138,0.83 [0.56-1.21],0.3307760762021691
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPA1,Pulmonary surfactant-associated protein A1,15268,155,1.00 [0.79-1.28],0.974752175452254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPA2,Pulmonary surfactant-associated protein A2,15268,155,1.32 [1.01-1.71],0.0394270363764193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPD,Pulmonary surfactant-associated protein D,15635,156,0.99 [0.80-1.23],0.949572772131198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SGSH,N-sulphoglucosamine sulphohydrolase,13375,143,1.06 [0.79-1.41],0.7097745080441359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH2B3,SH2B adapter protein 3,15268,155,1.09 [0.94-1.26],0.2406593961060822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH2D1A,SH2 domain-containing protein 1A,15623,160,0.79 [0.59-1.05],0.102052924308742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,13169,137,0.98 [0.76-1.28],0.9081199984035704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3BP1,SH3 domain-binding protein 1,13524,142,1.15 [0.86-1.54],0.3546286704302254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3GL3,Endophilin-A3,13234,143,1.03 [0.85-1.24],0.7762278836819794
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SH3GLB2,Endophilin-B2,13545,141,0.97 [0.76-1.22],0.7737013022256689
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHBG,Sex hormone-binding globulin,13597,143,0.93 [0.70-1.25],0.6484492792568102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHC1,SHC-transforming protein 1,13103,139,0.97 [0.84-1.12],0.7176196599330342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHD,SH2 domain-containing adapter protein D,13141,136,0.99 [0.82-1.20],0.9243635948415724
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHH,Sonic hedgehog protein,13206,139,0.92 [0.62-1.36],0.6748576827232265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHISA5,Protein shisa-5,13569,142,1.72 [0.93-3.18],0.0843971752208348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHMT1,"Serine hydroxymethyltransferase, cytosolic",15693,156,1.08 [0.92-1.27],0.3451302342503944
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHPK,Sedoheptulokinase,13310,143,0.96 [0.66-1.41],0.854644087590131
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIAE,Sialate O-acetylesterase,15656,158,1.05 [0.78-1.41],0.7649550116419932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC1,Sialoadhesin,15718,156,1.07 [0.77-1.49],0.6720219035113181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC10,Sialic acid-binding Ig-like lectin 10,15623,160,1.21 [0.80-1.85],0.3652573288705898
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC15,Sialic acid-binding Ig-like lectin 15,15248,155,0.98 [0.83-1.17],0.8602933448149864
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC5,Sialic acid-binding Ig-like lectin 5,15634,160,1.12 [0.98-1.28],0.1077857319131076
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC6,Sialic acid-binding Ig-like lectin 6,15780,157,0.93 [0.61-1.44],0.7576249713682572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC7,Sialic acid-binding Ig-like lectin 7,15635,156,1.20 [0.73-1.98],0.4687160803059056
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC8,Sialic acid-binding Ig-like lectin 8,13218,134,1.22 [0.85-1.75],0.272551542597337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC9,Sialic acid-binding Ig-like lectin 9,15763,157,0.99 [0.62-1.59],0.9805215553386528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIL1,Nucleotide exchange factor SIL1,13218,134,1.05 [0.65-1.70],0.8457510230587207
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,15671,160,1.40 [1.07-1.84],0.0138645633888635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRPB1,Signal-regulatory protein beta-1,15611,155,1.38 [1.00-1.90],0.051692955307929
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT1,NAD-dependent protein deacetylase sirtuin-1,13206,139,1.07 [0.91-1.25],0.3985816188803814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT2,NAD-dependent protein deacetylase sirtuin-2,15572,159,1.00 [0.86-1.17],0.959160546098662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",15248,155,0.97 [0.75-1.25],0.8095747801842281
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIT1,Signaling threshold-regulating transmembrane adapter 1,15330,154,1.08 [0.84-1.39],0.5407589026644561
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKAP1,Src kinase-associated phosphoprotein 1,15499,157,1.03 [0.85-1.24],0.7673474525370579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKAP2,Src kinase-associated phosphoprotein 2,15718,156,0.93 [0.82-1.07],0.3018813740095061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SKIV2L,Helicase SKI2W,13163,138,0.90 [0.60-1.37],0.6302472469755709
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLA2,Src-like-adapter 2,13571,143,1.03 [0.89-1.20],0.6943141212893388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF1,Signaling lymphocytic activation molecule,15330,154,1.07 [0.84-1.36],0.6009319252530159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF6,SLAM family member 6,15268,155,0.84 [0.57-1.23],0.3622533494988335
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF7,SLAM family member 7,15623,160,0.87 [0.68-1.12],0.2841303879106051
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLAMF8,SLAM family member 8,15268,155,0.91 [0.70-1.18],0.4740811370645956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC12A2,Solute carrier family 12 member 2,13163,138,0.58 [0.30-1.12],0.1048523844129616
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC13A1,Solute carrier family 13 member 1,13509,145,0.87 [0.64-1.17],0.3492536307702962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC16A1,Monocarboxylate transporter 1,15248,155,1.08 [0.86-1.35],0.5137877310827192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC1A4,Neutral amino acid transporter A,13194,139,1.05 [0.78-1.41],0.7565548731288073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC27A4,Long-chain fatty acid transport protein 4,15248,155,0.97 [0.78-1.21],0.767290427445927
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC28A1,Sodium/nucleoside cotransporter 1,13103,139,0.96 [0.73-1.26],0.7685830552420039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC34A3,Sodium-dependent phosphate transport protein 2C,13103,139,1.15 [0.86-1.54],0.3410536653323072
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A14,Zinc transporter ZIP14,15248,155,1.01 [0.65-1.58],0.9483690767871896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A5,Zinc transporter ZIP5,15623,160,0.89 [0.68-1.17],0.4040881194812089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC44A4,Choline transporter-like protein 4,13194,139,1.04 [0.83-1.30],0.7244116103205385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC4A1,Band 3 anion transport protein,13569,142,0.97 [0.69-1.36],0.869866722243667
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC51B,Organic solute transporter subunit beta,13163,138,0.99 [0.80-1.22],0.9373875072624288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,13289,138,1.08 [0.89-1.31],0.4179088170017366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,13524,142,1.11 [0.85-1.45],0.4524024828786475
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13103,139,0.79 [0.57-1.10],0.1621697596983156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLIT2,Slit homolog 2 protein,15248,155,0.86 [0.64-1.15],0.3070228410395781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK1,SLIT and NTRK-like protein 1,13206,139,1.75 [1.08-2.84],0.023359644995682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK2,SLIT and NTRK-like protein 2,15780,157,1.49 [1.03-2.16],0.0344147584363636
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLITRK6,SLIT and NTRK-like protein 6,15372,156,1.72 [1.20-2.46],0.0028587034338583
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLK,STE20-like serine/threonine-protein kinase,13310,143,1.19 [1.02-1.39],0.0319420460720544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLMAP,Sarcolemmal membrane-associated protein,13524,142,1.02 [0.84-1.23],0.85452120696584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLURP1,Secreted Ly-6/uPAR-related protein 1,13464,142,1.16 [0.80-1.70],0.4315901543303925
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD1,Mothers against decapentaplegic homolog 1,15268,155,1.08 [0.91-1.29],0.3819485224838369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD2,Mothers against decapentaplegic homolog 2,13509,145,1.14 [0.91-1.43],0.2619754255873224
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD3,Mothers against decapentaplegic homolog 3,13509,145,0.95 [0.69-1.31],0.7600770166904413
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMAD5,Mothers against decapentaplegic homolog 5,15572,159,1.16 [0.59-2.28],0.669402971711242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMARCA2,Probable global transcription activator SNF2L2,15248,155,1.16 [0.97-1.38],0.1140709297819997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMC3,Structural maintenance of chromosomes protein 3,13103,139,1.20 [0.93-1.54],0.1560002797189945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMNDC1,Survival of motor neuron-related-splicing factor 30,13524,142,0.96 [0.74-1.25],0.7635477168127228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMOC1,SPARC-related modular calcium-binding protein 1,15780,157,1.23 [0.81-1.88],0.3279268630267897
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMOC2,SPARC-related modular calcium-binding protein 2,15718,156,1.02 [0.71-1.47],0.909686642876622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPD1,Sphingomyelin phosphodiesterase,15703,160,0.99 [0.74-1.32],0.9394289433129688
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPD3,Sphingomyelin phosphodiesterase 3,13206,139,1.22 [1.00-1.49],0.0505528051385687
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,15689,156,0.90 [0.72-1.11],0.3169094614282735
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,13509,145,1.11 [0.93-1.33],0.2519172645627793
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMS,Spermine synthase,13169,137,1.11 [0.88-1.41],0.3698019479545557
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMTN,Smoothelin,13514,140,0.91 [0.76-1.08],0.2718481759757529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP23,Synaptosomal-associated protein 23,15635,156,1.02 [0.86-1.19],0.8427412259797783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP25,Synaptosomal-associated protein 25,13169,137,1.24 [0.88-1.74],0.2229508592840301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAP29,Synaptosomal-associated protein 29,15681,158,1.03 [0.88-1.20],0.6877214208975653
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNAPIN,SNARE-associated protein Snapin,13571,143,1.16 [0.88-1.52],0.2897768718812278
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNCA,Alpha-synuclein,13289,138,1.02 [0.89-1.18],0.7523913630752521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNCG,Gamma-synuclein,15529,157,0.95 [0.77-1.18],0.661007854504313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",13218,134,1.05 [0.64-1.71],0.8573379730028603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNRPB2,U2 small nuclear ribonucleoprotein B'',13545,141,0.96 [0.67-1.39],0.8487611627334448
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNU13,NHP2-like protein 1,13163,138,1.04 [0.82-1.32],0.7447542599483863
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX15,Sorting nexin-15,13289,138,1.00 [0.75-1.35],0.9820701102644932
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX18,Sorting nexin-18,13524,142,0.92 [0.64-1.31],0.6386696976011972
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX2,Sorting nexin-2,13509,145,1.06 [0.88-1.29],0.5206601442385597
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX5,Sorting nexin-5,13218,134,1.04 [0.61-1.78],0.8788586927440116
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX9,Sorting nexin-9,15635,156,0.98 [0.80-1.20],0.8391265920994928
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD1,Superoxide dismutase [Cu-Zn],15278,151,0.88 [0.65-1.18],0.3872855488657465
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD2,"Superoxide dismutase [Mn], mitochondrial",15634,160,1.15 [0.81-1.64],0.4283733975562428
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOD3,Extracellular superoxide dismutase,13597,143,0.84 [0.61-1.16],0.2897857680230683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORBS1,Sorbin and SH3 domain-containing protein 1,13571,143,1.24 [0.88-1.76],0.2140650387243006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORCS2,VPS10 domain-containing receptor SorCS2,15268,155,1.20 [0.80-1.80],0.3888547016420993
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORD,Sorbitol dehydrogenase,15709,157,1.05 [0.85-1.29],0.675271380542821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SORT1,Sortilin,15613,156,1.32 [0.90-1.92],0.1544515019028152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOST,Sclerostin,15613,156,1.63 [1.14-2.33],0.0078261764665449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,13194,139,0.92 [0.65-1.31],0.6442399769407396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOX2,Transcription factor SOX-2,13553,143,1.04 [0.53-2.04],0.9032856452785768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SOX9,Transcription factor SOX-9,13194,139,0.89 [0.48-1.63],0.6959478280855393
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,13571,143,0.83 [0.46-1.48],0.5197691360925503
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPAG1,Sperm-associated antigen 1,13571,143,0.98 [0.75-1.28],0.8775020271457302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPARC,SPARC,15681,158,1.15 [0.94-1.41],0.1673707181235509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPARCL1,SPARC-like protein 1,15624,152,1.10 [0.65-1.85],0.7189185151835542
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPART,Spartin,13289,138,0.96 [0.78-1.19],0.7235101325683575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPESP1,Sperm equatorial segment protein 1,13588,144,0.76 [0.41-1.38],0.3637516335110555
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK1,Serine protease inhibitor Kazal-type 1,15634,160,1.07 [0.78-1.47],0.6700742723614868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK2,Serine protease inhibitor Kazal-type 2,13289,138,1.27 [0.83-1.94],0.2769315912714395
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK4,Serine protease inhibitor Kazal-type 4,15623,160,1.35 [1.10-1.66],0.0045257897079622
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK5,Serine protease inhibitor Kazal-type 5,15634,160,0.91 [0.59-1.40],0.6553650742331014
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK6,Serine protease inhibitor Kazal-type 6,15780,157,1.18 [0.92-1.52],0.1991739983293911
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINK8,Serine protease inhibitor Kazal-type 8,13163,138,0.93 [0.59-1.47],0.7714855862637462
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT1,Kunitz-type protease inhibitor 1,15583,159,1.17 [0.69-2.00],0.5596121941038723
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT2,Kunitz-type protease inhibitor 2,15718,156,1.36 [0.97-1.90],0.0771756481406058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPINT3,Kunitz-type protease inhibitor 3,13524,142,1.05 [0.92-1.19],0.4637559355127061
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPOCK1,Testican-1,15529,157,0.96 [0.55-1.69],0.8939860671693025
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPON1,Spondin-1,15669,156,1.19 [0.78-1.83],0.4149409253432023
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPON2,Spondin-2,15561,156,1.06 [0.70-1.61],0.7718657021789943
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPP1,Osteopontin,15802,160,1.22 [0.90-1.64],0.1977488756634225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",13206,139,1.05 [0.74-1.49],0.7803226332452444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRING1,SREBP regulating gene protein,13103,139,1.20 [0.96-1.51],0.1136712896380576
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR1B,Cornifin-B,13310,143,0.99 [0.82-1.19],0.8779815071230356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR3,Small proline-rich protein 3,13545,141,1.22 [0.98-1.52],0.071212164060432
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRY2,Protein sprouty homolog 2,15330,154,1.00 [0.86-1.16],0.9714841133341304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",13169,137,0.80 [0.47-1.37],0.4214691545738419
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTLC1,Serine palmitoyltransferase 1,13545,141,1.09 [0.72-1.65],0.6783059073509488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRC,Proto-oncogene tyrosine-protein kinase Src,15657,158,0.98 [0.88-1.10],0.7773327065908446
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRP14,Signal recognition particle 14 kDa protein,15572,159,1.14 [0.91-1.42],0.25317598142389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRPK2,SRSF protein kinase 2,15623,160,1.01 [0.85-1.19],0.9366287629138708
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRPX,Sushi repeat-containing protein SRPX,13588,144,0.93 [0.57-1.52],0.7785118952405942
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSB,Lupus La protein,15248,155,0.80 [0.60-1.06],0.1167993174451203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",13206,139,1.16 [0.77-1.75],0.4779551319018731
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,15613,156,0.99 [0.87-1.13],0.9323655790063524
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,15672,155,0.88 [0.63-1.22],0.4332950285087608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSH3,Protein phosphatase Slingshot homolog 3,13103,139,1.41 [0.86-2.30],0.1734619178757337
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SSNA1,Sjoegren syndrome nuclear autoantigen 1,13524,142,1.00 [0.73-1.36],0.9900664375767656
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST13,Hsc70-interacting protein,13289,138,0.98 [0.74-1.31],0.8984040975966132
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",15572,159,1.04 [0.76-1.44],0.7898759386845544
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",15834,160,1.72 [1.08-2.75],0.0234715924107736
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",13206,139,1.25 [0.98-1.59],0.0745123326933411
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAB2,Stabilin-2,13569,142,1.86 [1.09-3.18],0.0230244169619325
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAM,Signal transducing adapter molecule 1,13509,145,1.00 [0.66-1.50],0.9936393600824236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAMBP,STAM-binding protein,15499,157,0.99 [0.80-1.23],0.9251794054761832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAT2,Signal transducer and activator of transcription 2,13206,139,1.03 [0.83-1.27],0.817325659207309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAT5B,Signal transducer and activator of transcription 5B,15572,159,1.03 [0.93-1.14],0.6235664333536316
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13103,139,1.01 [0.80-1.29],0.903916750047594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STC1,Stanniocalcin-1,15780,160,1.23 [0.88-1.71],0.2274530180976773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STC2,Stanniocalcin-2,15610,160,1.19 [0.71-2.00],0.4985699574711681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STEAP4,Metalloreductase STEAP4,13169,137,0.86 [0.67-1.11],0.249198662953884
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STIP1,Stress-induced-phosphoprotein 1,15610,160,0.99 [0.80-1.23],0.9518306755620036
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK11,Serine/threonine-protein kinase STK11,15372,156,1.10 [0.91-1.33],0.3318732106496517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK24,Serine/threonine-protein kinase 24,15248,155,1.12 [0.89-1.40],0.344564680304444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STK4,Serine/threonine-protein kinase 4,15635,156,0.98 [0.83-1.15],0.7667842468526043
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STOML2,"Stomatin-like protein 2, mitochondrial",13103,139,0.97 [0.81-1.16],0.733314667232609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX16,Syntaxin-16,15268,155,0.88 [0.68-1.14],0.3291411445274572
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX1B,Syntaxin-1B,13194,139,1.14 [0.84-1.56],0.3913375961504022
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX3,Syntaxin-3,13545,141,0.86 [0.55-1.33],0.4941030828533251
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX4,Syntaxin-4,15572,159,0.90 [0.70-1.15],0.381176903686517
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX5,Syntaxin-5,13206,139,1.11 [0.77-1.59],0.5823635653420498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX6,Syntaxin-6,15268,155,1.09 [0.90-1.31],0.3996581145659343
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX7,Syntaxin-7,13206,139,1.11 [0.80-1.53],0.5295833628709242
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STX8,Syntaxin-8,15623,160,1.04 [0.79-1.37],0.7932599033789571
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STXBP1,Syntaxin-binding protein 1,13571,143,1.10 [0.89-1.35],0.3749855095602199
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STXBP3,Syntaxin-binding protein 3,15268,155,1.02 [0.74-1.41],0.9139254175314578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGP1,SURP and G-patch domain-containing protein 1,13524,142,1.04 [0.71-1.53],0.848376167725962
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGT1,Protein SGT1 homolog,15268,155,1.06 [0.89-1.27],0.4980907514710377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SULT1A1,Sulfotransferase 1A1,15780,160,0.99 [0.89-1.10],0.8808788696114358
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SULT2A1,Bile salt sulfotransferase,15623,160,0.97 [0.75-1.25],0.8097172202479057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUMF1,Formylglycine-generating enzyme,13206,139,1.15 [0.96-1.38],0.1303068302360186
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,15780,160,1.24 [0.95-1.63],0.1105023755019608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUOX,"Sulfite oxidase, mitochondrial",13571,143,1.10 [0.87-1.41],0.4160035476563933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD1,Sushi domain-containing protein 1,15372,156,1.10 [0.82-1.47],0.5267247133939026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD2,Sushi domain-containing protein 2,15634,160,1.06 [0.66-1.71],0.8109103871856421
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD4,Sushi domain-containing protein 4,13509,145,1.11 [0.79-1.55],0.5423941520384499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUSD5,Sushi domain-containing protein 5,13212,137,1.36 [0.84-2.20],0.2125098982927233
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SV2A,Synaptic vesicle glycoprotein 2A,13194,139,1.00 [0.77-1.29],0.9771395690780832
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SWAP70,Switch-associated protein 70,13524,142,1.06 [0.69-1.63],0.8008987041883991
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYAP1,Synapse-associated protein 1,13289,138,1.02 [0.76-1.36],0.9110261860027546
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,13169,137,0.88 [0.64-1.21],0.4228551023372996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYT1,Synaptotagmin-1,13545,141,1.09 [0.73-1.61],0.6756902447316366
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SYTL4,Synaptotagmin-like protein 4,13588,144,1.03 [0.83-1.28],0.7785767904289057
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,13310,143,0.94 [0.81-1.10],0.4466250619517229
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TACC3,Transforming acidic coiled-coil-containing protein 3,15572,159,1.03 [0.92-1.17],0.5813346806597655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TACSTD2,Tumor-associated calcium signal transducer 2,13875,136,0.93 [0.55-1.56],0.7797575301997077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TADA3,Transcriptional adapter 3,13509,145,1.23 [0.83-1.82],0.3007572319887375
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAFA5,Chemokine-like protein TAFA-5,15572,159,1.09 [0.73-1.63],0.6842867660583751
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAGLN3,Transgelin-3,13103,139,1.02 [0.78-1.32],0.8997550518488292
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TALDO1,Transaldolase,13525,141,1.03 [0.72-1.45],0.8815786115059127
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TANK,TRAF family member-associated NF-kappa-B activator,15330,154,1.02 [0.83-1.25],0.842296207754015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAP1,Antigen peptide transporter 1,13310,143,1.03 [0.80-1.34],0.8087908013799617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARBP2,RISC-loading complex subunit TARBP2,15248,155,1.00 [0.83-1.20],0.9996255422872496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",13194,139,0.87 [0.68-1.10],0.2400534906948606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",13509,145,0.89 [0.57-1.38],0.5957582727039336
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAX1BP1,Tax1-binding protein 1,13545,141,0.92 [0.71-1.19],0.5306763732218792
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D17,TBC1 domain family member 17,15248,155,0.88 [0.63-1.22],0.4476273624736915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D23,TBC1 domain family member 23,15572,159,0.96 [0.82-1.12],0.6327691881536748
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBC1D5,TBC1 domain family member 5,15623,160,0.92 [0.76-1.10],0.3443537034064315
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCA,Tubulin-specific chaperone A,13289,138,1.01 [0.84-1.21],0.9213842409833372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCB,Tubulin-folding cofactor B,15529,157,1.02 [0.89-1.17],0.7758127841613454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBCC,Tubulin-specific chaperone C,15529,157,1.01 [0.85-1.20],0.8965159455789847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBL1X,F-box-like/WD repeat-containing protein TBL1X,15268,155,1.09 [0.92-1.29],0.315876584728607
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TBR1,T-box brain protein 1,13194,139,0.97 [0.69-1.37],0.8680700258588528
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCL1A,T-cell leukemia/lymphoma protein 1A,15500,156,1.04 [0.90-1.22],0.579560488196241
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCL1B,T-cell leukemia/lymphoma protein 1B,15372,156,0.89 [0.73-1.09],0.2639481405520945
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCN1,Transcobalamin-1,13323,141,1.01 [0.62-1.65],0.9607717541057093
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCN2,Transcobalamin-2,15802,160,1.27 [0.81-1.99],0.295441130514665
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCOF1,Treacle protein,13588,144,0.86 [0.50-1.47],0.5824840532365821
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCP11,T-complex protein 11 homolog,13310,143,0.94 [0.70-1.25],0.6584727657913123
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCTN3,Tectonic-3,13588,144,1.15 [0.67-1.98],0.6126012778072081
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDGF1,Teratocarcinoma-derived growth factor 1,15248,155,0.96 [0.86-1.06],0.4047871171103443
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDO2,"Tryptophan 2,3-dioxygenase",13194,139,0.78 [0.48-1.25],0.2999955329947348
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDP1,Tyrosyl-DNA phosphodiesterase 1,13509,145,1.07 [0.87-1.31],0.5510120921779387
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TDRKH,Tudor and KH domain-containing protein,15248,155,0.94 [0.79-1.12],0.4742023420507635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEF,Thyrotroph embryonic factor,13163,138,0.88 [0.59-1.31],0.5358489523435845
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEK,Angiopoietin-1 receptor,15681,158,1.18 [0.62-2.24],0.6202027428216332
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TERF1,Telomeric repeat-binding factor 1,13206,139,1.04 [0.61-1.78],0.8846840415860334
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TET2,Methylcytosine dioxygenase TET2,13293,143,0.96 [0.81-1.14],0.6612062052872317
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEX101,Testis-expressed protein 101,13194,139,1.21 [0.80-1.81],0.3642703854622849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TEX33,Testis-expressed protein 33,13310,143,1.04 [0.71-1.51],0.8524577251610193
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TF,Serotransferrin,13612,142,1.22 [0.60-2.49],0.5792588375977294
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFAP2A,Transcription factor AP-2-alpha,13169,137,1.09 [0.84-1.40],0.5196753244621338
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF1,Trefoil factor 1,15557,159,1.00 [0.82-1.21],0.9706201668079418
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF2,Trefoil factor 2,15693,156,0.93 [0.73-1.20],0.5834951130163956
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF3,Trefoil factor 3,15602,150,0.94 [0.72-1.23],0.6689985386652715
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFPI,Tissue factor pathway inhibitor,15569,155,1.26 [0.83-1.91],0.2751348852911551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFPI2,Tissue factor pathway inhibitor 2,15624,158,1.18 [0.88-1.59],0.2731468475660369
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFRC,Transferrin receptor protein 1,15682,155,1.03 [0.73-1.45],0.8847415990837504
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TG,Thyroglobulin,13509,145,1.00 [0.87-1.15],0.9867492511858624
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFA,Protransforming growth factor alpha,15623,160,1.20 [0.90-1.59],0.2164573080633451
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFB1,Transforming growth factor beta-1 proprotein,15783,159,1.24 [0.87-1.77],0.2332397455292997
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFB2,Transforming growth factor beta-2 proprotein,13509,145,1.04 [0.78-1.39],0.7850886890337714
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBI,Transforming growth factor-beta-induced protein ig-h3,15523,155,0.85 [0.51-1.44],0.5549282683731926
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR1,TGF-beta receptor type-1,13206,139,1.23 [0.62-2.46],0.5491334389709529
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR2,TGF-beta receptor type-2,15681,158,1.40 [0.90-2.19],0.1363111409374933
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGFBR3,Transforming growth factor beta receptor type 3,15834,160,1.23 [0.80-1.89],0.3506492478236847
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGM2,Protein-glutamine gamma-glutamyltransferase 2,15608,156,0.92 [0.76-1.10],0.3616464238303318
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGOLN2,Trans-Golgi network integral membrane protein 2,13597,143,1.48 [0.78-2.79],0.2300431624421112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THAP12,52 kDa repressor of the inhibitor of the protein kinase,13079,139,0.94 [0.78-1.13],0.5111396735790419
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBD,Thrombomodulin,15635,156,1.19 [0.71-1.99],0.5150659223492466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBS2,Thrombospondin-2,15634,160,0.91 [0.61-1.34],0.6256822537516892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THBS4,Thrombospondin-4,15626,155,0.95 [0.70-1.29],0.7371725008364521
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THOP1,Thimet oligopeptidase,15576,156,1.09 [0.69-1.72],0.7069341821523718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THPO,Thrombopoietin,15372,156,1.35 [0.94-1.96],0.1048029230110409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THRAP3,Thyroid hormone receptor-associated protein 3,13163,138,1.00 [0.88-1.15],0.9446751698812909
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THSD1,Thrombospondin type-1 domain-containing protein 1,13105,137,1.53 [1.02-2.29],0.039604113753344
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THTPA,Thiamine-triphosphatase,13485,145,1.05 [0.88-1.25],0.6024047360562181
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THY1,Thy-1 membrane glycoprotein,15780,160,0.97 [0.58-1.63],0.9126730005927648
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIA1,Nucleolysin TIA-1 isoform p40,15204,155,1.02 [0.91-1.15],0.6920470694504774
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIE1,Tyrosine-protein kinase receptor Tie-1,15834,160,0.98 [0.71-1.35],0.883705406284873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",15218,155,1.19 [0.89-1.58],0.2436261855637758
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,13310,143,0.83 [0.51-1.33],0.4347111084101658
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,15672,155,1.40 [1.03-1.91],0.0331293728906805
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,13588,144,1.10 [0.75-1.63],0.6195734260487549
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,13545,141,1.04 [0.87-1.25],0.6636728285087992
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP1,Metalloproteinase inhibitor 1,15431,149,1.28 [0.78-2.11],0.324795294240872
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP2,Metalloproteinase inhibitor 2,13588,144,0.73 [0.35-1.55],0.4147910005420118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP3,Metalloproteinase inhibitor 3,15718,156,1.00 [0.90-1.11],0.9718461592460068
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP4,Metalloproteinase inhibitor 4,15634,160,0.98 [0.69-1.40],0.929239111099725
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TINAGL1,Tubulointerstitial nephritis antigen-like,15584,156,0.94 [0.50-1.78],0.859987360473033
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TJAP1,Tight junction-associated protein 1,15681,158,0.98 [0.83-1.16],0.8068428143646582
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TJP3,Tight junction protein ZO-3,13169,137,0.61 [0.38-0.97],0.0362577535733058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TK1,"Thymidine kinase, cytosolic",13310,143,1.15 [0.83-1.60],0.3890406333861261
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR1,Toll-like receptor 1,13206,139,1.58 [0.89-2.81],0.1176000732653327
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR2,Toll-like receptor 2,13310,143,1.01 [0.51-2.02],0.9784516200732548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR3,Toll-like receptor 3,15813,160,1.16 [0.92-1.46],0.202116082229313
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TLR4,Toll-like receptor 4,13206,139,1.28 [0.72-2.26],0.4006018615680442
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,13194,139,1.04 [0.77-1.41],0.7776704774064052
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED1,Transmembrane emp24 domain-containing protein 1,13310,143,0.74 [0.53-1.04],0.0828198267648578
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED10,Transmembrane emp24 domain-containing protein 10,13163,138,0.71 [0.45-1.11],0.1286697375989429
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED4,Transmembrane emp24 domain-containing protein 4,13163,138,0.99 [0.73-1.32],0.9225688376155275
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMED8,Protein TMED8,13524,142,1.06 [0.90-1.24],0.4816971057112309
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM106A,Transmembrane protein 106A,13509,145,1.06 [0.85-1.32],0.6217845791421288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM132A,Transmembrane protein 132A,13218,134,0.81 [0.62-1.06],0.1323083971329627
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMEM25,Transmembrane protein 25,13571,143,1.22 [0.89-1.68],0.2185390617156073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMOD4,Tropomodulin-4,13103,139,1.09 [0.74-1.59],0.6712427626104389
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS11B,Transmembrane protease serine 11B,13169,137,0.97 [0.78-1.20],0.755728275438236
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS11D,Transmembrane protease serine 11D,13512,141,1.59 [1.09-2.33],0.0173700374029752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS15,Enteropeptidase,15572,159,1.09 [0.93-1.26],0.2843738774518269
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMPRSS5,Transmembrane protease serine 5,15450,156,0.91 [0.63-1.32],0.6232961550089487
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TMSB10,Thymosin beta-10,15634,160,1.10 [0.92-1.32],0.3030373687471367
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNC,Tenascin,15672,155,1.02 [0.75-1.37],0.9092144611077796
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNF,Tumor necrosis factor,15349,156,0.90 [0.61-1.33],0.5999362872757248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,13524,142,1.02 [0.73-1.41],0.9206810160345652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,15330,154,0.76 [0.50-1.14],0.1781899746377248
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,13289,138,1.00 [0.78-1.29],0.9918296553443472
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,15529,157,1.03 [0.66-1.60],0.9043713782753549
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,15529,157,1.03 [0.73-1.44],0.8852224260721585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,15663,160,0.99 [0.74-1.31],0.9320939180982458
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,15813,160,1.27 [0.87-1.84],0.2098121555908301
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,15640,155,1.37 [0.87-2.14],0.170115723249192
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,15681,158,1.16 [0.77-1.75],0.466437418464575
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,15669,156,0.85 [0.53-1.34],0.4751915379518449
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,15330,154,1.06 [0.75-1.50],0.7358925339275274
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,15669,156,1.52 [0.96-2.42],0.0755458981034506
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,13289,138,0.85 [0.56-1.29],0.4427288684923878
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,15780,157,1.59 [1.02-2.47],0.0390203593661609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,15634,160,1.40 [0.86-2.28],0.1757932732806664
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,15634,160,1.15 [0.79-1.66],0.4636874044414699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,15780,160,1.49 [0.90-2.47],0.1227476202045508
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,15783,159,1.37 [0.96-1.96],0.0808760002069762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,15529,157,1.55 [1.24-1.94],0.0001382947015007
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,15780,160,0.88 [0.64-1.21],0.4386743479407984
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,15529,157,1.15 [0.80-1.64],0.4502711212614996
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF10,Tumor necrosis factor ligand superfamily member 10,15813,160,1.01 [0.60-1.71],0.9584107277548924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF11,Tumor necrosis factor ligand superfamily member 11,15623,160,0.87 [0.70-1.09],0.2399564557315225
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF12,Tumor necrosis factor ligand superfamily member 12,15813,160,1.19 [0.75-1.89],0.4566977235604916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13,Tumor necrosis factor ligand superfamily member 13,15718,156,1.60 [0.95-2.70],0.0778477572947005
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,15803,160,1.52 [0.94-2.45],0.0885840956868213
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF14,Tumor necrosis factor ligand superfamily member 14,15529,157,1.01 [0.79-1.30],0.9133006227978856
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF8,Tumor necrosis factor ligand superfamily member 8,13569,142,1.20 [0.78-1.85],0.400598240826377
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNIP1,TNFAIP3-interacting protein 1,13545,141,0.94 [0.78-1.13],0.4934034996480753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNN,Tenascin-N,13569,142,1.18 [0.82-1.70],0.3660226061071175
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNNI3,"Troponin I, cardiac muscle",15372,156,0.96 [0.82-1.13],0.6294108235197753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNPO1,Transportin-1,13310,143,1.10 [0.70-1.70],0.6843687570597476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNR,Tenascin-R,15529,157,1.03 [0.74-1.44],0.8390039379414492
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNXB,Tenascin-X,15634,160,1.25 [0.73-2.15],0.4102712650851345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,13588,144,1.11 [0.91-1.36],0.3055088470193606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP1,DNA topoisomerase 1,13524,142,0.95 [0.82-1.11],0.5310147663647868
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP1MT,"DNA topoisomerase I, mitochondrial",13103,139,1.08 [0.79-1.48],0.6338601046922302
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOP2B,DNA topoisomerase 2-beta,13206,139,1.05 [0.85-1.28],0.6655076637207742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOR1AIP1,Torsin-1A-interacting protein 1,13218,134,0.85 [0.60-1.19],0.3324669886362444
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53,Cellular tumor antigen p53,15268,155,1.23 [0.89-1.69],0.2015964440267811
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53BP1,TP53-binding protein 1,13206,139,1.08 [0.91-1.30],0.3777201131330133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53I3,Quinone oxidoreductase PIG3,12992,136,1.09 [0.81-1.48],0.5619472189931551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP53INP1,Tumor protein p53-inducible nuclear protein 1,15372,156,1.09 [0.72-1.64],0.6982444596703701
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TP73,Tumor protein p73,13194,139,0.90 [0.56-1.44],0.6622939148033359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPBGL,Trophoblast glycoprotein-like,13194,139,1.10 [0.76-1.58],0.6233381855680464
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPD52L2,Tumor protein D54,13289,138,1.03 [0.88-1.19],0.7370112975386559
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPK1,Thiamin pyrophosphokinase 1,13588,144,1.21 [0.68-2.14],0.5209350616002895
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPM3,Tropomyosin alpha-3 chain,13163,138,1.08 [0.75-1.55],0.6853571981794255
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPMT,Thiopurine S-methyltransferase,15268,155,1.08 [0.90-1.30],0.4187113100223916
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPP1,Tripeptidyl-peptidase 1,15543,154,1.01 [0.74-1.39],0.9397540772868896
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPPP2,Tubulin polymerization-promoting protein family member 2,13310,143,1.02 [0.85-1.23],0.8282370825577536
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPPP3,Tubulin polymerization-promoting protein family member 3,15248,155,0.92 [0.63-1.34],0.6595542016733039
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPR,Nucleoprotein TPR,13163,138,0.91 [0.64-1.29],0.5930064551635152
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPRKB,EKC/KEOPS complex subunit TPRKB,13103,139,1.26 [1.05-1.51],0.0140742721593551
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSAB1,Tryptase alpha/beta-1,15783,160,1.29 [0.99-1.68],0.0601479442395496
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSD1,Tryptase delta,13571,143,1.31 [0.93-1.84],0.1199906816076966
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPSG1,Tryptase gamma,13206,139,0.88 [0.48-1.63],0.6829685263375467
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPT1,Translationally-controlled tumor protein,15330,154,1.05 [0.86-1.29],0.6015826822419625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF2,TNF receptor-associated factor 2,15623,160,0.93 [0.76-1.13],0.4483525688029395
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF3,"TNF receptor-associated factor 3, Isoform 2",13206,139,0.92 [0.59-1.44],0.7306164365359757
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,13163,138,0.93 [0.65-1.33],0.6881554942886791
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,13310,143,1.13 [0.95-1.35],0.1777800158079272
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREH,Trehalase,13569,142,1.00 [0.81-1.24],0.9664921484577754
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREM2,Triggering receptor expressed on myeloid cells 2,15640,155,1.19 [0.91-1.55],0.2117999631161482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML1,Trem-like transcript 1 protein,13597,143,1.01 [0.74-1.36],0.97383382345045
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML2,Trem-like transcript 2 protein,15634,160,1.23 [0.81-1.88],0.3290225567516694
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIAP1,TP53-regulated inhibitor of apoptosis 1,15780,157,1.09 [0.88-1.36],0.4240288441744603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM21,E3 ubiquitin-protein ligase TRIM21,15623,160,1.05 [0.87-1.26],0.6117334918408974
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM24,Transcription intermediary factor 1-alpha,13283,143,1.18 [0.95-1.48],0.131753240442365
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,13524,142,0.99 [0.86-1.15],0.918244141072562
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM26,Tripartite motif-containing protein 26,13103,139,1.07 [0.82-1.40],0.6001580888997892
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM40,E3 ubiquitin ligase TRIM40,13194,139,1.14 [0.92-1.41],0.2389341567315782
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM5,Tripartite motif-containing protein 5,15623,160,0.93 [0.79-1.10],0.4159523497739817
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRIM58,E3 ubiquitin-protein ligase TRIM58,13509,145,1.03 [0.86-1.24],0.7643394749670285
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TRPV3,Transient receptor potential cation channel subfamily V member 3,13163,138,1.01 [0.73-1.38],0.9749690850911024
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSC1,Hamartin,13206,139,1.04 [0.86-1.26],0.690634186208849
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSC22D1,TSC22 domain family protein 1,13571,143,1.13 [0.90-1.41],0.2826621960095195
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSHB,Thyrotropin subunit beta,15635,156,0.84 [0.71-1.00],0.0483301945153299
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSLP,Thymic stromal lymphopoietin,15372,156,1.00 [0.79-1.27],0.9829592943873776
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSNAX,Translin-associated protein X,13163,138,0.92 [0.61-1.39],0.694994137557573
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN1,Tetraspanin-1,15372,156,0.90 [0.56-1.44],0.6485583699165289
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN15,Tetraspanin-15,13163,138,0.77 [0.53-1.12],0.1776835579602753
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN7,Tetraspanin-7,13169,137,1.07 [0.91-1.26],0.4189300646785905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPAN8,Tetraspanin-8,13524,142,0.90 [0.77-1.06],0.206091180900227
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TSPYL1,Testis-specific Y-encoded-like protein 1,13206,139,1.19 [0.81-1.74],0.3775729490589252
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TST,Thiosulfate sulfurtransferase,15228,155,1.07 [0.89-1.29],0.4629431390484707
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTF2,Transcription termination factor 2,13194,139,1.09 [0.79-1.51],0.6058807248861579
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTN,Titin,13163,138,1.09 [0.88-1.35],0.4127039289632304
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TTR,Transthyretin,13460,139,1.24 [0.66-2.34],0.50531439585
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TUBB3,Tubulin beta-3 chain,13169,137,0.64 [0.35-1.17],0.1494395813922157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TWF2,Twinfilin-2,13569,142,1.04 [0.86-1.26],0.6746930356717603
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXK,Tyrosine-protein kinase TXK,13310,143,1.01 [0.82-1.24],0.952754165625904
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXLNA,Alpha-taxilin,15529,157,1.03 [0.88-1.20],0.7506742265466934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXN,Thioredoxin,13361,141,0.89 [0.61-1.30],0.5416594538564006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC15,Thioredoxin domain-containing protein 15,15681,158,0.77 [0.46-1.28],0.309887007196257
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC5,Thioredoxin domain-containing protein 5,15780,160,1.07 [0.87-1.31],0.5310812104503846
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNDC9,Thioredoxin domain-containing protein 9,13545,141,1.19 [0.89-1.58],0.2373697503495048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNL1,Thioredoxin-like protein 1,13142,137,1.06 [0.91-1.24],0.4543251704957634
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",15634,160,1.08 [0.81-1.46],0.592371864901873
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYMP,Thymidine phosphorylase,15540,155,0.98 [0.80-1.21],0.8680405526934265
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYRO3,Tyrosine-protein kinase receptor TYRO3,15635,156,1.43 [0.87-2.35],0.1577844722341917
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",13206,139,1.29 [0.98-1.71],0.0708125196731783
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBAC1,Ubiquitin-associated domain-containing protein 1,15572,159,0.82 [0.55-1.21],0.3094564176739809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2B,Ubiquitin-conjugating enzyme E2 B,13509,145,0.72 [0.41-1.27],0.2602811500151787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,13588,144,1.02 [0.79-1.32],0.8746415115795982
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,13206,139,1.22 [0.97-1.53],0.0909528469256488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBQLN3,Ubiquilin-3,13163,138,0.86 [0.57-1.30],0.4762564298106885
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UBXN1,UBX domain-containing protein 1,13289,138,1.06 [0.84-1.34],0.631955618487623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,13524,142,1.07 [0.95-1.20],0.2557268723189654
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UGDH,UDP-glucose 6-dehydrogenase,13163,138,1.12 [0.98-1.28],0.0871790423420635
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UHRF2,E3 ubiquitin-protein ligase UHRF2,13163,138,0.79 [0.47-1.34],0.3829287803756135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ULBP2,UL16-binding protein 2,15529,157,1.14 [0.78-1.67],0.4966195824727359
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UMOD,Uromodulin,15785,160,0.77 [0.60-0.98],0.0359034457761835
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNC5D,Netrin receptor UNC5D,13206,139,1.54 [0.92-2.57],0.0980283929839347
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNC79,Protein unc-79 homolog,13103,139,0.89 [0.66-1.21],0.4637647622521514
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UNG,Uracil-DNA glycosylase,13509,145,0.83 [0.51-1.34],0.4400199456182621
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPB1,Beta-ureidopropionase,13588,144,1.11 [0.94-1.30],0.2328831869497197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3A,Uroplakin-3a,13169,137,1.44 [1.10-1.89],0.0081852967531827
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3BL1,Uroplakin-3b-like protein 1,13292,143,0.98 [0.73-1.32],0.9142677645431212
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UROD,Uroporphyrinogen decarboxylase,13289,138,0.99 [0.79-1.24],0.9217862091343324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UROS,Uroporphyrinogen-III synthase,13194,139,1.04 [0.83-1.30],0.7183484536281208
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USO1,General vesicular transport factor p115,15572,159,0.98 [0.84-1.15],0.8197647942529802
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP25,Ubiquitin carboxyl-terminal hydrolase 25,13509,145,1.04 [0.84-1.29],0.7248639502370133
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP28,Ubiquitin carboxyl-terminal hydrolase 28,13545,141,0.75 [0.46-1.23],0.2558322021851053
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP47,Ubiquitin carboxyl-terminal hydrolase 47,13163,138,0.95 [0.78-1.16],0.6041458407886617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",USP8,Ubiquitin carboxyl-terminal hydrolase 8,15372,156,1.02 [0.88-1.18],0.7546581451942077
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UXS1,UDP-glucuronic acid decarboxylase 1,15268,155,0.85 [0.64-1.11],0.2341713970218122
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAMP5,Vesicle-associated membrane protein 5,15372,156,1.03 [0.80-1.32],0.8420570757918155
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAMP8,Vesicle-associated membrane protein 8,13206,139,1.00 [0.83-1.20],0.9953235130505784
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASH1,Tubulinyl-Tyr carboxypeptidase 1,15623,160,1.04 [0.88-1.23],0.6690361538605905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASN,Vasorin,15365,152,1.65 [0.99-2.76],0.0547277002642814
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VASP,Vasodilator-stimulated phosphoprotein,13597,143,1.02 [0.82-1.28],0.8314206334811545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,15572,159,0.84 [0.42-1.69],0.6290000386755592
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VAV3,Guanine nucleotide exchange factor VAV3,13169,137,0.99 [0.84-1.16],0.860001202213312
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCAM1,Vascular cell adhesion protein 1,15650,155,0.86 [0.50-1.46],0.5697551012451101
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCAN,Versican core protein,15780,160,1.06 [0.67-1.69],0.8020851212129672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VCPKMT,Protein-lysine methyltransferase METTL21D,13103,139,1.11 [0.95-1.30],0.1886777301318617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFA,Vascular endothelial growth factor A,15759,160,1.33 [1.07-1.67],0.0116478208639342
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFB,Vascular endothelial growth factor B,13206,139,1.31 [0.74-2.31],0.3560452732864809
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFC,Vascular endothelial growth factor C,15681,158,1.14 [0.89-1.46],0.3079573239501768
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VEGFD,Vascular endothelial growth factor D,15785,160,1.05 [0.69-1.59],0.8256226612139752
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VGF,Neurosecretory protein VGF,13571,143,1.04 [0.61-1.78],0.8823003689481466
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIM,Vimentin,15372,156,0.97 [0.86-1.09],0.5888089562262431
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIPR1,Vasoactive intestinal polypeptide receptor 1,13218,134,0.56 [0.27-1.16],0.1189699495413623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIT,Vitrin,13588,144,1.28 [0.83-1.98],0.2644103019031164
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VMO1,Vitelline membrane outer layer protein 1 homolog,15572,159,1.08 [0.87-1.34],0.4993448440630967
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VNN1,Pantetheinase,13597,143,1.21 [0.96-1.51],0.1001775617068298
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VNN2,Vascular non-inflammatory molecule 2,15572,159,1.01 [0.74-1.37],0.9477606533953934
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS28,Vacuolar protein sorting-associated protein 28 homolog,13310,143,1.10 [0.87-1.38],0.4397603244331384
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS37A,Vacuolar protein sorting-associated protein 37A,15572,159,0.94 [0.79-1.13],0.5161670238103704
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS4B,Vacuolar protein sorting-associated protein 4B,13509,145,1.07 [0.91-1.26],0.4193522100869591
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VPS53,Vacuolar protein sorting-associated protein 53 homolog,15572,159,0.97 [0.80-1.16],0.7103974422792685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG10,V-set and immunoglobulin domain-containing protein 10,13509,145,1.01 [0.66-1.53],0.9731870175828548
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,13163,138,0.95 [0.58-1.56],0.8361970423414761
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG2,V-set and immunoglobulin domain-containing protein 2,13509,145,1.39 [1.07-1.80],0.0145076276480008
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIG4,V-set and immunoglobulin domain-containing protein 4,15610,160,1.38 [0.96-1.97],0.0795877725066625
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,15615,156,1.08 [0.86-1.35],0.4999469558865297
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSNL1,Visinin-like protein 1,13545,141,1.56 [1.08-2.25],0.0185265606413729
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM1,V-set and transmembrane domain-containing protein 1,15248,155,0.84 [0.62-1.14],0.2622612807704604
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM2B,V-set and transmembrane domain-containing protein 2B,13310,143,1.08 [0.76-1.53],0.6852623819343427
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,15372,156,0.98 [0.76-1.26],0.8811990038004762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,15780,160,0.98 [0.81-1.18],0.8150554880605781
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTCN1,V-set domain-containing T-cell activation inhibitor 1,15268,155,0.89 [0.57-1.37],0.5859427664685394
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,13289,138,0.96 [0.73-1.27],0.7850040218595682
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWA1,von Willebrand factor A domain-containing protein 1,15757,157,1.17 [0.85-1.62],0.3381987484298409
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWA5A,von Willebrand factor A domain-containing protein 5A,13103,139,1.11 [0.94-1.31],0.2232996999093197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWC2,Brorin,15472,157,1.30 [0.90-1.88],0.1656538527730324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWC2L,von Willebrand factor C domain-containing protein 2-like,13571,143,0.89 [0.62-1.28],0.5184259437952699
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VWF,von Willebrand factor,15834,160,0.99 [0.82-1.19],0.8903723170846143
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WARS,"Tryptophan--tRNA ligase, cytoplasmic",15634,160,1.31 [0.90-1.90],0.1583729104819201
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WAS,Wiskott-Aldrich syndrome protein,15330,154,1.04 [0.85-1.28],0.7105124787587869
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASF1,Wiskott-Aldrich syndrome protein family member 1,15372,156,0.98 [0.84-1.15],0.8447435780503163
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASF3,Wiskott-Aldrich syndrome protein family member 3,15248,155,0.99 [0.83-1.17],0.8732833784946288
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASHC3,WASH complex subunit 3,13545,141,0.95 [0.77-1.18],0.662734889368064
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WASL,Neural Wiskott-Aldrich syndrome protein,13206,139,1.03 [0.80-1.33],0.7972636572592293
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WDR46,WD repeat-containing protein 46,13509,145,0.76 [0.48-1.22],0.2554623373317135
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC1,WAP four-disulfide core domain protein 1,13254,145,1.16 [0.90-1.51],0.2515826374648082
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC12,WAP four-disulfide core domain protein 12,15757,157,0.99 [0.80-1.23],0.9332354646241924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFDC2,WAP four-disulfide core domain protein 2,14822,151,1.02 [0.68-1.52],0.9279681958392574
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",15484,157,0.82 [0.58-1.17],0.2818459110731685
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",15669,156,1.02 [0.68-1.54],0.9299284298381584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WIF1,Wnt inhibitory factor 1,15780,157,1.28 [0.85-1.92],0.2349369919021924
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WNT9A,Protein Wnt-9a,15330,154,1.19 [0.73-1.94],0.4744606519179476
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,15529,157,1.01 [0.78-1.31],0.932060200566618
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XCL1,Lymphotactin,15780,157,0.99 [0.77-1.27],0.9234091661197718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XG,Glycoprotein Xg,15750,159,1.32 [0.82-2.12],0.2574951455803385
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XIAP,E3 ubiquitin-protein ligase XIAP,13206,139,0.95 [0.72-1.26],0.731237530831749
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XPNPEP2,Xaa-Pro aminopeptidase 2,15681,158,0.99 [0.84-1.15],0.8507993786689187
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",XRCC4,DNA repair protein XRCC4,15248,155,1.10 [0.75-1.60],0.6244457200289019
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YAP1,Transcriptional coactivator YAP1,13545,141,1.70 [0.96-3.02],0.069361401504422
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",13524,142,1.02 [0.91-1.13],0.7520992720869198
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YES1,Tyrosine-protein kinase Yes,15572,159,1.01 [0.89-1.14],0.858489336736806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YJU2,Splicing factor YJU2,13509,145,0.99 [0.60-1.61],0.958590375256454
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YOD1,Ubiquitin thioesterase OTU1,13163,138,1.00 [0.77-1.29],0.984854490783371
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YTHDF3,YTH domain-containing family protein 3,15330,154,1.10 [0.93-1.30],0.2825429327403602
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YWHAQ,14-3-3 protein theta,13289,138,1.01 [0.81-1.26],0.9600835610256788
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YY1,Transcriptional repressor protein YY1,13206,139,0.94 [0.52-1.70],0.8364427367454532
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBP1,Z-DNA-binding protein 1,13206,139,1.06 [0.73-1.54],0.7432823703356177
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB16,Zinc finger and BTB domain-containing protein 16,15268,155,1.05 [0.85-1.28],0.6553351156011156
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB17,Zinc finger and BTB domain-containing protein 17,15372,156,1.13 [0.82-1.55],0.4610086836822374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZCCHC8,Zinc finger CCHC domain-containing protein 8,13163,138,0.77 [0.56-1.06],0.1051100856752165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZFYVE19,Abscission/NoCut checkpoint regulator,13524,142,1.08 [0.90-1.28],0.4107160200746755
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZHX2,Zinc fingers and homeoboxes protein 2,13545,141,0.93 [0.57-1.53],0.7847942880047015
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF174,Zinc finger protein 174,13206,139,0.85 [0.53-1.36],0.5034408756962613
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF75D,Zinc finger protein 75D,13310,143,0.91 [0.69-1.21],0.519234504102112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNF830,Zinc finger protein 830,13509,145,1.02 [0.85-1.23],0.8229079750904773
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNRD2,Protein ZNRD2,13524,142,0.97 [0.76-1.23],0.7801278025672287
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,13509,145,1.04 [0.78-1.38],0.7961179901117954
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZP3,Zona pellucida sperm-binding protein 3,13218,134,0.92 [0.87-0.98],0.0123954006700516
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZP4,Zona pellucida sperm-binding protein 4,13103,139,0.94 [0.57-1.55],0.8161729761138399
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZPR1,Zinc finger protein ZPR1,13169,137,1.08 [0.92-1.25],0.3591123932139705
